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Chapter 1
THE PATHOGENESIS OF NOSOCOMIAL PNEUMONIA IN MECHANICALLY
VENTILATED PATIENTS
Patterns of colonization leading to pneumonia
Chapter 1
INTRODUCTION
Among mechanically ventilated patients pneumonia is an important infection
associated with increased morbidity and mortality (1-6). Due to its association with
mechanical ventilation this infection has also been called Ventilator Associated
Pneumonia (VAP), although this falsely suggests a predominant causative role of
the ventilator in the pathogenesis. Many studies elucidating pathogenic pathways,
therapeutic options, prevention and accurate diagnosis of VAP have been
performed over the last twenty years. The pathogens causing VAP have been
assumed to be from endogenous origin, and current hypothesis suggests that the
gastropulmonary route of colonization is of main importance in the pathogenesis
of VAP (7,8). The gastropulmonary route assumes that enteric microorganisms
colonize the stomach, migrate to the oropharynx and eventually reach the lungs
of mechanically ventilated patients by aspiration. The purpose of this review is to
critically assess the evidence for the existence and the importance of the
gastropulmonary route of colonization and infection in mechanically ventilated
patients. Although the gastropulmonary route has been assumed to be of main
importance, other routes of colonization, like exogenous colonization and the
rectopulmonary route, may also lead to the development of VAP. The possible
role of these routes will be discussed as well.
wiorfa//'fy
Incidences of VAP among ICU-patients ranged between 7% and 85%, depending
on the severity of illness of patients studied as well as on the diagnostic modalities
and criteria used to establish the diagnosis (9-13). In most studies the diagnosis of
VAP was based on a combination of nonspecific clinical criteria such as fever,
leucocytosis, cultures of trachéal aspirates and infiltrates on chest radiograph.
However, recent studies clearly demonstrate that these criteria are unreliable for
diagnosing VAP, because they do not enable us to distinguish between
colonization and infection of the lower respiratory tract (1,14,15). Bronchoscopic
techniques to obtain uncontaminated samples from the distal airways in
combination with quantitative culture techniques are nowadays recommended to
diagnose VAP and studies, using these techniques, are needed to establish the true
incidence of this infection (16). The problems in diagnosing VAP will be discussed
in more detail in chapter 3.
Clear associations between the incidence of VAP and increased mortality have
been reported (3,5,10), but it remains uncertain whether a patient succumbs due to
VAP or whether the infection is merely a marker of the patients' physical
deterioration eventually leading to death. In keeping with the former a
retrospective case-control study recently demonstrated an attributable mortality
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risk ratio of VAP of 2.0, and even 2.5 when VAP was caused by Pseudomonas spp.
or Acinetobacter spp., and a mean excess of 20 days in ICU stay for surviving
patients as compared to unaffected controls (6).
Efio/ogy o/ W1P
In most cases VAP is caused by enteric Gram-negative bacteria. In the National
Nosocomial Infection Study (NNIS), performed between 1985 and 1988 in the
United States, 58.7% of the cases were associated with Gram-negative bacteria,
especially Pseudomonas aer«gi;iosa (17.2%), Enterobacter species (10.4%), and
K/ebs/e//a pneumonia? (7.4%) (17). Percentages comparable to those observed in
this large multicenter study were reported by many single hospital studies
(2,3,10,18). Sfap/iy/ococcus a«reus is, after Psewdomonas aerugi/josa, the second
most frequent pathogen causing VAP: 14.6% of all cases in the NNIS-study and
56% of all cases among multiple trauma patients in coma (11). However, it must
be stated that in many cases these percentages were derived from studies not using
bronchoscopic techniques to diagnose VAP. Therefore, the real incidence of this
infection may be lower when diagnosed more accurately.
Because bacteria such as Enterobacteriaceae, Pseudomonas spp. and Sfap/iy/ococcus
o«re«s are known to cause serious infections under certain circumstances they are
grouped together and labelled as potentially pathogenic microorganisms (ppmo).
PATHOGENESIS
In infectious diseases the pathogenic pathway consists of three entities: The source
of pathogenic microorganisms (a), from where microorganisms reach the porte
d'entrée (b) via a certain route (c). In the human body the intestine is the most
important source of bacteria. However, other body cavities, that do not contain
ppmo under physiological circumstances, may be colonized under pathologic
conditions, and serve as reservoirs of bacteria. In case of pneumonia the distal
airways are the porte d'entrée. In theory, the source of microorganisms can be
situated within the patient (the intestine; an endogenous source) or anywhere in
its surroundings (an exogenous source). Although the oropharynx is not a sterile
cavity, it is usually colonized with anaerobes and Gram-positive cocci, labelled as
normal oropharyngeal flora. These bacteria are definitely able to cause
pneumonia, although they seldomly cause VAP (17). In addition, the trachea and
stomach do not harbor ppmo under physiologic circumstances, and may,
therefore, not be considered as likely sources of microorganisms causing VAP,
although colonization at these sites occurs frequently before the onset of VAP (19-
21). Important exogenous sources are contaminated mechanical equipment,
enterai feedings, or other patients in the ICU.
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The exact route of colonization has been the subject of much debate.
Microorganisms may reach the distal airways after colonization of the trachea, the
oropharynx, the stomach or the small and large intestine. In all cases, the source of
bacteria may have been either endogenous or exogenous (Figure 1). For instance,
intestinal bacteria may reach the lungs via the stomach, the oropharynx and the
trachea, but may also colonize the trachea directly via hands of nurses after contact
with colonized skin or perineum. The importance of the different routes of
colonization and the sources of microorganisms will be discussed in detail below.
ENDOGENOUS
SOURCES
EXOGENOUS
SOURCES
STOMACH
OROPHARYNX INTESTINE
TRACHEA
VAP
1: Bacteria/ sources and routes /eading lo Venfi/ofor Associated Pneumonia
Co/onizafion o/ ffce upper respiratory
Colonization of the upper respiratory tract (i.e. oropharynx and trachea) by ppmo
is common among critically ill patients on mechanical ventilation. Reported
percentages of patients colonized ranged from 16% in moderately ill patients
(19,20) to 57% in critically ill patients and even 100% in those with long-term
intubation (22,23). Although a substantial percentage of patients might enter the
ICU at a stage where they are already colonized, many patients acquire
colonization during their stay in ICU (20,22). There is no doubt about the
relationship between colonization of the upper respiratory tract and development
of VAP. Johanson et al demonstrated twenty years ago how 23% of colonized ICU-
patients developed nosocomial respiratory infections as compared to only 3% of
noncolonized patients (20). Bacteria reach the lungs after aspiration of
oropharyngeal fluid containing colonizing bacteria, an event that has been
demonstrated to occur frequently in critically ill patients (24). Factors associated
12
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with increased colonization of the respiratory tract in ICU-patients have been
listed in Table 1.
Tab/e 2: Factors associated u>i7/i increased co/oiiizad'on and in/ec/ion o/ //ie respiratory /racf in JCU-
palienfs:
Factor Reference
Sysfemic
Underlying disease
COPD
Thoracoabdominal surgery
Malnourishment/depletion
Depressed consciousness
Intracranial pressure monitoring
Fall-winter season
Age (>70)
Upper respiratory (racf
Nasogastric tube
Size of the NG-tube
Intubation
Reintubation
Mechanical ventilation
Duration of MV
PEEP
Tracheostomy
Viral infection
Sfomacft
Position of the patient
Stress ulcer prophylaxis
^-antagonists
Antacids
Enterai feeding
Gastric aspiration
1,5
5
28
5
3
3
5
5
52
27
1
1
1
27
24
3,12,42-45
12,41
50
1,5,24
Reason /or increased co/om'zah'on
Increased colonization of the upper respiratory tract could either be a result of
increased exposure to ppmo, or of a diminished capacity to clear such organisms
from the upper respiratory tract or both. Extensive exposure of the upper
respiratory tract to ppmo only does not seem to be an adequate explanation for the
increased colonization rates observed in these patients. Indeed, members of the
medical and nursing staff, working in the same environment, rarely become
13
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colonized with ppmo and massive exposure of normal subjects to ppmo does not
lead to colonization of the upper respiratory tract (25,26). Therefore, defective
clearance mechanisms are more likely to account for the increased colonization
rates of the upper respiratory tract in critically ill patients.
An increased cell binding capacity of trachéal epithelial cells probably is an
essential step in the pathogenesis of colonization, as schematically depicted in
Figure 2. Both decreased immunologie functions of the host and destruction of the
integrity of the epithelium, leading to exposure of the underlying connective
tissue, have been shown to increase the cell binding capacity (27,28). The first
occurrence of colonization initiates a vicious cycle, facilitating colonization with
other bacteria. For instance, bacteria such as Psewdomonas aerug/nosa,
Haemop/iz'/HS /«//wenzfle or Gram-positive bacteria, may impair mucociliary
clearance or produce pro-inflammatory enzymes, such as elastase, which can
degrade IgA (29). In addition, colonization can be stimulated by the production of
proteases which results in loss of fibronectin from the epithelial surface (30).
Besides a risk factor for development of VAP, colonization of the upper
respiratory tract may, therefore, also be a marker for critically ill patients who have
multiple deficiencies in the host defense system of their respiratory tract (28).
THE GASTROPULMONARY ROUTE
In the etiology of VAP enteric Gram-negative bacteria form the largest group of
pathogens. The question is how these microorganisms, originally colonizing the
intestine, reach the upper respiratory tract. Since gastric colonization with these
bacteria is a common finding in critically ill patients (21,23,31,32), colonization at
this site has been presumed to have an etiologic role in the development of VAP
(the gastropulmonary route of colonization). The putative role of the stomach as a
reservoir for microorganisms causing VAP was based on correlations between the
occurrence of VAP and simultaneous or preceding gastric colonization with the
same bacterial species (31,33). However, a definite proof of the existence of the
gastropulmonary route would need accurate monitoring of colonization in the
stomach and the upper respiratory tract over time. Moreover, a reliable diagnosis
of VAP by isolation of the pathogens from the distal airways would be needed and
similarity of the bacteria that cause VAP and previously colonized the stomach
should be proven biochemically. Up till now, no such studies have been
published.
14
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Figure 2: Pflf/iogenesis 0/ bacfena/ co/oniza/ion 0/ f/ie upper respiratory rracf
Despite the lack of definite proof many researchers felt that there was compelling
evidence for the importance of the gastropulmonary route of colonization. For
instance, Daschner et al studied the pH of gastric aspirates together with bacterial
counts in gastric fluid and trachéal secretions in 142 mechanically ventilated 1CU-
patients (23). When isolates from both samples were identical, they were typed by
agglutination, bacteriocin or phage typing. Bacterial counts, especially for Gram-
negative organisms, increased with rising gastric pH. In 31.6% of all patients
identical bacterial species were first isolated from gastric aspirate and subsequently
from trachéal secretions. The incidence of VAP was correlated with gastric pH,
being 40.6% when gastric pH was below 3.4 and 69.2% when gastric pH was above
5.0 (23). However, the high incidences of VAP might have been an overestimation
as no bronchoscopic techniques were used to establish the diagnosis accurately.
Moreover, gastric acidity was measured incidentally with pH papers, a method
which has been criticized extensively (34,35). Computerized continuous
intragastric pH monitoring probably is a more reliable method to study intragastric
acidity (36) (chapter 8).
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Inglis et al also demonstrated that bacteria colonizing the stomach can eventually
colonize the tracheobronchial tree (37). In this study only bacterial isolates with the
same plasmid and biochemical profile, antibiotic resistance pattern and repetitive
extragenic palindromic sequences were considered to be identical. However, as a
chronological pattern of colonization from the stomach to the tracheobronchial
tree was demonstrated in only six out of 100 ICU-patients, according to this study
the gastropulmonary route would be of little importance in mechanically
ventilated ICU-patients. Moreover, since isolation of bacteria from trachéal
aspirates was used as an endpoint, the importance of this route for VAP would
even be lower (37). Other studies also cast doubt on the role of the stomach as a
source for bacteria causing VAP. Reusser et al studied the role of gastric
colonization and infections in 40 neurosurgical patients (38). Fifteen patients
developed VAP but the stomach was the evident source of the causative agent in
only one case (38). In another study 67 out of 100 mechanically ventilated ICU-
patients developed gastric microbial colonization. Nasopharyngeal colonization
occurred in 33 patients, which in only eight cases was preceded by gastric
colonization (39).
Although gastric and tracheobronchial colonization are common in mechanically
ventilated patients, the sequence of colonization and the role of the stomach as a
source of bacteria causing VAP in this patient population have not yet been firmly
established and need further study (chapter 9 and chapter 10).
In the studies mentioned above evidence for a causal relationship between gastric
colonization and VAP was derived mainly from observations of coincidental
colonization at both sites. The alleged importance of the gastropulmonary route
would be further supported if modulation of gastric colonization indeed changed
the incidence of VAP. In this respect, several regimens have been developed to
decrease gastric bacterial colonization as a preventive measure for the
development of VAP. The three topics receiving the most attention (i.e. stress
ulcer prophylaxis, selective decontamination of the digestive tract and modulation
of enterai feeding) will be discussed below in more detail.
Stress u/cer
In physiologic circumstances gastric acidity serves as a very adequate protection
against bacterial growth. However, among critically ill patients who need
mechanical ventilation, gastric acidity may be reduced due to stress ulcer
prophylaxis. Antacids, for instance, neutralize gastric acid whereas ^-antagonists
decrease acid production. In contrast, sucralfate has been claimed to prevent stress
ulcers without altering gastric acidity (40). Theoretically, therefore, patients
receiving sucralfate should have lower intragastric pH values as compared to
patients receiving antacids or ^-antagonists, and, as a result, gastric colonization
16
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and VAP should develop with a lower frequency in sucralfate-treated patients.
The effects of sucralfate and 'acid-reducing' agents on the incidence of VAP has
been addressed by several investigators (Table 2) (12,41-45). Although four studies
demonstrated lower incidences of VAP in patients receiving sucralfate as
compared to patients receiving antacids and /or ^-antagonists (12,41,43,45), the
results of these studies, in our view, are still not conclusive. Criticisms regarding
these studies include the facts that no bronchoscopy was applied to accurately
diagnose VAP and that the studies were neither double-blind nor placebo-
controlled (12,41-45). Moreover, measurements of gastric pH were performed
incidentally, and in most studies with pH papers. The reliability of the latter has
been criticized (34,35) and temporary changes of gastric pH cannot be measured
(46). Furthermore, none of the studies provided microbiological data that prove
the identity of bacterial strains colonizing the stomach and eventually causing
VAP.
The most important objection, however is, that although significant differences in
pH-values were demonstrated in all studies, mean gastric pH values were always
above 4.25, both in patients receiving sucralfate and in patients receiving antacids
and /or ^-antagonists. It is, indeed, questionable whether differences in pH-
values above 4.0 have any influence on bacterial growth (12,41-45). Similar to the
analyses of pH-measurements, the observed incidences of VAP, determined in
five studies, are subject to discussion (12,41,43-45). No significant differences
between patients receiving sucralfate and those receiving other prophylactic agents
were observed in three studies (12,43,44), although the differences bordered on
significance in two of these (12,43). In the study of Driks et al significance was
reached when crossover patients were excluded from analysis (12). Despite the
methodological drawbacks, a meta-analysis of these studies demonstrated a
significantly lower incidence of VAP among patients receiving sucralfate as
compared to patients receiving antacids or ^-antagonists (47).
In summary, an association between lower gastric pH-values and a lower
incidence of VAP was demonstrated in only two out of five studies (41,45), the
interpretation of which is seriously hampered because of methodological
problems. Therefore, it remains difficult to see that small differences in mean
gastric pH values can explain the observed differences in VAP. Alternatively, a
bactericidal effect of sucralfate might be an explanation, but this effect has only
been demonstrated in vitro (48,49) and its relevance in vivo remains to be
established. Therefore, a double-blind placebo-controlled study comparing
sucralfate and antacids or ^-antagonist, and using continuous gastric pH-
measurement and bronchoscopic techniques to diagnose VAP is warranted
(chapter 10).
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TiiWe 2: Studies on (he in/Kuence 0/ sucra//are as compared to acid reduced agents 011 i/itragastric acidify and (he incidence 0/ VMP in
mec«anica//y uenti/afed /CU patients
Author:
Design:
prose pctive:
randomized:
Population:
Numbers of patients:
Sucralfate:
dosage:
Controls I:
agent:
dosage:
Controls II:
agent:
dosage:
pH (critical point)
Proportion (in %)
Sucralfate:
Control I:
Control II:
p-value:
Mean pH
Sucralfate:
Control I:
Control II:
p-value:
Incidence of VAP (in %):
Sucralfate:
Control I:
Control II:
p-value:
Driks '87
mixed
61
lgq.6h
69
AA and/or Hj-A
10 ml q.2h
<4.0
47.9
25.3
9.4
<0.001
Tryba '87
surgical
50
lgq.4h
50
AA
6x50-100 mg/d
5.4.0
46.5
10.4
<0.01
Laggner'88 Kappstein '91
11.5
23.2
28.1
0.11
10.3 (3/29) '
34.4(11/32)
<0.05
mixed
41
lgq.4h
43
Ranitidine
2000; 3x400 mg/d
<3.5
47.0
25.8
<0.05
mixed
49
lgq.6h
55
Cimetidine
6x20-40 ml
4.34
4.85
5.06
0.044
26.5
45.5
0.0549
Simms '91
surgical
30
1 gq.i.d.
37
AA
4x50 mg/d
32
Cimetidine
6x900-1200 mg
<4.0
20.0
11.1
n.s
4.73
5.55
0.006 (S vs I)
0.07 (S vs II)
26.7
29.6
Eddleston '91
mixed
21
lgq.6h
17
Ranitidine
4.26
5.50
<0.01
10.3
35.7
<0.01
AA = Antacids; H2-A = Hj-antagonist; ' 39 patients were withdrawn because of thoracic trauma or pneumonia on admission
Pathogenesis
Entera/ /
If administration of enterai feeding would be a risk factor for VAP, it would
certainly strengthen the hypothesis of the stomach being an important reservoir
for bacteria causing this infection. The suggested mechanism would be that enterai
feeding promotes gastric bacterial growth due to dilutional alkalinization of gastric
contents and to aspiration of an increased gastric volume. Although increased
bacterial colonization of gastric contents following enterai feeding has, indeed,
been found (50,51), it remains unclear whether this is a result of reduced gastric
acidity. Pingleton et al (50) reported on 18 patients with gastric bacterial
colonization during enterai feeding. However, 14 of these patients (78%) were
already colonized before enterai feeding was started and the mean gastric pH (5.7
without enterai feeding) did not increase after institution of enterai feeding.
Although colonization appeared to proceed from the stomach to the trachea in
five patients, a route from the trachea or oropharynx to the stomach was found
with equal frequency. Moreover, the identity of the bacteria isolated from gastric
contents and of those causing pneumonia, which occurred in 11 patients (68%),
was not studied (50).
Torres et al demonstrated in mechanically ventilated patients that pulmonary
aspiration of gastric fluid depends on the body position of the patient (24). In
addition, Ibanez et al demonstrated gastroesophageal reflux in 37 out 50 intubated
patients (74%) with nasogastric tubes as opposed to seven out of 20 patients, of
whom 12 were studied in supine position, without a nasogastric tube (p<0.05) (52).
They concluded that the presence of a nasogastric tube is the most important risk
factor for gastroesophageal reflux and that this cannot be prevented by placing the
patient in a semirecumbent position (52). In both studies radioactive labelled
enterai feedings were used to measure reflux (24,52).
The combination of enhanced gastric colonization, increased aspiration of gastric
contents, possibly due to enterai feeding, and higher incidences of VAP would
support the view that stresses the importance of the gastropulmonary route in the
pathogenesis of VAP. However, neither the correlation between administration of
enterai feeding and increased aspiration nor that between any of these and an
increased incidence of VAP have yet been firmly established. In most ICU's enterai
feeding is only instituted when bowel movements are present. If the stomach
indeed is an important reservoir for bacteria causing VAP, then patients with
massive gastrointestinal fluid retention would be at high risk for VAP. However,
to the best of our knowledge, no data are available on this aspect. Therefore, the
relation between enterai feeding and gastric colonization needs further study
(chapter 6 and chapter 10).
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Se/ecfiue Decowfam/Mflf/OM 0/ Me Digesfiw rraci
Selective decontamination of the digestive tract (SDD) has been used to decrease
the incidence of VAP (13,53-57). With this method of infection prevention
antimicrobial activity was established simultaneously in the intestine, the
stomach, the oropharynx, systemically and probably also in the tracheobronchial
tree (58). Therefore, it remains elusive to what extent each component contributed
to the effect of SDD. As a result, a lower incidence of VAP in patients treated with
SDD neither proved the importance of the gastropulmonary route of colonization
nor that of the intestine as a source for bacteria causing VAP. There are even two
reasons to assume that studies using SDD suggested the opposite. The first is that
in two studies selective decontamination of the stomach and the intestine
exclusively had no influence on infection rates (59,60). Secondly, in two other
studies a reduction of VAP was established with application of antibiotics to the
oropharynx only, without decontamination of the stomach and the intestine
(61,62). Thus, evidence for a pathogenetic role of the stomach and the intestine in
the colonization and infection of the upper respiratory tract is far from conclusive
(chapter 5). The benefits of selective decontamination of the digestive tract as
method of infection prevention in mechanically ventilated ICU-patients will be
reviewed in chapter 2.
THE RECTOPULMONARY ROUTE
When the role of the stomach as a source of microorganisms causing VAP is not
as important as generally assumed, it may be that the importance of other routes
has been underestimated. For instance, from the large intestine, the most
abundant source of Gram-negative bacteria, microorganisms may spread to the
skin of the patient or the nursing personnel and subsequently to the upper
respiratory tract of the patient. However, this rectopulmonary route of
colonization has not been studied extensively, and only three studies have
demonstrated the relevance of rectal colonization with PseMdomowas aerugiwosa
in ICU-patients.
In one study the rectum was the most common primary site of colonization of
Psewdomonas fler«^i«osa among surgical ICU-patients (63), and in another study
colonization with this species was more frequently demonstrated in the rectum
than in the oropharynx (64). Moreover, in those patients colonized at both sites,
rectal colonization occurred first (64). Finally, rectal colonization with
PseudomoMas aerugmosa was demonstrated to occur more frequently than
trachéal colonization, although rectal strains did not appear in trachéal secretions
later (65). Unfortunately, in these studies colonization was studied at two sites
20 ' •
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only, so a particular sequence of colonization could not be determined with
confidence. Comparable observations were made for Enterobacter spp. During a
study on cefazolin prophylaxis, 58 out of 87 cardiac surgery patients became
colonized with Enterobacter species in the throat, rectum, groin or sternal area
(66). Because Enterobacter spp. were isolated prior to admission from 28 patients,
and colonization was most frequently demonstrated in the rectum first, the
patients' endogenous flora probably was the main source (66). Moreover, only
nine cases of horizontal transmission occurred and bacterial typing showed 50
distinct strains of Enterobacter (66). Among patients undergoing cardiothoracic
surgery groin flora was found to be the source of bacteria causing mediastinal
infections following transfer on contaminated saphenous vein grafts or by the
hands of surgeons after harvesting the vein (67).
As for the gastropulmonary route, accurate monitoring of colonization is needed
to establish the real importance of the rectopulmonary route of colonization.
EXOGENOUS SOURCES
Many reports described outbreaks of nosocomial infections due to microorganisms
that had contaminated complex medical devices, such as respirators, which are
difficult to clean and sterilize (68-72). Likewise, enterai feeding may be a reservoir
of microorganisms, especially after preparation under non-sterile circumstances or
storage at room temperature (73). Contaminated enterai nutrition occasionally
leads to nosocomial sepsis with Enterobacfer c/oacae and K/ebs/e//a j;Heumoniae
(74) or nosocomial pneumonia due to .Acinefobacter bowmanm'/ (75). Strict
hygienic measures with continuous control are therefore needed to exclude the
permanent danger of acquired colonization from contaminated sources.
Of/ier
Several studies indicated that patients themselves, rather than the inanimate
environment, were major reservoirs of microorganisms (65,76,77). Weinstein et al
demonstrated that 'antibiotic-resistance precautions' decreased the spread of
aminoglycoside-resistant Enterobacteriaceae, suggesting that these strains can
spread by cross-acquisition (76,77). As airborne transmissions only sporadically
contribute to spread of Gram-negative microorganisms (78), transfer most probably
occurs via hands of the nursing and medical staff. Pseudomonas species have been
isolated frequently from the hands of personnel, even after hand washing and
after gloves had been put on for contact with patients (65,79). Widmer et al
described an outbreak of PsewdomoHas aeruginosa infections in an ICU in which
identical strains were isolated from three patients and from the hands of a health
21
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care worker providing care for all three patients (80). Further evidence for the role
of hands in cross-acquisition was provided by studies demonstrating lower
incidences of infections after increasing the frequency of hand washing, and the
use of gloves (81) or antiseptic hand washing products (82-84). Taken together, data
demonstrating carriage of pathogens by hands of health care workers and those
demonstrating poor compliance with hand-washing procedures, especially in the
ICU and with physicians being the worst offenders (85-87), suggest that colonized
patients may be an important exogenous source of microorganisms within an ICU.
Therefore, it would be interesting to study the influence of decontamination of,
for instance, half the ICU-population on colonization rates of the other, non-
decontaminated half (chapter 7).
STAPHYLOCOCCUS AUREUS
Among the pathogens frequently associated with VAP, Stap/iy/ococcus awrews has,
when compared to Gram-negative bacteria, an exceptional source, since this
microorganism is derived exclusively from human reservoirs (78). The principal
site of staphylococcal colonization are the anterior nares; up to 80% of adults are
found to harbor Sfap/iy/ococcus oureus transiently, while 20-40% of adults are
colonized permanently (63,88). Therefore, the gastropulmonary route probably is
of no importance for colonization and infection with Sfap/iy/ococcws aureus.
Thus, although several microorganisms (Enterobacteriaceae, Pseudomowas
aerug/nosa and Sfaphy/ococcus awreus) are generally grouped together and
labelled as potential pathogenic microorganisms, their role and behaviour in the
pathogenesis of VAP may differ significantly. Moreover, since the group of
Enterobacteriaceae is a mixture of different bacteria, individual bacteria may have
different colonization patterns as well. These patterns of colonization of different
species of bacteria need to be studied in more detail (chapter 8 and chapter 10).
CONCLUSIONS
The etio-pathogenesis of VAP can only be studied, when the sequence of
colonization at several body sites is monitored in time, and the diagnosis of VAP
is established with bronchoscopic techniques. The effects of stress ulcer prophylaxis
or enterai feeding on gastric acidity should be studied with continuous intragastric
pH monitoring, instead of incidental measurements of acidity in aspirated gastric
juice with indicator papers. Up till now, no such studies have been performed and
interpretation of available data is, therefore, hampered by methodological pitfalls.
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Although there is no doubt that enterai microorganisms can reach the lungs via
stomach and oropharynx, and eventually cause VAP in mechanically ventilated
ICU-patients, the importance of this route has yet to be established. In addition, the
patterns of colonization of different species of microorganisms should be
determined.
It is also important to realize that, besides the gastropulmonary route of
colonization, bacteria may reach the lungs via other routes, either from exogenous
sources or from the intestine after spreading outside the patient. The importance
of these routes of colonization need to be established as well.
In conclusion, the studies reviewed above demonstrate a sharp contrast between
the limited knowledge of the patterns of colonization leading to VAP and the
widespread medical consequences of this dreaded infection. Therefore, it is
essential to elucidate these patterns in order to develop preventive strategies.
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SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT IN ICU-
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INTRODUCTION
The results of the European Prevalence of Infections on Intensive Care Study
(EPIIC Study), conducted in 1992, demonstrated that Selective Decontamination of
the Digestive Tract (SDD) as a method of infection prevention, was used by 47% of
the Dutch Intensive Care Units (National Symposium of Hospital Infections in
Intensive Care, Amsterdam, March 12th 1993). Although SDD is an established
method of infection prevention in long-term granulocytopenic patients (1), its use
remains controversial with respect to mechanically ventilated ICU-patients,
because no beneficial effects on mortality and costs have been demonstrated so far,
and, at least theoretically, a constant risk of increased antibiotic resistance is
present.
Van Dalen and van der Meer concluded three years ago that "the benefits of this
potentially attractive method of infection prevention as well as the subgroup of
patients who are likely to benefit most have yet to be established (2)". A definitive
judgement on the value of SDD in mechanically ventilated ICU-patients can only
be made when based on results obtained from well-designed studies, preferably
double-blind, with patient populations large enough to draw statistically reliable
conclusions, and in which not only clinical endpoints but also side-effects, such as
selection of antibiotic resistant bacteria and costs, were studied. The aim of this
paper is to review recent studies on the routine use of SDD in mechanically
ventilated ICU-patients.
SELECTIVE DECONTAMINATION
Nosocomial infections in the ICU, especially pneumonia, are associated with
prolonged ICU-stay, increased costs for medical care and increased mortality (4,5).
The incidence of pneumonia in mechanically ventilated patients varies between
10 and 85%, depending on the criteria used to establish the diagnosis (6,7). The
correlation between colonization of the upper respiratory tract with
Enterobacteriaceae, Psendo/MOMas aernginosa and Sfap/iy/ococcus aurews, the so-
called potential pathogenic microorganisms (ppmo), and the development of
nosocomial pneumonia has already been demonstrated in the early seventies (8,9).
The intestinal flora of the patient has been assumed to be the most important
source of ppmo, eventually causing infection of the lower respiratory tract (10,11).
SDD is based on the enterai administration of non-absorbable antibiotics and the
application of an oropharyngeal paste, containing the same antimicrobial agents.
The anaerobic intestinal flora should remain unaffected (12), because of its alleged
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preventive effect on colonization with aerobic Gram-negative bacteria: the
principal of colonization resistance (13). Colistin and an aminoglycoside are
generally used in the SDD-regimen, because both agents are hardly absorbed, do
not affect the anaerobic flora, and are effective against Gram-negative
microorganisms and Sfap/iyZococcus ai/rews, the most important species in the
etiology of nosocomial pneumonia. To prevent overgrowth with yeasts,
amphotericin B has been added to the regimen (12). In addition, systemic
prophylaxis has been used in many studies to prevent 'early' infections, occurring
before selective decontamination is achieved.
CLINICAL STUDIES
The patient populations, the inclusion criteria, the SDD-regimens used, the results
and the costs of SDD of seven recently published clinical studies are summarized
in Table 1 (14-20). In contrast to studies published in the eighties (2), the patient
populations under study, the SDD-regimens and study designs were comparable in
these recent studies. In all studies mixed populations of surgical, medical and
trauma patients were investigated, and patients were comparable regarding
underlying disease, APACHE II-score and age (14-20). All studies were prospective
and randomised (14-20), and three were double-blind and placebo-controlled.
Systemic antibiotic prophylaxis during the first days of admission was
administered in six out of seven studies (14,16-20).
Finally, a distinction between 'early' and 'late' (or primary and secondary)
pneumonia was made in all analyses (14-20). Early (or primary) infections are
usually caused by microorganisms already colonizing the patient on admission,
such as Streptococcus pneumonias, Moraxe/Za ca/arr/ja/;'s and Haemop/i/'/us
m/Zueuzae (12). Pneumonia caused by these species of bacteria cannot be prevented
by SDD, in the first place because eradication of these pathogenic microorganisms
by SDD takes several days (7,12,21), and secondly because SDD cannot eradicate
bacteria already colonizing the lower respiratory tract, which in most cases has
already occurred before admission to the ICU. Late (or secondary) pneumonia is
usually caused by typical species, such as Enterobacteriaceae, Pseudomonas
aeruginosa and Sfap/iyZococcws aureus, which colonize patients during their ICU-
stay. In most studies the distinction between 'early' and 'late' cases of pneumonia
is based on the moment of diagnosis of infection; prior to or after 48-96 hours after
admission to the ICU (14-20).
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TaWe I : The rqjimCTis 0/ SDD, c/inica/ outcomes and costs in seuen rece«f/y puWis/ied fria/s.
Blair Gastinne Hammond Winter Cockerill Rocha Verhaegen
1991 (14) 1992 (15) 1992 (16) 1992 (17) 1992 (18) 1992 (19) 1993 (20)
patient population
including criteria
minimal days in ICU
ventilated (%)
SDD-regimen
enterai administered
(dosages in mg per day)
polymyxin
tobramycin
gentamicin
ofloxacin
amphotericin B
nystatin
antimicrobial oropharyngeal paste
intravenous prophylaxis
agent
dosage (in mg)
duration (days)
Study-design
randomised
placebo-controlled
double-blind
patient numbers
test population
control population
mixed '
>2
93
cefotaxim
50rrg/kg/dag
4
126
130
mixed
100
mixed
>5
100
mixed
>2
100
mixed mixed
>5
mixed
>2
4x100
4x80
4x100
4x100
4x80
4x100
4x100
4x80
4x100
4x100
4x80
4x500
4x100
4x80
4 x 2.10E6
4x100
4x80
4x500
4xl.lOE6
4x80
4x500
2x200
4x500
cefotaxim * ceftazidim cefotaxim cefotaxim cefotaxim
4x1000 50rrg/kg/dag 3x1000 6000/dag 4x1000
3 3 3 4 4
220
225
114
125
91
92
75
75
47
54
200
185
ofloxacin
1x200
4
193
historical control group
Cinical outcome 3 ^
Incidence of late F
test population
control population
historical control group
p-value
Mortality (%)
test population
controlpopulat.cn
historical control group
p.value
Costs SDD-medication (in fl
per patient/per day
mean per patient
9.5
34.6
0.002
14.9
18.8
n.s.
12
15
n.s.
34
30
n.s.
122,-
1277,-
7
6
n.s.
18
17
n.s.
920,-
84
4
12
19
<0.05
36
43
40
n.s.
71.-'
15 12.5
5
4
n.s.
11
29
n.s.
13
n.s.
21
44
<0.05
44,-
18.4
n.s.
15.5
16.8
n.s.
62,70
3021
8.8
17.6
20,75 5
1417,-
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A statistically significant reduction in mortality was demonstrated in only one
study (19), while in another study statistical significance was approached (p=0.07)
in a subgroup of patients with an APACHE II-score between 10-19 on admission
(14). A lower incidence of 'late' pneumonia in SDD treated patients was
demonstrated in four out of seven studies (15,16,18,20). Although a statistically
significant lower incidence of pneumonia due to Gram-negative bacteria was
demonstrated in a French trial, this difference was offset by a higher incidence of
pneumonia due to Sfap/jy/ococcus «urews (15). Similar observations were reported
by Hammond et al.: the total number of infections did not differ significantly
between both treatment groups, although the number of infections caused by
Gram-negative bacteria was significantly lower in the patients receiving SDD (16).
A significant benefit with respect to the overall incidence of infections for SDD-
treated patients was demonstrated only in a small subgroup of patients with an
APACHE II-score between 17-23 on admission (16).
Verhaegen compared a placebo-group to two SDD-regimens: the conventional
SDD-regimen with non-absorbable antimicrobial agents and a regimen with
ofloxacin, which is absorbed and results in continuous therapeutic drug levels (20).
Although the number of respiratory tract infections caused by Gram-negative
bacteria was significantly lower in patients receiving SDD containing non-
absorbable antimicrobial agents, the total number of infections was not
significantly reduced, in comparison to patients receiving placebo-medication (20).
The use of ofloxacin did result, however, in a significant decrease in the incidence
of respiratory tract infections (20).
The lower incidence of respiratory tract infections in SDD-treated patients in the
study of Cockerill et al (4 versus 14) was largely a result of a lower incidence of
purulent tracheobronchitis in study patients versus control patients (1 versus 10)
(18). A lower incidence of pneumonia in SDD-treated patients was also
demonstrated by Blair et al, but in their study the incidence of other infections did
not differ between both treatment groups (14). Winter compared the efficacy of
SDD in ICU-patients with conventional treatment in both a concomitant and a
historical control group (17). The total number of 'late' infections in patients
receiving SDD was lower as compared to both control groups (3% versus 32% and
35%), and the difference in incidence between the SDD-population and the
concomitantly studied control group was statistically significant (17).
Finally, Rocha et al demonstrated a significant decline in the overall incidence of
respiratory tract infections, but this reduction was based on differences in the
incidence of 'early' infections only (19). In this study, the diagnosis 'early'
respiratory tract infection was established in one out of 47 SDD-patients (receiving
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cefotaxim 6 g/day), versus 18 out of 54 (33%) patients receiving placebo
medication. The numbers of 'late' infections, six in the SDD-group (13%) and
seven in the placebo-group (13%), were similar. In addition, the numbers of
urinary tract infections, cases of bacteremia and wound infections developing after
at least 48 hours admission to the ICU were similar in both study groups (19).
Given the caveats of the study designs and endpoint evaluation, one may
conclude that the above-metioned studies fail to provide convincing evidence for
a beneficial effect of SDD in ICU-patients.
ANTIBIOTIC USE AND COSTS
The costs of antibiotic use were analyzed, albeit in different ways, in six out of the
seven studies listed in Table 1 (15-20). Both the daily costs of SDD-medication and
the total costs of SDD per patient were calculated (15-20). The relatively low total
costs in the study of Cockerill et al (/390,- per patient) were a result of a cheaper
SDD-regimen, in which tobramycin and amphotericin B were replaced by
gentamicin and nystatin (18). None of the studies, however, demonstrated a cost-
saving effect of SDD (15-20). Moreover, in four studies the total costs of antibiotics
(for prophylactic as well as therapeutic use) were distinctly higher in the SDD-
population (15,16,19,20). A cost-saving effect of SDD could not be demonstrated
either by Winter et al, who, in addition, found that the number of days of
antibiotic therapy divided by the number of ICU-days was comparable in their
three study groups (17).
OVERGROWTH AND INFECTIONS DUE TO GRAM-POSITIVE COCCI
The choice of colistin and an aminoglycoside in the SDD-regimen implies that
several Gram-positive species, such as Enrerococcus /aeca/is and Coagulase
negative staphylococci, resistant to these agents, will not be attacked. Although
overgrowth and infections due to these resistant species have been reported by
some (22), these complications were considered as innocent side-effects by others
(23). Nevertheless, recent publications underscore the pathogenetic importance of
these phenomena. For instance, a significant decrease in the incidence of
pneumonia caused by Gram-negative bacteria was almost completely offset by an
increase in the incidence of pneumonia caused by Gram-positive bacteria, in two
of the seven studies listed in Table 1 (15,16). Moreover, the number of cases of
bacteremia with staphylococci or enterococci was significantly higher in patients
receiving the conventional SDD-regimen as compared to control patients in the
study of Verhaegen et al (20). Furthermore, a fatal case of peritonitis caused by
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Sfop/iy/ococcus epùferm/rfis after intestinal perforation was described in a patient
receiving SDD (24). Finally, an epidemic of infections with methicillin-resistant
Sfap/jy/ococcus ot/reus, also resistant to the antibiotics used in SDD, has been
described (25). Although the use of SDD was not the primary cause of the
epidemic, the authors suggested that SDD substantially contributed to spreading of
the bacteria to cause the epidemic within the ICU (25).
SDD AND ANTIBIOTIC RESISTANCE
Antibiotic resistance associated with the use of SDD is encountered with
increasing frequency. Rocha et al reported on a significant increase of
Stap/iy/ococcus aureHS and Acinetobacter species resistant to cefotaxim and
tobramycin, although the number of infections caused by these resistant species
did not increase (19). In addition, Nau and coworkers found the number of
aureus resistant to cefuroxim, oxacillin and gentamicin, and of
aerugi/iosa resistant to gentamicin, to be significantly increased
following SDD, when compared to historical data (26). However, in both studies it
remained unclear how many copy strains were included in the analysis (19,26).
Verhaegen performed an analysis of only those strains causing infection (20). In
this study conventional SDD resulted in an increase of tobramycin-resistant
Enterobacteriaceae and of Sfa/j/iy/ococcws aureus resistant to oxacillin and
amikacin. The prophylactic regimen containing ofloxacin resulted in an increase
of Enterobacteriaceae resistant to tobramycin, amikacin and ofloxacin, and of
PseudomoHos aeri/g/Hosa resistant to ofloxacin. Because almost all oxacillin-
resistant strains were also resistant to tobramycin and ofloxacin, both SDD-
regimens probably contributed to the selection of oxacillin-resistant strains of
Stap/iy/ococcws aurei/s (20). Recently, an increase of tobramycin-resistant strains of
Pseudomonas aerug/'/josa was reported after the use of SDD for four years in one
out of two ICU-wards. In this study only one isolate per patient, derived from
samples obtained by protected specimen brush, was analysed (28). The increase in
the number of resistant isolates, fromO% in 1987 to 42.9% in 1991, was observed
only in the ICU-ward where SDD was used. The percentage of resistant isolates did
not change in the other ward: 6.3% in 1987 and 6.5% in 1991 (27).
CONCLUDING REMARKS
Remarkably, a decrease in the incidence of 'late' pneumonia was not observed in
five out of seven recent studies (15,16,18-20). This is in contrast to earlier studies,
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in which almost without exception a lower incidence of pneumonia was reported
in patients treated with SDD (7,12,28-32). Interestingly, this difference seems to be a
result of the differences in the incidence of pneumonia in control patients. In the
seven studies listed in Table 1 the incidence among control patients ranged from
13 to 35% (14-20). However, in previous investigations the incidences among
control patients ranged from 45 to 85% (7,12,28-30,32). Exceptionally low incidences
of pneumonia were reported in the study from Ledingham et al, both in treated
and in non-treated patients (2% and 11% respectively) (31). However, since only
38% of the patients were intubated, the results could hardly be compared to those
reported in other studies. In contrast to the large differences in incidence of
pneumonia in control patients, the incidence in patients receiving SDD did not
differ much: 2 to 15% and 4 to 15% in the early and recently published studies
respectively (7,12,14-20,28,32). Therefore, the lack of a positive effect of SDD on the
incidence of pneumonia in the later investigations seems to be a result of a lower
incidence of pneumonia among control patients, rather than absence of the
alleged protective effect of SDD in the test populations.
Several explanations could be put forward to account for the apparent decline in
pneumonia incidence in control patients. For instance, no distinction was made
between 'early' and 'late' cases of pneumonia in three studies, and as a result,
'early' infections might have influenced the total incidence of pneumonia to a
substantial degree (12,28,30). In addition, the combination of clinical, radiographie
and microbiological criteria to establish the diagnosis of pneumonia, which
combination has a high sensitivity but low specificity (33), might also have
contributed to the high incidences (7,12,28-32). When using these criteria, false-
positive diagnoses may be made because colonization of the lower respiratory tract
or tracheobronchitis might erroneously be interpreted as pneumonia. Indeed,
tracheobronchitis occurs more frequently in a population with an expected higher
incidence of pneumonia (i.e. control patients). Moreover, the use of criteria with
low specificity might have influenced the results in another way. For instance,
antibiotics present in the oropharyngeal paste may yield effective drug levels in
trachéal secretions, leading to false-negative results of microbiological cultures in
patients receiving SDD (34). Therefore, bronchoscopy with bronchoalveolar lavage
(BAL) and/or protected specimen brush (PSB) probably provide the most accurate
diagnosis of pneumonia in mechanically ventilated patients (33). However, since
bronchoscopic techniques were used in only three of the seven studies listed in
Table 1 (15,17,19), this argument cannot explain the differences between the earlier
and the more recently published trials. Finally, one should realize that of the older
studies mentioned (7,12,28-32), four were not randomised (12,30-32) - although in
one study a crossover model in two ICU's was used -, and three used a historical
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control group (12,31,32); of the randomised studies none was placebo-controlled or
double-blind (7,12,28-32).
The composition of the conventional SDD-regimen is open for discussion. Brun-
Buisson et al demonstrated that selective decontamination of the intestine did not
influence the total number of infections (22), underscoring prior observations
made by Stoutenbeek and coworkers (32). In the latter study the addition of an
oropharyngeal paste to the regimen appeared to decrease the incidence of 'late'
pneumonia, but the total incidence of pneumonia still did not differ significantly
from the incidence in a historical control group. Only when systemic prophylaxis
was added a significant fall in the incidence of respiratory tract infections was
observed (32). Therefore, systemic prophylaxis was given until all ppmo were
eradicated in several early SDD-studies (7,12,32). In two of these the mean duration
of systemic prophylaxis was 9 and 8,4 days respectively, whereas the mean
duration of ICU-stay was 11 and 13,4 days respectively (7,12). Probably, the
prolonged systemic prophylaxis has had a substantial influence on the reported
difference between treated and non-treated patients. In later studies the duration
of systemic prophylaxis was given independently of the eradication of ppmo from
the gastrointestinal tract, and shortened to three or four days, or abandoned
completely (14-20,30,31). However, because of differences in study-design, patient
populations and criteria for infection in these studies, it remains unknown to
what extent incidences of pneumonia have been influenced by systemic
prophylaxis.
The 'selective' part of SDD refers to the fact that the anaerobic intestinal flora
remains intact, while ppmo are eliminated, which is presumed to offer protection
against colonization with ppmo. Van der Waay et al demonstrated in an animal
model that an intact anaerobic flora contributed to so-called colonization
resistance, thereby preventing overgrowth with ppmo (35). However, the impact
of colonization resistance on the effects of SDD on intestinal colonization has
never been studied. It is possible that antibiotics, administered orally, eradicate
ppmo and prevent new colonization, independent of colonization resistance. The
secondary Gram-positive infections during SDD even indicate that colonization
resistance has been disturbed. In addition, the impact of amphotericin B on SDD
has never been studied in a controlled design.
The effects of SDD on colonization of oropharynx and rectum have been studied
by Tetteroo et al (21). Incomplete decontamination was observed in 49 out of 154
episodes (32%) and recolonization with Gram-negative bacteria resulting in three
respiratory tract infections was observed after SDD had been stopped (36).
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Therefore, SDD may only suppress rather than eliminate the targeted microbial
flora.
COHC/MSIOWS
Based on the available data there is no scientific justification for the routine use of
SDD in an Intensive Care unit. The growing number of publications reporting
overgrowth and infections due to Gram-positive microorganisms (15,16,20,24,25),
and the absence of any cost saving effects of SDD (15-20) should further discourage
its routine use in mechanically ventilated ICU-patients. Finally, the incidental
reports of increases in bacterial resistance to the antibiotics used in SDD should
caution us even more (19,20,26,27).
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Chapter 3
PROBLEMS IN DIAGNOSING NOSOCOMIAL PNEUMONIA IN MECHANICALLY
VENTILATED PATIENTS: A REVIEW
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SUMMARY
Many efforts have been made to diagnose nosocomial pneumonia more accurately.
Protected specimen brush and bronchoalveolar lavage, both performed via flexible
bronchoscopy, are two promising new diagnostic modalities. Depending on study
design and patient selection, sensitivity and specificity of bronchoalveolar lavage
and protected specimen brush differ widely, ranging from 50 to 100%. However,
interpretation of study results is seriously hampered because a standardized
diagnostic threshold is not available, the influence of previous antimicrobial
therapy on culture results remains unclear and, most importantly, a well-defined
gold standard to study the value of both methods is lacking. Because studies of
bronchoalveolar lavage and protected specimen brush are seriously hampered by
several pitfalls, these studies as well as clinical results must be interpreted with
caution.
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INTRODUCTION
In the beginning of the twentieth century Sir William Osier called pneumonia the
"Captain of the Men of Death", as it was one of the most widespread and fatal
causes of acute diseases (1). Now, at the end of the century, pneumonia still is a
major cause of death, despite the introduction of an armament of antibacterial,
antiviral and antifungal agents. Improved medical care and widespread use of
antibiotics have directed the attention from community-acquired pneumonia to
nosocomial pneumonia. Pneumonia is considered nosocomial when it develops 72
or more hours after hospital admission (2). Treatment is hampered by increased
resistance of typical hospital pathogens to antimicrobial agents. Besides difficulties
in treatment, clinicians face another problem: how to diagnose pneumonia. This
review describes and compares the benefits and pitfalls of conventional and
recently introduced diagnostic modalities. Furthermore epidemiology, etiology and
risk-factors of nosocomial pneumonia are described.
EPIDEMIOLOGY
Nowadays pneumonia is the second most frequent cause of hospital-acquired
infections in the United States (3) and adult ICU-patients on mechanical
ventilation suffer the highest incidence rates: from 20 to 60% (4-11). The risk to
acquire pneumonia increases with time on mechanical ventilation (12). The mean
added hospital stay for patients with ventilator-associated pneumonia was
calculated to be approximately 10 days with extra costs attributable to the
prolongation of stay of US$ 8.800 (13,14).
RISK FACTORS AND MORTALITY
In general, nosocomial pneumonia is preceded by colonization of the upper
respiratory tract with pathogenic microorganisms (15). Among risk factors
associated with nosocomial pneumonia, intubation probably is the most important
one, leading to a 7- to 21-fold higher incidence rate as compared to non-intubated
patients (16,17). Other risk factors are underlying lung diseases, high age, large
surgical procedures, tracheostomy, immunosuppression, mechanical ventilation,
treatment with H2-blockers and reduced consciousness (6,8,17-19). These factors
explain the high rates of nosocomial pneumonia in mechanically ventilated ICU-
patients, since they usually are exposed to one or more of these conditions.
Of all hospital-acquired infections the highest mortality is accounted for by
pneumonia. Recently, an attributable mortality of 27% and a risk ratio of 2.0 was
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ascribed to nosocomial pneumonia and especially Pseudomowas aeruginosa and
Acinetobacter spp. were categorized as "high-risk" pathogens (20). Other risk factors
that worsen prognosis are bilateral involvement on chest radiograph, the presence
of respiratory failure, age higher than 60 years, an ultimately or rapidly fatal
underlying condition and inappropriate antibiotic therapy (8). From these
prognostic factors only the choice of antibiotic therapy can be influenced by the
medical staff, which underscores the need of a quick and accurate diagnosis.
ETIOLOGY
Most frequently, nosocomial pneumonia is caused by enteric Gram-negative
microorganisms. In the National Nosocomial Infection Study (NNIS), performed
between 1985 and 1988 in the United States, half of the cases were associated with
enteric Gram-negative bacteria, especially Pseudomonas aeruginosa (17.2%),
Enterobacter spp. (10.4%) and K/efosi'e//a pneumoniae (7.4%) (3). The results of this
large multicenter study were confirmed by many single hospital data (6,7,10,18,21).
Overall, Sfaphy/ococcus aureus is, after Pseudomonas aerug/nosa, the second most
frequent pathogen causing nosocomial pneumonia (14.6% of all cases in the NNIS-
study) (3). Other Gram-positive microorganisms were only seldomly associated
with nosocomial pneumonia (3). Incidentally, enterococcal pneumonia has been
documented as a superinfection among patients receiving broad spectrum
cephalosporin therapy and enterai feeding (22). A change in the spectrum of
etiologic agents has been observed in recent years. Sporadic outbreaks of
nosocomial pneumonia due to Acinetobacter spp. were reported in the 1970s and
1980s (3,23), but an increasing incidence of nosocomial pneumonia caused by this
microorganism has been described lately (6-9,24). Recently, nosocomial pneumonia
due to E/iterococcHS /aeca/is has been described as a side-effect of a regimen that is
directed towards prevention of infections with Gram-negative microorganisms and
Sfaphy/ococcMS aurews (25). Despite the availability of sophisticated diagnostic
modalities, the etiologic agent of nosocomial pneumonia remains unknown in a
number of cases, in some studies ranging from 38-60% (7,10,17,26).
DIAGNOSIS
To establish a diagnosis of nosocomial pneumonia in the ICU-setting is difficult.
Usually, pulmonary infection is diagnosed using several easily available
parameters: fever, leucocytosis, positive culture from trachéal aspirate with many
leucocytes and bacteria in the Gram stain and new or worsening infiltrates on chest
radiograph. Although each variable may have a reasonable sensitivity for
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pneumonia, specificity certainly is very poor, since fever, leucocytosis or
radiological abnormalities in ICU-patients are often due to noninfectious causes
and culture results of trachéal aspirate, even in combination with the Gram stain,
do not enable one to distinguish colonization from pneumonia (27-32). Two
studies among patients with the Adult Respiratory Distress Syndrome (ARDS)
clearly showed the risks of basing the diagnosis on these criteria, since pneumonia
was misdiagnosed in respectively 29% and 38% of cases due to false positive as well
as false negative results, as verified later by cultures and histology from lung tissue
(27,33). In another study, clinical diagnoses and therapeutic plans were related to
final results based on strict histopathologic and /or bactériologie criteria. The clinical
diagnosis of nosocomial pneumonia was accurate in 62% of the cases while the
proposed therapeutic plans proposed were appropriate in only 33%. Reasons for
inappropriate or inadequate treatment included missed diagnoses of pneumonia
and failure to effectively treat highly resistant microorganisms. Moreover, in 16%
of cases therapeutic plans included unnecessary antimicrobial therapy (34).
Quantitative and semi-quantitative cultures from trachéal aspirates, performed
routinely in mechanically ventilated patients, have a very poor specificity in the
diagnosis of pneumonia (8,35-38). Since these patients are frequently colonized in
their oropharynx with a complex microbial flora at high concentrations (>10^
cfu/ml), contamination of trachéal secretions often occurs (15,21,36,39,40).
However, by using the number of bacteria in Gram stains and analyzing trachéal
aspirates for the presence of elastin fibers, Salata and associates reported a specificity
of 73% for diagnosing nosocomial pneumonia (41). The presence of elastin fibers,
however, is a specific indicator for pulmonary necrosis (42), so its specificity for
nosocomial pneumonia may decrease due to noninfectious necrotizing lung
diseases like ARDS (38). Although Stap/iy/ococcws aurews, Gram-negative rods and
anaerobic microorganisms can cause pulmonary necrosis, the sensitivity of 67%
reported in Salatas' study is rather low (41,42). Furthermore, Sfrepfococcws
pneumom'ae, Mycop/asma pneumoniae and respiratory viruses cause pneumonia
without necrosis (38). Nevertheless, in view of its high positive predictive value,
examination of trachéal aspirates for elastin fibers for the diagnosis of necrotizing
pneumonia may be a readily available method, which needs further validation.
In another attempt to use a combination of easily available clinical, bacteriological
and radiological parameters to make a diagnosis of nosocomial pneumonia, Pugin
and coworkers developed a clinical pulmonary infection score (38). Although the
results of this scoring system look very promising, more studies are needed to
validate it. Other cultures, such as those from blood and pleural fluid, have little
value in diagnosing nosocomial pneumonia. Although they have high specificity,
sensitivity is rather low (21).
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Tab/e 3: Resu//s o/ auanfifafrwe cu/fures 0/samp/es ob/ained by broncnoscopi'c in diagnosing nosocomia/ pneumonia.
Reference Method A/B* cutoff-point sensitivity specificity criteria used as "gold standard" for the presence of
(cfu/ml) (%) (%) nosocomial pneumonia
96 94 -clinical parameters
-response to antibiotic-therapy
88 100 -fever
-chest radiograph
-purulent trachéal aspirate and/or leukocytosis
-response to antibiotic-therapy
100 60 -autopsy
60 100 -fever
-chest radiograph
-leukocytosis
100 % -postmortem histology
53 -response to antibiotic-therapy
-positive elastin fiber test
-autopsy
100 95 -clinical history
87 100 -response to antibiotic therapy
-cytological or pathological specimens
Pollock
(57)
Winterbauer
(58)
Chastre
(28)
Lorch
(59)
Fagon
(29)
Torres
(60)
Thorpe
(61)
PSB"
PSB
PSB
PSB
PSB
PSB
BALC
113/78
91/33
26/6
20/15
147/34
15/15
92/15
Kahn
(35)
Cantral
(62)
Meduri
(63)
BAL 75/13
BAL 154/8
46/13
>10>
88
50
97
97 -fever
98
100
^oSJet
-response to antibiotic therapy
-postmortem findings
-response to antibiotic therapy
-confirmation by biopsy or autopsy
-positive blood culture
92 -fever
aspirate or leucocytosis
100 -CP1S >6 S
96
- < BAL= bronc/iofl/ueolar
protected BAL, NB ^
Score «s de/i«ed by Png» 08).
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Semiquantitative or quantitative cultures of lavage fluid are difficult to interpret
without referring to a well-defined diagnostic threshold. In one study all patients
with pneumonia had >10'* cfu/ml lavage fluid. Raising the diagnostic threshold to
>105 cfu/ml resulted in 2 false negative results in 15 patients (61). In another study,
Kahn and Jones tried to exclude contamination of the upper respiratory tract by
evaluating only cultures with 1% or less squamous epithelial cells on a differential
cell count of the lavage pellet. However, despite a sensitivity of 100% a threshold of
10^ cfu/ml did not allow strict discrimination between acute bacterial bronchitis
and pneumonia (35). For instance, all five patients with acute bacterial bronchitis
had culture results of >10'' cfu/ml, of whom 3 even had >10^ cfu/ml. Moreover, in
28 patients without any respiratory tract infection, the mean number of cfu/ml was
3.3x10' and from 12 isolates even >10'' cfu/ml were cultured. Unfortunately, in
these two studies the number of patients on mechanical ventilation was not
metioned and the diagnosis of pneumonia was not verified by histological or
bacteriological examination of lung tissue.
Table 1 lists several other studies in which bronchoalveolar lavage was used to
diagnose nosocomial pneumonia. They all show that a diagnostic threshold of 10$
cfu/ml can lead to false negative results. Moreover, a significant amount of
nosocomial pneumonia is polymicrobial (28,35,64,68). In these cases, a culture
yielding two microorganisms in concentrations of 10' cfu/ml, for example, would
be considered negative. To circumvent such an erroneous classification, Johanson
and coworkers calculated a "bacterial index" (defined as the sum of the logarithmic
concentrations of individual species) to determine lower respiratory tract infection.
When in mechanically ventilated baboons a bacterial index >6 was taken as
diagnostic threshold, a sensitivity of 100% and a specificity of 92% were found. The
authors concluded that the bacterial index is more accurate in detecting pneumonia
than the concentration of individual bacterial species (40).
Consensus on the cutoff point of quantitative cultures, especially from
bronchoalveolar lavage, is essential before these procedures can be introduced into
routine practice. As in many cases nosocomial pneumonia is polymicrobial, the use
of a bacterial index probably is more logical and accurate. However, the value of
this index in patients has hardly been studied yet and certainly has not been
validated in cases of pneumonia caused by one single pathogen. Nevertheless, for
the time being a cutoff point of >10'' cfu/ml is recommended (69). As is also true for
the protected specimen brush, antibiotic administration before the diagnostic
procedure may lead to false negative cultures of bronchoalveolar lavage
(40,52,63,72).
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A benefit of bronchoalveolar lavage may be the immediate microscopic
examination of lavage fluid (68,73). Although total and differential counts of
leukocytes had little value in diagnosing pneumonia (35,53,61), extracellular
bacteria, polymorphonuclear leukocytes with intracellular bacteria and elastin
fibers were more often observed in Gramstained samples of cytocentrifuged lavage
fluid in patients with pneumonia (38,41,53,61,63).
The complications of bronchoalveolar lavage in ventilated patients are mainly
those that accompany fiberoptic bronchoscopy and are usually minor (64,65,71,74).
They include a drop in PaC>2 (54,55,64), arrhythmias (65), transient progression of
pulmonary infiltrates and fever (73,75). Recently - following bronchoalveolar
lavage -, a significant rise in body temperature, a decrease in mean systemic arterial
pressure and arterial oxygénation, together with high endotoxin levels in lavage
fluid was observed in mechanically ventilated patients with pneumonia. This may
have been caused by intravascular translocation of toxins or mediators producing
pyrogenic and hypotensive effects (76).
As bronchoscopy requires specific skills and is costly, bronchoalveolar lavage
without bronchoscopy has been evaluated as well. Obtaining lavage fluid using a
flexible catheter, introduced blindly, is associated with lower sensitivity (73%) and
specificity (96%) than culture of lavage fluid sampled by bronchoscopy (93 and 100%
respectively). Similar results for qualitative and quantitative bacteriology and
microscopic examination of fluids obtained by both procedures was found, even if
lavage fluids originated from different lobes or from the contralateral lung (38). If
further studies confirm the usefulness of non-bronchoscopic bronchoalveolar
lavage it may become be a simpler and cheaper alternative for the bronchoscopic
procedure. Recently, a protected bronchoalveolar lavage method has been
developed to avoid or minimize contamination (63). However, the extra value of
this expensive method has yet to be established.
COMPARISON OF PROTECTED SPECIMEN BRUSH AND BRONCHOALVEOLAR
LAVAGE
In several studies the diagnostic values of protected specimen brush and
bronchoalveolar lavage have been compared (Table 2). Chastre et al reported false
positive results in 5 out of 13 patients and false negative results in 2 out of 5
patients with bronchoalveolar lavage, whereas cultures from protected specimen
brush had a sensitivity and specificity of 100% (53). Drawing definite conclusions
from this study is hampered because of the small number of patients with
pneumonia (n=5). In another study protected specimen brush also led to higher
specificity (86%) than bronchoalveolar lavage (71%), but a cutoff point of
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cfu/ml was set for both techniques, which explains the low specificity of
bronchalveolar lavage (36). After studying the merit of bronchoalveolar lavage and
protected specimen brush in baboons, Johanson concluded that bronchoalveolar
lavage was the best method to establish infection of the lungs. When related to
histologie and bactériologie findings of open-lung biopsy, false positive culture
results were found with similar frequency for specimens obtained by means of
bronchoalveolar lavage as for those obtained by protected specimen brush.
However, cultures of lavage fluids recovered 74% of all species present in the lung
tissue as compared with only 41% to those of protected specimen brush (40).
GOLD STANDARD
The interpretation of the data reviewed here is seriously hampered because the
populations studied vary widely and the use of antimicrobial agents, strongly
influencing the yield of bactériologie procedures, was not always taken into
account. The greatest problem, however, relates to the gold standard used to verify
the value of the diagnostic procedures. Histological and bacteriological examination
of lung tissue remains the optimal standard to establish pneumonia, but this can
only be obtained via open-lung biopsy or at autopsy.
In the absence of an easily available gold standard alternative "standards" have
been developed, frequently combining clinical, radiological, bacteriological and (if
possible) histological parameters. There is no question that comparing any
diagnostic procedure with a standard that lacks 100% sensitivity and specificity
weakens correct interpretation of the results. Furthermore, the technique of
postmortem examination of lung tissue is important. The risk of using small lung
specimens was demonstrated by histological examination of both small lung
biopsies and of total lungs. Histological features of pneumonia, demonstrated in
complete lung examination, were absent in 25% of biopsies (81). Moreover, cultures
of lung tissue with histologically proven bronchopneumonia remained sterile,
reflecting either pneumonia in its resolution phase or suppressed microbial growth
due to a combination of antimicrobial agents and antibacterial defences of the host
(82).
CONCLUSION
A rapid diagnosis of nosocomial pneumonia remains a challenge, especially in
mechanically ventilated patients. Bronchoalveolar lavage and protected specimen
brush are promising diagnostic tools, although the results of most studies are not
conclusive due to the lack of a gold standard with 100% sensitivity and specificity.
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7ab/e 2: Resu/fs o/ sfudr'es comparing <jHanWaf/i>e c«//ures ofcfained by PSB and B/4i. m diagnosing pneumonia.
Reference method^ A/B cutoff-point sensitivity specificity criteria used as "gold standard" for the presence of
(cfu/ml) (%) (%) nosocomial pneumonia
-positive culture of pleural fluid
-rapid cavitation on chest radiograph
-histopathology
-favorable clinical response to antimicrobial therapy
-postmortem histology
nosocomial pneumonia excluded by:
-no new antimicrobial therapy necessary
-absence pathological signs at autopsy
-response to antimicrobial therapy
-positive culture of blood
-histology and bacteriology via open-lung biopsy and
autopsy (in 8 cases)
-postmortem histology for those who died
-positive blood culture
-histology and bacteriology via autopsy
Chastre (53)
Torres (36)
Martos (37)
Meduri (77)
Padro (78)
Ebiary (79)
Violan (80)
BAL
PSB
BAL
PSB
BAL
PSB
PBAL
PSB
BAL
PSB
BAL
PSB
BAL
PSB
18/5
41/34
10/0
11/4
13/?
49/26
45/20
> 10'
> 10'
> 10'
BI>6t"
BI>6
>S
> 10"*
> 1 0 '
> 10*"
> 1 0 '
60
100
56
56
100
25
50
55
100
62.5
25
72.7
66.6
76
64
85
100
71
86
70
70
50
90
100
100
78.5
76
56
70.8
75
66.6
88
100
100
" Bi4L=bronc/ia/wo/ar /auage, PSB=pro/«rfed specimen brus/i PB/4L=profec/ed B/IL; * B/=bac(<;n'a/ index as de/i»ed by /o/ianson (40);
/VB = no o/ pfs/no o/ p(s u;i7/i pneumonia according /o /he go/d standard
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As discussed, consensus on the cutoff point of quantitative cultures is essential
before introducing these procedures into routine practice. More studies are needed
with strictly defined uniform populations, either with or without previous
antibiotic therapy and also with bactériologie and histologie results of lung tissue as
gold standard. The use of a bacterial index should be validated in the same way and
more attention should be paid to microscopic analysis of lavage fluid, as it can offer
a quick answer whether to start antimicrobial therapy or not. In addition, more
conventional methods like quantitative cultures of trachéal aspirates and analysis
of elastin fibers might prove to be useful adjunctive modalities to establish or reject
the diagnosis of nosocomial pneumonia. Since bronchoscopic techniques are
expensive, its use should be evaluated in a formal cost-benefit analysis. In one
study, use of protected specimen brush resulted in fewer costs compared to the
projected costs entailed in treating all patients clinically suspected of having
nosocomial pneumonia (29).
The studies reviewed demonstrate the risks of using only clinical criteria, like
fever, leucocytosis, positive cultures from trachéal aspirates and abnormalities on
chest radiograph, for diagnosing nosocomial pneumonia in mechanically
ventilated patients. However, most studies providing data on epidemiology,
etiology and risk factors of nosocomial pneumonia relied on these nonspecific
clinical criteria and should therefore be interpreted with caution. Bronchoalveolar
lavage and protected specimen brush have a higher specificity in diagnosing
nosocomial pneumonia, despite inconsistent results and difficulties in validation.
As a result, the use of these procedures may have a significant influence on
incidence rates, etiology and risk factors of pneumonia in mechanically ventilated
patients. For instance, use of protected specimen brush resulted in only 52 cases of
nosocomial pneumonia out of 162 clinically suspected episodes (30).
Accurate determination of the agent causing nosocomial pneumonia is of
paramount importance for treating patients. In the first place because antimicrobial
therapy can be optimalized or withheld, so to prevent the risk of bacterial resistance
and saving costs. Moreover, inappropriate or unnecessary antimicrobial therapy
will hamper interpretation of further diagnostic procedures and will increase the
risk of infections with high-risk pathogens.
Given the above-mentioned difficulties and uncertainties in diagnosing
pneumonia in the intensive care setting, what practical approach can be advised to
the physician who is facing a patient suspected of having pneumonia? If there is a
high likelihood for nosocomial pneumonia, on account of high clinical suspicion
and no other underlying diseases that can be held responsible for the clinical
symptoms, antimicrobial therapy should be started. In fact, in these situations
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invasive procedures that lack 100% sensitivity and specificity hardly contribute to
establishing the diagnosis. Likewise, antimicrobial therapy should also be started in
the critically ill patient with a systemic inflammatory response syndrome and
suspected pneumonia, because of the high mortality in this clinical setting. In both
situations protected specimen brush and bronchoalveolar lavage do not influence
the decision to start antimicrobial therapy. However, since ICU-patients are
frequently colonized with different microorganisms in the upper respiratory tract,
cultures from bronchoscopic techniques may add specific information on the
strains of bacteria that cause the infection, thereby guiding the choice for the most
appropriate antibiotics.
In contrast to these situations in which antibiotics have to be started immediately,
in many situations it is unclear whether a patient has pneumonia or not. In these
circumstances bronchoscopic techniques may determine the decision to institute
antimicrobial therapy. However, when using these techniques, the clinician has to
be aware of the pitfalls of these techniques and should interpret the culture results
with caution.
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Among mechanically ventilated ICU-patients, nosocomial pneumonia (i.e.
ventilator associated pneumonia (VAP)) is the most frequent infection, which is
associated with increased morbidity and mortality, a longer ICU-stay for survivors,
and therefore increased medical costs. For these reasons, prevention of this
infection has been the issue of many studies. After improvements in hygienic
procedures to protect patients for colonization via exogenous routes, infection
prevention in the last 10 years has been directed towards modulating the bacterial
flora of the digestive tract, because most bacteria causing VAP were assumed to be
from endogenous origin.
In this respect the gastropulmonary route received the most attention as it was
presumed to be the most important way of colonization. The intestinal bacteria
were thought to retrogradely colonize the stomach and the oropharynx, from
where they would reach the distal lung tissue through aspiration. The physiologic
defense mechanism against gastric colonization, i.e. gastric acidity, may be absent in
critically ill patients, either due to the underlying disease or due to stress ulcer
prophylaxis. Therefore, prevention of colonization of the stomach played a key role
in the prevention of VAP. Prevention of colonization was attempted by topical
application of non-absorbable antibiotics, and by preserving an acid gastric
environment using sucralfate for stress ulcer prophylaxis. Sucralfate, in contrast to
antacids and H2-antagonists, has been claimed not to lower intragastric acidity.
The pathogenesis of the pulmonary infection, the values of preventive strategies
and the problems, and alternatives, for diagnosing pneumonia with optimal
accuracy were described in the first 3 chapters. The different routes of colonization
leading to pneumonia and a critical appraisal of the relevant studies supporting the
putative gastropulmonary route of colonization, have been described in chapter 1.
In chapter 2, the value of Selective Decontamination of the Digestive Tract (SDD)
has been reviewed. This method of infection prevention has been used and studied
extensively. However, its usefulness for routine practice has not yet been
established, and our doubts regarding the benefits of this method formed the
starting-point of the studies described in this thesis.
An important issue in the studies addressing the pathogenesis, prevention and
treatment of pneumonia in mechanically ventilated, ICU-patients is the diagnosis
of the infection. In general, the combination of clinical, radiological and
microbiological criteria has been used to establish the diagnosis. However, data
from the literature clearly demonstrate the inaccuracies of these criteria. In chapter
3 the problems of diagnosing pneumonia in mechanically ventilated patients and
recently developed alternatives with higher specificity have been reviewed. The
importance of using bronchoscopic techniques to establish the diagnosis of
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pneumonia in mechanically ventilated, ICU-patients has been stated and, as a
consequence, in all studies in this thesis Protected Specimen Brush, and
Bronchoalveolar lavage, have been used.
The studies performed in our clinic are described in chapters 5 to 10. Those
addressing the effects of topical antimicrobial prophylaxis in oropharynx and
stomach on colonization and infection form the basis of chapters 5, 6 and 7, and
those addressing the importance of intragastric acidity and the stomach as a
reservoir of pathogens in the development of pneumonia in mechanically
ventilated ICU-patients are the subject of chapters 8, 9 and 10.
In chapters 5, 6 and 7 a regimen of Topical Antimicrobial Prophylaxis (TAP) was
studied, using non-absorbable antimicrobial agents, that were applicated to the
oropharynx and the stomach. In contrast to the concept of SDD, intestinal
decontamination was not aimed for and no systemic prophylaxis was given. In
chapter 5 the influence of TAP on colonization of the upper respiratory tract was
studied. The question behind this pilot study was whether decontamination of the
colon, as part of SDD, was necessary to achieve lower colonization rates of the
upper respiratory tract.
In chapter 6 we studied the efficacy of TAP to decontaminate the stomach, in
patients with and without enterai feeding. Although the institution of enterai
feeding in critically ill patients is widely recommended, several studies have
reported a relation between institution of enterai feeding and the subsequent
occurrence of pneumonia. Allegedly, this was due to dilutional alkalinization of
gastric contents, by that favouring the gastropulmonary route of colonization.
However, the influence of enterai feeding on the efficacy of a regimen of
decontamination has never been studied.
If endogenous sources (i.e. reservoirs of bacteria within the patient) were of major
importance for the development of colonization and infection of the upper
respiratory tract in mechanically ventilated patients, then modulation of
colonization should not influence colonization of other patients. This hypothesis
was tested in chapter 7. Colonization was studied in 3 groups of patients: one group
receiving topical antimicrobial prophylaxis of oropharynx and stomach, one group
not receiving any prophylaxis and treated in the same ICU as patients receiving
prophylaxis, and finally one group not receiving prophylaxis and treated in
another, identical, ICU.
As described previously, in chapters 8, 9 and 10 the role of gastric colonization and
intragastric acidity in the pathogenesis of pneumonia was studied. Measuring
intragastric acidity with optimal accuracy is absolutely necessary, when studying the
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influence of intragastric acidity on colonization and infection. However, up till
•now, most studies measured intragastric acidity with color-scaled indicator papers
in aspirated gastric juice. Moreover, in most cases these measurements were
performed only sporadically, in some studies less than once daily. Computerized
intragastric pH monitoring is a reproducible and accurate method, which probably
provides more reliable data on intragastric acidity than occasional measurements
in aspirated samples. In chapter 8 measurements of gastric pH performed once daily
with color-scaled indicator papers in aspirated gastric juice, were compared to
results of computerized continuous intragastric pH monitoring during 24 hours.
In chapter 9 colonization rates of rectum, stomach, oropharynx and trachea were
prospectively determined in 64 mechanically ventilated patients. In addition,
initial sites of colonization and chronological colonization patterns were assessed.
In this way the importance of the stomach as a source of bacteria for colonization
and pneumonia could be studied.
The last study of this thesis, chapter 10, addresses the correlation between
intragastric acidity and colonization of stomach and upper respiratory tract as
determined in 141 mechanically ventilated patients receiving either sucralfate or
antacids for stress ulcer prophylaxis. In addition, the correlation between
intragastric acidity and the incidence of nosocomial pneumonia was studied. The
influence of sucralfate and antacids on intragastric acidity, colonization rates and
incidences of infection were studied in a randomized double-blinded controlled
fashion, with stratification according to initial gastric pH. Measurements of
intragastric acidity were performed with continuous intragastric monitoring and
nosocomial pneumonia was diagnosed with Protected Specimen Brush and
Bronchoalveolar Lavage.
Recapitulating, the main questions addressed in this thesis are:
1. Can colonization of the upper respiratory tract be modulated without
influencing colonization of the colon? chapter 5
2. Can colonization of the stomach be modulated by topical antimicrobial
prophylaxis of stomach and oropharynx? chapter 6
3. Does continuous enterai feeding influence the protective efficacy of topical
antimicrobial prophylaxis of the stomach? chapter 6
4. Does modulation of the bacterial flora of the upper respiratory tract by topical
antimicrobial prophylaxis influence colonization in other patients not-
receiving prophylaxis and treated within the same ICU-ward? chapter 7
5. What is the role of the gastropulmonary route of colonization in the
development of nosocomial pneumonia in mechanically ventilated patients?
chapters 9 and 10
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6. Do discontinuous measurements of acidity in aspirated gastric juice accurately
reflect 24 hour values of intragastric acidity, as obtained with computerized
continuous monitoring? chapter 8
7. What is the influence of sucralfate on intragastric acidity as compared to high
dosages of antacids? chapter 10
8. Does sucralfate influence colonization rates and incidences of pneumonia as
compared to high dosages of antacids? chapter 10
9. What is the role of intragastric acidity and gastric colonization in the
pathogenesis of pneumonia in mechanically ventilated ICU-patients receiving
sucralfate or antacids for stress ulcer prophylaxis? chapter 10
10. What is the influence of enterai feeding on intragastric acidity and gastric
colonization? chapter 10
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Chapter 5
MICROBIOLOGICAL OBSERVATIONS DURING TOPICAL ANTIMICROBIAL
PROPHYLAXIS OF OROPHARYNX AND STOMACH IN MECHANICALLY
VENTILATED PATIENTS.
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INTRODUCTION
Nosocomial pneumonia is an important cause of morbidity and mortality in
hospitalized patients, especially in those receiving ventilatory support. Treatment
of manifest infection is usually unsatisfactory and the mortality rate is estimated to
be as high as 20-60% (1).
In general, Ventilator Associated Pneumonia (VAP), i.e. nosocomial pneumonia
occurring more than three days after admission to the Intensive Care Unit (ICU), is
believed to be caused by microorganisms of endogenous origin. One of the first steps
in the development of VAP allegedly is colonization of the oropharynx with Gram-
negative bacteria (2). After one week of mechanical ventilation, colonization of the
oropharynx by Enterobacteriaceae, Pseudornowas aerugmosa, Stap/iy/ococcus aureus
or yeasts - so called potentially pathogenic microorganisms (ppmo) - has occurred in
70-90% of patients (2,3).
Oropharyngeal colonization by ppmo has been described to be preceded by
colonization of the stomach, which is facilitated by an increased gastric pH and by
disturbances in gut motility (4). Increased gastric pH levels may lead to bacterial
growth in the stomach for example when H2-blocking agents or antacids are used as
stress ulcer prophylaxis (5). Alternatively, sucralfate, a chemical complex of sucrose
octasulfate which does not influence the physiologic gastric pH can be used as stress
ulcer prophylaxis (5).
In another approach to reduce the incidence of nosocomial pneumonia
antimicrobial agents were administered orally to eradicate ppmo from the colon
and the oropharynx without disturbing the allegedly protective anaerobic flora:
Selective Decontamination of the Digestive tract (SDD) (6-13). In most studies orally
and intravenously administered antibiotics were used concomitantly. Others,
however, focused on the use of topical non-absorbable antimicrobial agents in the
oropharynx exclusively to prevent development of nosocomial pneumonia (14-16).
Most studies showed a significant reduction of colonization by ppmo and morbidity
due to nosocomial pneumonia, although mortality rates were not reduced. In
addition, the beneficial effects of SDD on the duration of hospitalization and
mechanical ventilation, antibiotic use, emergence of antibiotic resistance in bacteria
and on medical costs remain unclear. It is mainly for these reasons that the merits
of SDD in ICU-patients continue to be debated (17,18).
We studied the microbiological effects of topical antimicrobial prophylaxis (TAP) of
oropharynx and stomach in combination with sucralfate as stress ulcer prophylaxis
on colonization of the upper respiratory tract and the colon. In contrast to several
other studies intravenously administered antimicrobial agents were not included in
this prophylactic regimen and orally administered non-absorbable antimicrobial
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agents were given in low doses as eradication of ppmo from the colon was not
intended. The main questions of this study were how topical antimicrobial
prophylaxis modulated colonization of the upper respiratory tract, and whether
topical antimicrobial prophylaxis influenced colonization of the colon.
MATERIAL AND METHODS
Sixty-nine patients admitted to the ICU of the University Hospital Maastricht,
between September 1990 and March 1992 were included in the study. All met the
following criteria: newly admitted to ICU, intubation within 24 hours after
admission, age between 15 and 90 years and an expected ventilation period of more
than five days. Eight patients were withdrawn from the study before day 5 due to
detubation (n=3) or death (n=5). The remaining 61 patients were studied until
detubation or death.
To assess the severity of the acute illness the APACHE II score was calculated on
admission to the ICU as described elsewhere (19). Each patient's demographic
characteristics, diagnosis on admission, underlying diseases, reason for intubation,
laboratory values, medication and clinical data were recorded and prospectively
monitored for evidence of infection. Cultures from oropharynx, trachéal aspirate
and rectal swabs were performed within 24 hours after admission and thereafter at
least twice a week until extubation. Unfortunately, the culture results from rectal
swabs are available only for the first 25 patients under study.
The regimen of Topical Antimicrobial Prophylaxis (TAP) and sucralfate,
administered 4 times daily, consisted of:
- suspension of tobramycin (8 mg/ml) and colistin (5 mg/ml) 1 ml in each nostril
and 5 ml through nasogastric tube
- suspension of amphotericin B (100 mg/ml) 0.5 ml in each nostril and 2.5 ml
through nasogastric tube
- application of tobramycin/colistin/amphotericin B 2% in Orabase to oropharynx
-1 g sucralfate suspension through nasogastric tube.
In case of clinical suspicion of pneumonia bronchoscopy was performed for
bronchoalveolar lavage (BAL) and protected specimen brush (PSB). Diagnosis of
pneumonia was established by a positive quantitative culture of PSB or BAL and a
new or persistent infiltrate on chest X-ray and when at least three of the following
criteria consistent with infection were met: (1) rectal temperature above 38.0 °C or
below 35.5 °C, (2) blood leukocytosis (>10.10' /mm') and/or left shift or blood
leukopenia (<3.10' /mm'), (3) more than ten leukocytes per high-power field in
gram stain of trachéal aspirate, and (4) a positive culture from trachéal aspirate. The
cutoff points for positive quantitative culture results from bronchoscopic
techniques were >10' cfu/ml for PSB and >1Q5 cfu/ml for BAL. The chest X-rays
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were retrospectively interpreted by a radiologist, who was unaware of the clinical
situation of the patient. In the analysis of ICU-acquired pneumonia,
Enterobacteriaceae, Pseudomonadaceae and Stap/jy/ococcus aureHs were grouped
and labelled as potentially pathogenic microorganisms (ppmo).
Collection and processing of samples from PSB and BAL were performed as
described elsewhere (20). Colonization was defined as the isolation of
microorganisms from oropharynx, trachéal aspirate or feces without signs of
infection. Colonization was designated as 'persistent' if there was a positive culture
with the same species on admission and from at least one consecutive sample.
Colonization was designated as 'acquired' if there were positive cultures with the
same species from at least two consecutive samples and no colonization with the
same microorganism on admission. Colonization was analyzed semi-quantitatively
as follows: Oropharyngeal swabs, rectal swabs, and 10 nl of trachéal aspirate were
streaked using the four-quadrant streak method on sheep blood, CLED, chocolate,
and Sabauroud plates. All media were incubated at 35 0 °C for 18 to 24 hours.
Growth density was graded as follows: Growth in the first quadrant= + l, in the
second quadrant=+2, in the third quadrant=+3, and on the whole plate=+4.
Informed consent was obtained from the patient or, if this was not possible because
of the clinical condition, from a representative of the family. The study protocol was
approved by the hospital ethical committee.
RESULTS
The characteristics, underlying diseases and admitting medical specialties of the 61
patients are shown in Table 1. In the study population the diagnosis pneumonia
was established in 5 patients (8%) on admission (Table 2).
o/ f/«e
Oropharyngeal colonization with Gram-negative rods on admission was
demonstrated in 23 patients (38%); 19 patients (31%) were colonized with
Enterobacteriaceae and 7 patients (11%) with Pseudomonadaceae (Table 3). In
addition, 4 patients (7%) were colonized with Staptoy/ococcus aureus and 2 (3%)
with Enferococcus /aeco/is on admission. In most patients ppmo colonizing the
oropharynx on admission were eradicated by TAP, but colonization with Gram-
negative rods in the oropharynx persisted in 5 out of 23 patients. Four patients (77»)
acquired colonization with Gram-negative rods in the oropharynx during the study.
Interestingly, acquired oropharyngeal colonization with Enferococcus /aeca/is,
intrinsically resistant to the antibiotics used in TAP, was demonstrated in 31
patients (48%).
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1: C/iurac/ens/ics o/ Me paflenfs.
Characteristics No. of patients
Age*
Days in hospital before admission at ICU '
Days in study *
APACHE II score »
Medical specialty on admisison
Medicine
Surgery
Trauma
Neurology
Surgical procedures
None
Abdominal surgery
Thoracic surgery
Mortality (%)
* median (range)
n=61
63 (29-89)
4 (1-61)
11 (5-97)
18 (4-38)
31
21
8
1
38
17
6
23(38%)
Coiomzafion o/ f/ie frac/jea
Fifteen patients (25%) were colonized with Gram-negative rods in the trachea on
admission; 10 patients with Enterobacteriaceae and 7 with Pseudomonadaceae
(Table 3). Four patients (7%) were colonized with Sfap/iy/ococcMS aureus on
admission. Persistent trachéal colonization with Gram-negative rods occurred in 6
patients, and with Staphy/ococcus aureHs in none. Fourteen patients (23%) acquired
colonization with Gram-negative rods despite the use of TAP. Of these patients, 7
(11%) acquired colonization with Pseudomonadaceae, and 7 patients (11%) with
Gram-negative rods not belonging to the group of ppmo. These patients acquired
colonization with Acinetobacter species (n=5), F/fluobacfen'um /udo/ogenes (n=l),
Achromobacter spp. (n=l) and /4/ca/igenes xy/osoxydans (n=l). Because colonization
with these species was not demonstrated in the oropharynx, colonization probably
occurred via exogenous routes, thereby bypassing the oropharynx. Acquired
colonization with EnferococcMS /aeca/is was demonstrated in 17 patients (28%).
77
Chapter 5
7ab/e 2: Numbers 0/ pa/ienfs ififA in/ecfions on udm/sston and V.AP, and Me
microorganisms associa^d wif/i in/ection.
Infection
On admission
Septicaemia
origin:
abdomen
urinary tract
ostemyelitis
necrotizing fasciitis
e.c.i.
Pneumonia
ICU-aquired
Pneumonia: total
ppmo
non-ppmo
Recurrent pneumonia
Number of
patients (%)
4(7%)
1 (2%)
1 (2%)
1 (2%)
2 (3%)
5 (8%)
13 (21%)
7(11%)
6 (10%)
2(3%)
Pathogenic microorganism
unknown
Escherichia coli
Staphylococcus aureus
Clostridium species
Escherichia coli
Staphylococcus aureus
Streptococcus group A
unknown
Klebsiella pneumoniae
Streptococcus group G
Streptococcus pneumoniae
Mycobacterium tuberculosis
Pseudomonas aeruginosa
Enterobacter species
Enterococcus faecalis
Staphylococcus epidermidis
Acinetobacter species
Alcaligenes xylosoxydans
Streptococcus group B
Pseudomonas aeruginosa
Acinetobacter species
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(6)
(4)
(3)
(1)
(1)
(2)
(1)
Feed/ co/onizaff'on
Enterobacteriaceae and Enferococcus /aeca/zs were cultured on admission from
rectal swabs of almost all patients analyzed (n=25), and persisted in most of them
(Table 3). Six patients (24%) were colonized with Pseudomo/ias aeruginosa on
admission. In addition, five patients became colonized with /4cinefobacfer anitrafus,
in all cases after preceding trachéal colonization with this microorganism.
Sfap/iy/ococcMS flureus were not isolated from rectal swabs of any of the patients.
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TaWe 3- Number o/ pflfienis co/om'zed a»ir/i di^erenJ genera o/ microorganisms according fo dura/ion o/
co/oniza/io».
Cultures available
Gramnegative rods
Enterobactericeae
Pseudomonas aeruginosa
non-ppmo '
Grampositive cocci
Enterococcus faecalis
Staphylococcus aureus
Oropharynx
A
58
23
19
7
1
6
2
4
B
58
5
4
2
0
2
2
0
C
58
4
2
2
1
31
31
0
A
60
15
10
7
0
4
0
4
Trachea
B
60
6
2
4
0
0
0
0
c
60
14
2
7
7
17
17
0
A
25
21
21
6
0
18
18
0
Feces
B
25
17
17
5
0
17
17
0
C
25
5
3
1
5
6
6
0
/4=co/onizafion on admission; B=persisfen/ co/onizafion; C=ac<juired co/onizafion; ' non-ppmo inc/udes
<4cinefob<icter spp., F/auofcacferium indo/ogenes, /icnromobacter spp. and i4/cn/ig(?n« xy/osoxydans
/n/ecf/o«s
Thirteen patients (21%) developed an episode of VAP (Table 2). Ppmo were isolated
in significant numbers from samples obtained by PSB and/or BAL in 7 patients
(11%). In all these cases pneumonia was caused by Psendomo/jas aerMginosa, in 1
patient in combination with Enterobacter spp.. In 6 patients (10%) pneumonia was
caused by bacteria not belonging to the group of ppmo. In all these cases pneumonia
was polymicrobial involving EwferococcMS /aeca/i's, in combination with
Pseudomcmas aerug/noso (1 patient), or Sfap/iy/ococcus epidermidis (3 patients), or
Acinetobacter spp. (3 patients), or /4/ca//'ge«es xy/osoxydans (1 patient). In 5 of these
patients pneumonia was preceded by colonization of the oropharynx with
Enferococcus /aeca/is, and in two of them it was accompanied by bacteremia (cases 1
and 2, Table 4). Bacteremia with EnferococcKS /aeca/is but without evidence of
pneumonia was demonstrated in two patients (cases 7 and 8, Table 4).
DISCUSSION
This study reveals some important microbiological findings regarding the use of the
combination of TAP and sucralfate in mechanically ventilated ICU-patients. In the
first place, when compared to colonization rates reported in SDD trials, the results
of this open and uncontrolled study strongly suggest that the combination of TAP
and sucralfate had, without eradicating ppmo from the fecal flora, a similar
preventive effect on colonization of the respiratory tract with ppmo. In addition,
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two limitations of this regimen were encountered: colonization and infection of the
respiratory tract by Gram-negative rods from exogenous origin and a tendenc
towards colonization of oropharynx and trachea by Enterococcws
4: MicroWo/ogica/ resu/ts of pa/ienfs (feve/oping V.AP and/or bacteremia invo/ving Entero
/aeca/i's.
case:
Pneumonia:
E. faecalis cultured from: '
oropharynx:
trachea:
Gramstain: *
no of PMN:
no of GPC:
PSB/BAL
blood
>20 <5 >20
NA
>20 <5
NA
1-2
5-20
_
2-10
<5
NA
0
0
NA
M4 = no cu/ture avai/ab/e; ' + = positive cu/fure /or Enferococcus /aeca/i's; - = negative cu/fure /or
EnlerococcHS /aeca/is; ' PMN = po/ymorp/ionuc/ear /eucocytes per Jiign potyer /ie/d (400x ;^ GPC =
Gram-positive cocci in pairs or c/iains per oi7 /ie/d (lOOOx)
A finding of special interest was the colonization with EnterococcMS /aeca/is of
oropharynx or trachea in 31 out of 61 patients enrolled in the protocol. An increased
colonization by Gram-positive cocci has been reported by others (10,11,21), but was
often considered as representing commensal flora of the oropharynx, and therefore
not included in the reported colonization rates (6-8,14-16). However, in the present
study eight cases of pneumonia and/or bacteremia, involving Enterococcus /aeca/is
were demonstrated. Although infections caused by Enterococci have been reported
in other studies as well (8,21), pneumonia due to these microorganisms is rare.
Therefore, an incidence rate of 10% for VAP is extremely high and has never been
reported. The positive quantitative cultures obtained by PSB and BAL, sometimes
accompanied by bacteremia, strongly suggested that Enterococcus /aeca/is had an
etiologic role in the development of pneumonia in our patients. Although this was
not a randomized controlled study, we hypothesize that TAP modified the bacterial
flora of the patients under study, resulting in high colonization rates with species
intrinsically resistant to the antibiotics used, and leading to pneumonia caused by a
microorganism generally considered not to cause respiratory tract infection. The
causal relationship between the use of TAP and the development of colonization
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and infections with Gram-positive bacteria, intrinsically resistant to the topical
antibiotics used for prophylaxis, needs confirmation and further study.
With regard to eradication of ppmo from oropharynx and trachea our results are
comparable to the results of other studies (6-16, 21). In most studies non-absorbable
antimicrobial agents were applied to the oropharynx and administered to the
digestive tract with or without systemic prophylaxis to eradicate ppmo from the
colon (6-13,16). In contrast, our regimen did not attempt to eradicate ppmo from the
colon per se and, indeed, it did not. Three other studies using topical antimicrobial
prophylaxis of the oropharynx and stomach, but without the use of sucralfate, have
been published, but did not report the effect of the regimen on the fecal flora
(15,16,21). To our knowledge this is the first study in which it was shown that
colonization of the upper respiratory tract with ppmo from endogenous origin
could be prevented without eradicating ppmo from the fecal flora.
In the present study three patients developed pneumonia caused by Gram-negative
rods not belonging to the defined group of ppmo. These bacteria (i.e. Acinetobacter
spp. and A/ca/i'genes xy/oscm/cfo/is) colonized the trachea, without colonization of
the oropharynx. In six cases acquired colonization probably took place from an
exogenous source, thereby bypassing the assumed protective effect of TAP in
oropharynx and stomach, since these species were not cultured from oropharynx.
Acquisition with Acinetobacter spp. has been described to originate from hands and
gloves of nurses and doctors as well as from ventilation machines (22).
In conclusion, this regimen was successful in preventing colonization of
oropharynx and trachea with ppmo from endogenous origin, without intravenous
antimicrobial prophylaxis and without eradication of ppmo from the colon.
However, a tendency towards colonization and infection by Enferococcus
and exogenously acquired Gram-negative bacteria was demonstrated.
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CONTINUOUS ENTERAL FEEDING COUNTERACTS PREVENTIVE MEASURES
FOR GASTRIC COLONIZATION IN ICU-PATIENTS
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SUMMARY
The influence of continuously administered enterai feeding on gastric pH and;
gastric colonization was tested in patients receiving and not-receiving Topical
Antimicrobial Prophylaxis of oropharynx and stomach, including sucralfate as stress
ulcer prophylaxis. This prospective open trial was performed in two general ICU's in
a university hospital. Patients admitted to ICU for at least 5 days were eligeble for
this study.
Thirty-one patients received antimicrobial agents into the stomach and oropharynx
in combination with sucralfate (1 g every 6 hours) as stress ulcer prophylaxis. Sixty-
four other patients did not receive antimicrobial prophylaxis or sucralfate. These
patients received stress ulcer prophylaxis with antacids, ^-antagonists, or
omeprazole if indicated. Gastric colonization and gastric pH were measured on
admission and subsequently at least twice a week. Forty-eight patients (14 receiving
and 34 not-receiving antimicrobial prophylaxis) received enterai feeding.
Both enterai feeding and stress ulcer prophylaxis other than sucralfate
independently increased gastric pH: the risks for gastric pH >3.5 were 4.54 and 2.04
(Odds ratios) respectively. Enterai feeding also increased the risk for gastric
colonization by potentially pathogenic microorganisms (Odds ratio=4.52). Patients
receiving both topical antimicrobial prophylaxis and sucralfate remained free of
gastric colonization for a longer period than those receiving acid inhibitory stress
ulcer prophylaxis. In these two groups, patients without enterai feeding remained
free of gastric colonization for a longer period than those receiving enterai feeding.
Topical antimicrobial prophylaxis, in combination with sucralfate, successfully
prevented gastric colonization with potentially pathogenic microorganisms and
seemed to be correlated with lower gastric pH values. However, the risk of gastric
colonization was markedly increased when continuous enterai feeding was
administered simultaneous'"
Enterai Feeding
INTRODUCTION
The stomach has often been described as an important source for colonization of the
upper respiratory tract with subsequent pneumonia in mechanically ventilated ICU-
patients (1,2). In these patients gastric pH, in physiological situations an effective
barrier against bacterial growth (3), may be artificially elevated for several reasons.
An alkaline gastric environment may be the result of stress ulcer prophylaxis, either
due to inhibited acid production (H2-blocking agents, omeprazole) or to alkalization
of gastric contents through antacids or enterai feeding. Based on the assumed
importance of gastric colonization as a source for nosocomial pneumonia several
regimens have been developed to prevent gastric bacterial growth. Topical
application of non-absorbable antibiotics to selectively decontaminate the digestive
tract included application of these agents to the stomach (4). In another study
sucralfate was used as stress ulcer prophylaxis, leaving gastric acidity intact (5,6).
Although decreased incidences of nosocomial pneumonia were reported with both
regimens (5,6), other reports failed to show any benefit (7-11).
Since enterai feeding may interfere with these preventive measures, due to its effect
on gastric pH (12), we studied the influence of different stress ulcer prophylactic
agents and enterai feeding on gastric pH in 95 ICU-patients, admitted to ICU for at
least five days. In addition, the efficacy of a regimen to prevent gastric colonization,
using both topical antimicrobial prophylaxis and sucralfate, was determined with
and without simultaneous administration of enterai feeding. The primary outcome
parameters in this study were gastric pH and gastric colonization.
MATERIAL AND METHODS
Study-design
The study was conducted prospectively in two identical eight-bed ICU's at the
University Hospital of Maastricht. Both ICU's housed a mixed population of
trauma, medical, surgical and neurological patients. Pédiatrie patients were excluded
from the study. Age, gender, severity of illness, medical condition and need of
mechanical ventilation were recorded on admission.
Patients admitted to ICU were allocated to receive either no antimicrobial
prophylaxis and conventional stress ulcer prophylaxis, if indicated (group A), or
topical antimicrobial prophylaxis in combination with sucralfate (group B). Group A
(n=64) received, if indicated, stress ulcer prophylaxis with one of the following
agents: Antacids (n=34) (40 mg aluminumoxide/ 20 mg magnesiumhydroxide per
ml, 15 ml q.4h., p.o.), ^-antagonists (n=10) (ranitidine, 50 mg q.8h., i.v.) or
omeprazole (n=6) (40 mg q.8h., i.v.). Group B (n=31) received topical antimicrobial
prophylaxis, which included four times a day:
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- suspension of tobramycin (8 mg/ml) and colistin (5 mg/ml) 1 ml in each nostril
and 5 ml through nasogastric tube
- suspension of amphotericin B (100 mg/ml) 0.5 ml in each nostril and 2.5 ml
through nasogastric tube
- application of tobramycin/colistine/amphotericin B 2% in Orabase to oropharynx
-1 g sucralfate suspension through nasogastric tube.
To analyze colonization with potentially pathogenic microorganisms with time both
groups were subdivided into 2 separate groups (Al and A2, Bl and B2), according to
whether enterai feeding was simultaneously administered or not. Episodes were
analyzed, provided gastric samples were free of colonization with potential
pathogenic microorganisms on the first day of the episode and the patient could be
studied for at least five days. Thus a patient could be included sequentially in two
groups, provided there was no gastric colonization with potential pathogenic
microorganisms on the first day of the episode studied. Thus, four groups were
formed: Patients in group Al (n=9) did not receive topical antimicrobial prophylaxis
with sucralfate or enterai feeding. Patients in group A2 (n=13) did not receive
antimicrobial prophylaxis and sucralfate, but did receive enterai feeding. Patients in
group Bl (n=12) received topical antimicrobial prophylaxis and sucralfate but no
enterai feeding, while those in group B2 (n=9) received antimicrobial prophylaxis,
including sucralfate, in combination with enterai feeding.
Informed consent was obtained from the patient or, if this was not possible because
of the clinical condition, from a representative of the family. The study protocol was
approved by the hospital ethical committee.
To assess the severity of acute illness the APACHE II score was calculated on
admission to the ICU as described elsewhere (13). In all patients enterai feeding was
started when possible.
De//m fi'ows
Colonization was defined as the isolation of microorganisms from gastric aspirate.
Colonization on admission was established by a positive culture obtained within 48
hours after admission to the ICU. Colonization was designated as 'acquired' if there
were positive cultures of the same species of microorganisms from at least two
consecutive samples, where the first was taken no sooner than 48 hours after
admission to the ICU. Sterile cultures were labelled as 'no colonization'. Persistent
colonization was defined as colonization, present on admission and persisting for at
least three days.
In the analysis of colonization species of microorganisms were grouped as follows:
Enterobacteriaceae, Pseudomonadaceae, £«ferococc«s /aeca/j's and finally yeasts.
Enterobacteriaceae and Pseudomonadaceae were considered as potentially
pathogenic microorganisms (ppmo).
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Colonization was assessed by collecting gastric aspirates on admission and
subsequently at least twice a week. Samples were taken in the morning immediately
before administration of medication. Gastric juice was aspirated into a sterile vial
after the first 10 ml of gastric juice had been discarded.
Colonization was analyzed semi-quantitatively as follows: 10 ul of gastric aspirate
was streaked using the four-quadrant streak method on sheep blood, CLED,
chocolate, and Sabauroud plates. All media were incubated at 35.0 °C for 18 to 24
hours. Growth density was graded as follows: growth in the first quadrant= + 1, in the
second quadrant=+2, in the third quadrant=+3, and on the whole plate=+4. Indicator
papers were used to measure the pH of the aspirate (Schleicher & Schiill, range from
0-12). All samples were processed and cultured by the same analyst.
Enterai feeding ("Nutrison", Nutricia, Zoetermeer, The Netherlands) was
administered by nasogastric tube and prescription was taken care of by the
nutritional support team, which also delivered the feedings in sterile containers to
the ICU. The pH of enterai feeding was 7.0. Enterai feeding was administered
continuously.
ana/i/s/s
Comparisons of proportions were analyzed by Chi-square test. The relationship
between variables influencing gastric pH and rate of gastric colonization was tested
by stepwise logistic regression analysis. The probability of remaining free of
colonization with potentially pathogenic microorganisms in time was calculated
using the Kaplan-Meyer estimate, followed by a log-rank test for comparisons
between groups. A probability value of less than 0.05 was considered significant.
RESULTS
Pflfienfs
The characteristics of all patients are listed in table 1. No significant differences were
observed between group A and B. Of those patients not receiving topical
antimicrobial prophylaxis (group A), most received either antacids (34/64, 53%) or
H2-antagonists (10/64, 16%). Six out 64 patients (9%) received omeprazole because of
peptic ulcers in the medical history. In 14 patients (22%) stress ulcer prophylaxis with
antacids or ^-antagonists was discontinued and a period of at least five days
without stress ulcer prophylaxis could be studied.
Forty-eight patients, 34 in group A (53%) and 14 in group B (45%) received enterai
feeding for a period of at least five days. Forty patients, 26 in group A (41%) and 14 in
group B (45%), did not receive enterai feeding for a period of at least five days. Seven
patients were studied twice, one period with and one without enterai feeding.
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Tab/e 1: C/iaracterisfics 0/ Me patients
Characteristics
mean age (range):
Male/Female
days on ICU; mean (range):
APACHE II; mean (SD):
Medical conditions: *
cardiovascular disease
gastrointestinal disease
respiratory disease
alcoholism/drug abuse
neoplastic disease
diabetes mellitus
neurologic disease
Number of patients intubated:
Medical department:
surgery
trauma
medical
pulmonology
neurology
Enterai feeding: *
yes
no
both
stadïed
No. of patients (total
Group A
no TAP ' (n=64)
61.0 (17-69)
42/22
25.1 (5-145)
18.0 (8.0)
29
10
24
4
14
8
10
59
24
9
16
10
5
34
26
4
n=95)
Group B
TAP (n=31)
59.9 (23-80)
20/11
20.2 (6-95)
18.6 (9.2)
13
1
9
2
8
1
5
31
11
3
9
7
1
14
14
3
' = 7V4P= (opi'ca/ anfimicrobia/ prop/iy/axis; * = For eacn patient more /«an one condition is possible.
* = The number 0/ periods, 0/ at /east /iue days, with or wi'fnout entera/ /eeding. For 7 patients bod
periods cou/d be studied.
Gflsfn'c pH
Gastric pH of 308 samples was determined. The correlation between enterai feeding,
pH-raising medication and a gastric pH <3.5 is shown in figure 1. Three out of 75
(4%) gastric samples obtained from patients receiving pH-raising stress ulcer
prophylaxis and enterai feeding, had a gastric pH <3.5, whereas 17 out of 52 (33%) of
gastric samples obtained from patients with neither stress ulcer prophylaxis nor
enterai feeding had a pH <3.5 (p<0.00001, Chi-square). Stepwise logistic regression
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analysis showed that enterai feeding increased the risk for a gastric pH >3.5 by a
factor 4.54 (95% confidence interval: 2.30-8.96) and the absence of sucralfate for stress
ulcer prophylaxis increased this risk by a factor 2.04 (95% confidence interval: 1.06-
3.95).
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without pH raising
medication (n=104)
With
enterai feeding
with pH raising
medication (n=77)
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Figure 2; Percentage o/ gasfn'c samp/fs u>if/i pH <3.5 according fo simu/faneous/y administered entera/
/ d i and/or 'gasfric pH raising' sfress u/cer prop/jy/ajris. Statistics: /42 versus 82 p=0.J3: -42 uersus
p=0.002; A2 uersus B3 p<0.00003; B2 uersus /U p=0.09; B2 versus B3 p<0.00001; Al versus Bl p=0.0009
/ fey Chi-sauare).
Gflsfn'c
Altogether, 434 gastric samples from 95 patients were cultured, yielding 699 isolates
(Table 2). Enterobacteriaceae were most frequently isolated. Yeasts and Enterococcus
faecalis were isolated from 65 and 126 gastric samples, obtained from 41 and 49
patients respectively.
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On admission 24 out of 64 patients (37%) in group A and 13 out of 31 patients (41%jj
in group B were not colonized in the stomach. In those colonized
Enterobacteriaceae (25/64, 39% in group A and 7/31, 23% in group B; p>0.05) ar
yeasts (19/64, 29% in group A and 9/31, 30% in group B) were isolated mos
frequently. On admission, pseudomonadaceae were not cultured from gastric
samples of patients in group A and from samples of only 2 patients (7%) in group B.j
On admission, EnterococcMS /aeca/zs was isolated from samples of 7/64 (11%) and
3/31 (10%) patients in group A and B respectively.
As expected, differences in colonization during ICU-stay were observed betwee
groups A and B. Acquired colonization with Enterobacteriaceae was less frequently
observed in patients receiving topical antimicrobial prophylaxis (group B): 3 out
31 patients (10%) versus 24 out of 64 patients (38%) in group A, p=.009. The
difference in persistent colonization with Enterobacteriaceae between both groups
11/64 (17%) in group A and 2/31 (6%) in group B, did not reach statistica
significance. In group A ten patients (16%) acquired colonization with
pseudomonadaceae and nine (14%) with yeasts. Although acquired colonization^
with these species tended to be higher in group A than in group B (one patient with
Pseudomonadaceae (3%) and none with yeasts), these differences did not reach
statistical significance. Acquired colonization with Enterococcus /aeco/zs, intrinsically
resistant to colistin and tobramycin, tended to occur more frequently in patients
from group B: 20 out of 31 patients (32%) versus 12 out of 64 patients (19%) in group
A (difference not significant).
In patients not receiving the regimen of sucralfate and antimicrobial prophylaxis the
influence of enterai feeding on gastric colonization was determined by stepwise
logistic regression analysis. Enterai feeding was significantly correlated to gastric
colonization with ppmo (Odds ratio=4.52; 95% confidence interval; 2.61-7.83).
Altogether, 43 episodes of at least five days, without colonization with ppmo on the
first day, could be analyzed (Figure 2). The episodes were divided over 4 groups: 9
episodes in group Al (no topical antimicrobial prophylaxis, no sucralfate, and
without enterai feeding), 13 episodes in group A2 (no topical antimicrobial
prophylaxis, no sucralfate, and with enterai feeding), 12 episodes in group Bl (topical
antimicrobial prophylaxis without enterai feeding) and 9 episodes in group B2
(topical antimicrobial prophylaxis with enterai feeding). Acquisition of colonization
with ppmo differed widely between the groups (p<0.0001, log-rank test). Topical
antimicrobial prophylaxis, in combination with sucralfate, prevented colonization
successfully, provided no enterai feeding was administered: almost all patients from
group Bl remained free of gastric colonization. The length of the colonization-free
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period was shorter in patients receiving antimicrobial prophylaxis combined with
enterai feeding (group B2), although the difference did not reach statistical
significance (p=0.2194, log-rank test for group Bl to B2). The length in colonization-
free periods of patients in group B2 (topical antimicrobial prophylaxis with enterai
feeding) was comparable to the length of these periods in patients not receiving
topical antimicrobial prophylaxis and sucralfate, or enterai feeding (group Al)
(p=0.3505, log-rank test for group B2 to Al). The difference in length of the
colonization-free periods between group Bl and group Al was statistically significant
(p=0.0222, log-rank test for group Bl to Al). Colonization most rapidly occurred in
enterally fed patients, who also received 'gastric pH raising' stress ulcer prophylaxis
(group A2). The differences in length of colonization free periods between group A2
and each of the other groups was statistically significant.
TflW« 2: /terofric and /ncu//flh'ye anaerobic microor^flnisms isolated /rom gastric asptrates (n=434.) 0/ 95
mfensiue care unit porienfs.
Culture positivity according to isolated species
Microorganism
Enterobacteriaceae
Escherichia coli
Klebsiella species
Enterobacter species
Proteus vulgaris
Morganella morganii
Hafnia alvei
Serratia species
Citrobacter freundii
Pseudomonadaceae
Pseudomonas aeruginosa
Xanthomonas maltophilia
Other Gram-negative m.o.
Acinetobacter species
Alcaligenes xylosoxydans
Flavobacterium indologenes
Gram-positive m.o.
Staphylococcus aureus
Staphylococcus epidermidis
Enterococcus faecalis
Streptococci
Yeasts 65 41
No. of gastric samples
83
131
39
25
12
2
7
6
39
10
16
2
12
7
5
126
2
No. of patients
26
39
27
9
5
1
3
5
21
6
11
2
3
6
4
49
2
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sfc
6 7
days
10 11 12 13 14
Figure 2: Knp/«n-Mej>r estimate o/ f/ie probnbi/ify o/ remaining /ree o/ co/oniza(ion u>if/i pofenfifl//y
puf/iogem'c microorganisms in f/ie stomncfi in /our groups o/ patients. /W/ paficii/s were /ree o/
co/oniza/ion u>it/i potenfin//y paf/iogenic microorganisms on day 0. Group /M (OJ, receiving 'gastric
pH-raising' stress u/cer prop/ty/axis u>if/iouf e/ifera/ /eeding; group *42 (—), receiuing 'gasfric-pH
raising' stress u/cer prop/ty/axis and entera/ /eeding; group BI (X), receiving fopiea/ antimicrobifl/
prop/iy/axis u>it/iout entera/ /eeding; group B2 ( • ) , receiving fopiea/ antimicrobia/ prop/iy/axis uni
entera/ /eeding. T/ie numbers in f/ie /igure re/er to t/ie numbers o/ patients /ree o/ co/onizafion îfifi
ppmo at days 7 and 14. Statistics: Bl versus B2 p=0.2194; B] versus /41 p=0.0222; Bl versus A2 p<0.0001;
B2 versus ^41 p=0.3505; B2 versus i42 p=0.0014; Al versus A2 p=0036 fa// by /og-ran/c test}.
DISCUSSION
The main feature of this study is that gastric colonization was lower in a group of
ICU-patients receiving a combination of non-absorbable topical antimicrobial agents
and sucralfate, as compared to a group of patients not receiving antimicrobial
prophylaxis and sucralfate for stress ulcer prophylaxis. In addition, we found this
difference to be less apparent when enterai feeding was administered
simultaneously. Enterai feeding seemed to be an important risk factor for an
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increase in gastric pH and for gastric colonization at least under the circumstances
tested.
There is limited evidence supporting the hypothesis that gastric colonization plays a
causal role in the development of nosocomial pneumonia (2). In this
gastropulmonary route of colonization and infection the stomach would play a
crucial part, as it is the first obstacle for enteric bacteria to pass. In healthy subjects
gastric pH is below 3.5, which proved to be bactericidal for most species of
microorganisms (3,14). A correlation between a high gastric pH, either due to
hypochlorhydria or achieved artificially with stress ulcer prophylactic agents, and
bacterial colonization of the stomach has been described (15-18).
The combination of topical antimicrobial prophylaxis and sucralfate, administered
to 31 patients, modulated gastric colonization: a significant lower percentage of
patients acquired colonization with Enterobacteriaceae as compared to patients not
receiving topical antimicrobial prophylaxis. Moreover, acquired colonization with
Pseudomonadaceae and yeasts were also lower in patients receiving antimicrobial
prophylaxis, although statistical significance was not reached. In contrast, a tendency
towards increased colonization with E/iferococcus /oeca/is, intrinsically resistant to
tobramycin and colistin, was observed in patients receiving topical antimicrobial
prophylaxis. These differences could not be attributed to differences in colonization
on admission, because colonization rates for these microorganisms were comparable
for patients receiving and not-receiving topical antimicrobial prophylaxis. Increased
colonization with Enferococci/s /aeca/z's as a side-effect of this regimen, occasionally
leading to pneumonia and bacteremia, has been reported before (19,20).
The use of topical antimicrobial prophylaxis and sucralfate seemed to be associated
with lower gastric pH-values as compared to the pH-values obtained from a group of
patients of whom most received either antacids, ^-antagonists or omeprazole.
However, it should be stated that the administration of topical antimicrobial
prophylaxis with sucralfate, and antacids or ^-antagonists, was not performed in a
randomized matter, and that a control group without any stress ulcer prophylaxis
was lacking. The observation of lower pH values in gastric samples of patients
receiving sucralfate as compared to those from patients receiving antacids or H2-
antagonists is in line with other reports (5,6). However, in patients receiving
sucralfate a low gastric pH was less frequently observed when enterai feeding was
administered concurrently. As a result, the preventive effect of the prophylactic
regimen on gastric colonization was markedly decreased by concurrent
administration of enterai feeding.
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The same effect of enterai feeding was observed in those patients receiving stn
ulcer prophylaxis aimed to raise gastric pH: the number of gastric samples with a L
gastric pH was lower in patients receiving enterai feeding. Furthermore, in logisti
regression analysis enterai feeding appeared to be an independent risk facti
associated with colonization. The same correlations between enterai feediiv
increased gastric pH and gastric colonization have been observed before (12,21,22]
Pingleton described 18 mechanically ventilated patients receiving enterai feeding
who had a mean gastric pH above 4.0 and who all had gastric colonization at som
time during the study. However, of only four of these patients no growth was fount
in the initial gastric culture and patients were studied for only six days (21). In ;
randomized, double-blind trial acidified enterai feeding resulted in lower meai
gastric pH-values and lower gastric colonization rates as compared to those observe<
among patients receiving normal enterai feeding (22).
Although the current study was neither randomized nor blinded, the results of thi
study seem to support an important influence of enterai feeding on gastri
colonization. However, as in most other studies gastric pH was determined i n
infrequent samples with indicator paper. The use of continuous intragastric pr«
monitoring probably has major advantages. One of the drawbacks of the pH paper
method is that temporary changes in gastric pH cannot be measured (23). Moreover,
the reliability of the pH paper has been questioned (24), but others report a good
correlation between the pH paper method and a pH meter (r=.94, p<0.001) (25). To
overcome the interobserver variations using indicator paper for pH measurement
(26), all analyses were performed by the same technician, who was unaware of the
patients' medication.
In conclusion, the results of the present study show that a combination of non-
absorbable antimicrobial agents and sucralfate modulates gastric colonization in
mechanically ventilated ICU-patients, provided enterai feeding is not administered
simultaneously. Enterai feeding increased the risk of gastric colonization both in
patients receiving, as well as in patients not receiving the prophylactic regimen.
Based on these observations, enterai feeding, administered intermittently, may be
more appropriate since gastric pH may fall when enterai feeding is stopped, thereby
possibly preventing gastric colonization. The first two studies testing this hypothesis
have been reported recently (27,28). In view of the equivocal results of these
investigations, further studies, using continuous intragastric pH monitoring, are
therefore needed to confirm this hypothesis.
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COLONIZATION IN PATIENTS RECEIVING AND NOT-RECEIVING TOPICAL
ANTIMICROBIAL PROPHYLAXIS
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SUMMARY
The influence of Topical Antimicrobial Prophylaxis (TAP) on colonization of
oropharynx and trachea with potential pathogenic microorganisms was studied in
patients receiving and not-receiving prophylaxis. Twenty-two patients in ICU I
(group 1) received TAP, containing tobramycin, colistin and amphotericine B,
applied to the oropharynx and stomach. Simultaneous to group 1, a second group
of patients (group 2, n=21) that did not receive TAP was studied in ICU I. In
addition, a control group of patients admitted to another, identical, ICU (ICU II),
where no TAP was administered, were studied simultaneously (group 3a, n=23). A
second control group (group 3b, n=31), was formed by collecting data from all
patients admitted to ICU I in period II, which started after administration of TAP
had been stopped for one month.
Patients receiving prophylaxis were less frequently colonized in oropharynx or
trachea as compared to patients not-receiving prophylaxis. Moreover, of the
patients not-receiving prophylaxis, those staying in the ICU where prophylaxis was
administered (group 2), were less frequently colonized as compared to patients in
another ICU where no prophylaxis was administered (group 3). Of the patients not
colonized on admission, those staying in the ICU where prophylaxis was
administered (groups 1 and 2) remained free of colonization for a longer period of
time as compared to non-colonized patients in the ICU where no prophylaxis was
administered (group 3). In addition, in the ICU where no prophylaxis was
administered more patients were colonized simultaneously and cross-acquisition
occurred more frequently. In conclusion, TAP administered to oropharynx and
stomach significantly influenced colonization of oropharynx and trachea in
patients receiving and not-receiving prophylaxis within the same ICU as compared
to patients not-receiving prophylaxis in another identical ICU.
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INTRODUCTION
Lower respiratory tract infections in mechanically ventilated patients are usually
preceded by colonization of oropharynx and trachea with the same microorganisms
(1). These microorganisms reach the upper airways from exogenous sources or
from the gastrointestinal tract: the endogenous route. The latter has been accepted
as an important route of colonization leading to infection, especially in critically ill
patients (2). Based on the assumed importance of the endogenous route of
colonization several regimens have been developed to prevent colonization and
infection of the lungs. Non-absorbable antibiotics applied to oropharynx and
digestive tract to selectively eradicate potential pathogenic microorganisms (ppmo)
from these sites reduced the incidence of nosocomial pneumonia (3,4), although
other studies failed to confirm this (5,6).
To reduce the risk of colonization and infection from exogenous sources standard
protocols are used and strict hygienic measures should minimize the risk of
acquisition of microorganisms from equipment or ICU employees (7,8). However,
cross-acquisition from one patient to another might still be an important cause of
colonization in the ICU, where patients, colonized in oropharynx and trachea, act
as a reservoir of microorganisms (9).
Therefore, antimicrobial prophylaxis may not only prevent colonization in the
individual patient but might also influence cross-acquisition in an ICU. On the one
hand, it would be plausible that patients not receiving topical antimicrobial
prophylaxis, lying next to patients receiving prophylaxis, are protected against
acquisition of microorganisms. On the other hand, prophylactic use of
antimicrobial agents could lead to an increased colonization and spread of resistant
microorganisms. Indeed, cross-acquisition between patients in an ICU often has
been suggested to play an important role in the pathogenesis of nosocomial
pneumonia and therefore should be taken into account when developing and
evaluating preventive regimens. We studied colonization of oropharynx and
trachea in patients receiving Topical Antimicrobial Prophylaxis (TAP) and control
patients, not-receiving TAP, in the same ICU as compared to patients in another
identical ICU.
MATERIAL AND METHODS
Study-design
The study was conducted prospectively in two identical eight-bed ICU's at the
University Hospital of Maastricht in two four-months periods. Both ICU's
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contained a mixed population of trauma, medical, surgical and neurological
patients. During period I TAP was administered to mechanically ventilated patients
in ICU I if they met the following criteria: newly admitted to the ICU, intubation
within 24 hours after admission, age above 15 years and an expected ventilation
period of more than five days.
For every newly admitted patient who met the inclusion criteria, a decision was
made whether to administer TAP or not, based on the number of patients receiving
and not-receiving prophylaxis at that moment. As shown in Figure 1, in ICU I two
groups were formed consisting of patients receiving (group 1) and not-receiving
TAP (group 2). Patients admitted to the other ICU formed group 3a and served as
controls. A second control group (group 3b) was formed by collecting data from all
patients admitted to ICU I in period II, which started after administration of TAP
had been stopped for one month.
ICUl
GROUP 1
n = 22
GROUP2
n = 21
ICUl
GROUP 3B
n = 31
ICU 2
GROUP 3A
n = 23
1 month
4 months 4 months
Figure 1: Study design and number o/ pu/ients m /he dijfjferenf groups in /CU / and //.
Medicah'on
TAP consisted of the following regimen four times a day:
- suspension of tobramycin (8 mg/ml) and colistin (5 mg/ml) 1 ml in each nostril
and 5 ml through nasogastric tube
- application of tobramycin/colistin/amphotericin B 2% in Orabase to oropharynx
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- suspension of amphotericin B (100 mg/ml) 0.5 ml in each nostril and 2.5 ml
through nasogastric tube
-1 g sucralfate suspension (5 ml) through nasogastric tube.
A constant equilibrium between patients receiving (group 1) and not receiving the
prophylactic regimen (group 2) was aimed for. Since the ward contained eight beds
a maximum of four patients were studied simultaneously in group 1. In case of an
equal number of patients receiving and not receiving TAP, the next admitted
patient fulfilling the inclusion criteria would receive prophylaxis.
In total 188 patients, newly admitted to the ICU's in the defined periods, were
included in the study of whom 97 stayed for at least 5 days in ICU: 22 in group 1, 21
in group 2 and 54 in groups 3a and 3b. To assess the severity of acute illness the
APACHE II score was calculated on admission to the ICU as described elsewhere
(10). Clinical parameters, antibiotic therapy and laboratory values were recorded
prospectively.
Informed consent was obtained from the patient or, if this was not possible because
of the clinical condition, from a representative of the family. The study protocol
was approved by the hospital ethical committee.
monifonwg
Colonization was assessed by collecting oropharyngeal swabs and trachéal aspirates
serially on admission and subsequently at least twice a week. Samples were taken
in the morning immediately before administration of medication. Oropharyngeal
swabs and trachéal aspirates were examined for ppmo. Colonization was analyzed
semi-quantitatively as follows: Oropharyngeal swabs and 10 |il of trachéal aspirate
were streaked using the four-quadrant streak method on sheep blood, CLED,
chocolate, and Sabauroud plates. All media were incubated at 35.0 °C for 18 to 24
hours. Growth density was graded as follows: growth in the first quadrant= + l, in
the second quadrant=+2, in the third quadrant=+3, and on the whole plate=+4.
Gram-negative rods and lactose-fermenting microorganisms were identified using
the API20E/20NE-system (Biomérieux). Susceptibilities to antimicrobial agents
were determined using a microdilution method in ISO-Sensitest-Broth (Oxoid CM
471). The minimal inhibitory concentration (MIC) was defined as the lowest
concentration at which no visible growth was apparent after overnight incubation
at 37.0 °C. For all species susceptibilities were determined to at least six different
antimicrobial agents, including tobramycin. Antimicrobial susceptibilities were
analyzed for the five most frequently isolated Gram-negative microorganisms. The
breakpoints for resistance for Gram-negative microorganisms were as follows: > 128
mg/ml for piperacillin (for Pseudomonas aeruginosa and >64 mg/ml for
Enterobacteriaceae), > 32 mg/ml for amikacin, amoxycillin, ceftazidim, cefuroxim
and tobramycin, > 16 mg/ml for ciprofloxacin and >8 mg/ml for gentamicin.
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o/
Colonization was defined as the isolation of microorganisms from oropharynx and
trachéal aspirate. Colonization on admission was established when the first culture
obtained in the ICU, and obtained within 24 hours after entrance, was positive at
any of these sites. Colonization was designated as 'acquired' if cultures were
positive at two consecutive occasions and no colonization with that particular
species was present on admission. Persistent colonization was defined as
colonization, present on admission and persisting for at least three days.
To determine the time from admission until colonization occurred a Kaplan-
Meyer analysis was performed for patients not colonized with potentially
pathogenic microorganisms on admission. The colonization-free periods in ICU I,
period I (patients groups 1 and 2) were compared to the colonization-free periods of
patients from group 3A and 3B.
For analysis several families of microorganisms were grouped together.
"Enterobacteriaceae" included Esc/jer/'c/iia co/i, K/ebsiW/a pneumom'ae, C/7robacfer
/rewnd;'i, Mor^a>ie//fl morgan/i, Enferobacfer c/oac«e and Profeus
"Pseudomonadaceae" included Pseudomonas aerugiViosa and
ma/Mop/ii/;'fl. Enterobacteriaceae and pseudomonadaceae were considered as
potentially pathogenic microorganisms (ppmo).
•Analysis o/ cross-acquis/'f/oii
The analysis of cross-acquisition was performed for four species (K/ebs/'e/Za
pneumoniae, Pseudomonas aerwgiwosa, Esc/jen'c/i/a co/i and Enferobocfer c/oacae),
each separately and grouped as ppmo. Since cross-acquisition was studied in a ward
rather than in separate patient groups, groups 1 and 2 were lumped together for
this analysis. A patient in whom a member of the specified species was isolated
from either the trachea or oropharynx was considered to be colonized. The
transmission rate was calculated as follows:
Transmission rate:
no. of events of transmission
no. of days of non-colonized pts at risk for transmission
The 'number of days of non-colonized patients at risk for transmission' was
calculated as follows: The total number of patient days in groups 1/2 and 3 was
calculated and from this the number of colonized and non-colonized patient days
was derived. Non-colonized patients could be at risk for transmission if another
patient in the ward was, at that particular day, colonized. Thus, non-colonized
patients at risk to acquire colonization from a colonized patient were identified and
the numbers of 'days of non-colonized patients at risk for transmission' were
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calculated. For this analysis each patient could be at risk for transmission of
colonization only once a day, no matter how many other patients were colonized
on that particular day.
An 'event of transmission' was defined as acquired colonization with a strain,
identical to a strain colonizing another patient in the same ward, before or on the
same day of colonization. Strains were deemed identical when biochemical
reactions (API-profile) were identical and when the MIC's to six antimicrobial
agents were concordant, i.e. when three out of six MIC values differed no more
than one step of a twofold dilution sequence in the MIC determination.
/n/ecrion cowtro/ measures i« f/ie 7CU
Both ICU's have an identical floorplan and infrastructure but a separate entrance,
approximately 20 meters apart. Each ICU has its own nursing staff, 3.5 nurse per
bed. In a rotating system the same medical staff took care of the ICU's. During both
study periods surveillance cultures were taken from all sanitary equipment in both
ICU's.
Diagnosis 0/ iw/ecf/on
Pneumonia was considered as ICU-acquired if a clinical condition fulfilling the
criteria for pneumonia developed after the patient had been in the ICU for at least
three days. The diagnosis of pneumonia was established when at least three of the
following criteria were met: (1) Rectal temperature above 38.0 °C or below 35.5 °C,
(2) blood leucocytosis (>10.103/mm3), leucopenia (<3.10Vmm3) and/or left shift, (3)
more than ten leucocytes per high-power field in Gram stain of trachéal aspirate
and (4) a positive culture from trachéal aspirate in combination with a new or
changing infiltrate on chest X-ray, not attributable to a noninfectious etiology, and a
positive quantitative culture from Bronchoalveolar Lavage (BAL) (cutoff point 10*
cfu/ml). Blood cultures were taken in case of fever or suspicion of sepsis. Collection
and processing of samples from BAL were performed as described elsewhere (11).
Sfflffsficfl/ ana/ysfs
Frequency comparisons were analyzed by Chi-square test or Fisher's exact test. The
Kaplan-Meyer estimate of the colonization free periods was tested with Cox
regression. In this analysis the number of patients colonized simultaneously in the
ward, colonization pressure, was tested as a fixed covariate - being the mean of
colonization pressure over the non-colonized days for each patient - and as a time-
dependent covariate. A Kaplan-Meyer estimate was performed for the three groups
separately and for group 1/2 as compared to group 3.
The analyses of transmission rates were performed with a Chi-square test according
to a Poisson Distribution. A probability value of less than 0.05 was deemed
significant.
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RESULTS
The characteristics of patients staying in ICU for at least 5 days are listed in Table 1.
The APACHE H-score could not be calculated for 6 patients, due to incomplete data.
All patients in group 1 were intubated. In group 2 and 3, 86% and 91% of the
patients, respectively, were mechanically ventilated. The median values for age,
APACHE Il-score and duration of ICU-stay of the three groups studied were
comparable. In all groups the majority of patients were surgical or medical.
Tofa/e 1: Characteristics o/ f/ie parienfs
Characteristics
age median
range
M/F
days in ICU median
range
APACHE II median
range
No. of patients intubated (%)
Medical specialty
surgery
trauma
medical
pulmonology
neurology
Stress ulcer prophylaxis (%)
sucralfate
antacids
^-antagonists
omeprazole
Systemic antibiotic use (%)
Mortality (%)
group 1
n=22
67.0
23-77
13/9
13.0
6-55
14.0'
5-38
22(100)
8
3
7
4
0
22(100)
0
0
0
16 (73)
7(32)
No. of patients
group 2
n=21
62.0
17-82
13/8
9.0
5-45
17.0^
6-32
18 (86)
7
3
8
2
1
0
12(57)
6(29)
3(14)
14 (67)
6(29)
group 3
n=54
65.0
17-90
32/22
15.5
5-145
17.0'
0-36
49 (91)
21
7
15
7
4
0
37 (69)
13(24)
4(7)
44(81)
14 (26)
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In groups 2 and 3 comparable percentages of patients received antacids, H2-
antagonists or omeprazole for stress ulcer prophylaxis. The number of patients
receiving systemic antimicrobial therapy and the mortality rates were also
comparable in the 3 groups.
The occupation of ICU-beds in ICU I where TAP was administered during study
period I is shown in Figure 2. The ratio of patients receiving and not-receiving TAP
was almost constant throughout the study.
60
"g 50
'S.
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5 40
x 30 •
1/1
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1 1 0 •
0
Weeks
D group 1 13 group 2 I excluded
Figure 2: Occupation 0/ beds by patients receiving and not-receiving TAP in /Cli / in period /, expressed
m number 0/ bed-days per ziieefc. The /CU contained 8 beds, so a /u// occupation uwu/d be 56 bed-days
per week. Patients eiduded mere those with an /CU-stay <5 days.
Colonizafion on adm/ssion (TaWe 2)
Trachéal aspirates from 85 patients and oropharyngeal swabs from 84 patients were
obtained for cultures within 24 hours after admission to the ICU.
The number of patients not colonized with microorganisms on admission were 13
(62%), 9 (50%) and 16 (35%) for groups 1,2 and 3 respectively, whereas colonization
with ppmo was demonstrated in 5 (24%), 8 (44%) and 20 (43%) patients in groups
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1,2 and 3 respectively. For the individual bacteria the percentages did not differ!
significantly among the three groups studied, although significance was]
approached for colonization rates with Pseudomonadaceae between groups 2 and 31
(p=0.06, Fischer's exact test).
In oropharynx 6 (30%), 8 (44%) and 15 (32%) patients were not colonized with]
microorganisms on admission for groups 1,2 and 3 respectively and at this site]
colonization with ppmo was demonstrated in 7 (35%), 8 (44%) and 19 (40%) patients!
for groups 1,2, and 3 respectively. The differences in number of patients colonized]
with Pseudomonadaceae in oropharynx in group 3 (2%), as compared to group 2J
(17%), approached statistical significance (p=0.06, Fischer's exact test).
TaWe 2: Numbers o/ patients f%) co/om'zed /n frac/iea or oropharynx on admission.
group 1 group 2 group 3
Patients included
Trachea
number of samples available
No colonization
p.p.m.o.
Enterobacteriaceae
Pseudomonadaceae
Staphylococcus aureus
others '
Oropharynx
number of samples available
No colonization
p.p.m.o.
Enterobacteriaceae
Pseudomonadaceae
Staphylococcus aureus
others '
22 21 54
21
13 (62)
5(24)
2(10)
3(14)
1(5)
3(14)
19
6(30)
7(35)
5(25)
2(10)
1(5)
9(45)
18
9(50)
8(44)
5(28)
3(17)
1(6)
3(17)
18
8(44)
8(44)
7(39)
3(17)
0
5(28)
46
16 (35)
20 (43)
14 (30)
1(2)
10(22)
9(20)
47
15 (32)
19(40)
16(34)
1(2)
3(6)
13(28)
= "ot/iers" iHc/uflV yeos/s, streptococci, MoraxeZ/a cathara/is and Enferococcus /fleca/is
Persisfenf co/onizofion (TaWe 3)
Persistent oropharyngeal colonization with Enterobacteriaceae occurred less]
frequently in patients from group 1 as compared to patients from group 3 (p<0.01,
Fischer's exact test), and group 2 (p<0.05, Fischer's exact test). Of those patients not-j
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receiving TAP (groups 2 and 3), equal proportions were persistently colonized with
Enterobacteriaceae in trachea and in oropharynx, indicating that colonization was
not eliminated in these patients.
Persistent colonization with Pseudomonadaceae, in oropharynx and trachea, was
demonstrated in comparable numbers of patients in the three groups.
TnWe 3: Numbers o/ patient
according to study group
persistent and acquired co/onization in oropharynx and frac/iea
Oropharynx
group 1 (n=22)
group2(n=21)
group 3 (n=54)
Trachea
group 1 (n=22)
group 2 (n=21)
group 3 (n=54)
Enterobacteriaceae
Persistent
(%')
0(0)
5(71)#
14 (88) ##
1(50)
4(80)
13 (93)
Acquired
(%*)
1(5)
2(10)
15 (28) "
2(9)
3(14)
15 (28)
Total
<%*)
1(5)
7(33)
29 (54) *
3(14)
7(33)
28 (52)*
Pseudomonadaceae
Persistent
(*')
2 (100)
0(0)
1 (100)
3 (100)
3 (100)
1 (100)
Acquired
<%*)
1(5)
210)
11 (20)
2(9)
1(5)
21 (39) *
Total
<%*)
3(14)
2(10)
12(22)
5(23)
4(19)
22 (41)
'= % o/ pafients co/onized on admission (see Tab/e 2)
'= % o/n// patients inc/uded in f/ie group (group 3 n=22, group 2 n=2I, group 3 n=54)
# p<0.05, Fischer's exact test /or group 2 and 3; ## p<0.03, Fischer's exact test /or group 3 and 3;
* p<0.01, Cni-square /or fnree groups; ** p<0.03, Chi-square /or group 2 and 3
co/omzafion (Tab/e 3)
Acquired colonization with Enterobacteriaceae in oropharynx occurred less
frequently in patients from group 1 as compared to patients from group 3 (p=0.01).
In addition, patients from group 2 tended to acquire oropharyngeal colonization
less frequently as compared to patients from group 3, although the difference did
not reach statistical significance: 15/54 (28%) versus 2/21 (10%) (p=0.08, Fischer's
exact test).
Acquired colonization in trachea also tended to occur less frequently in patients
from group 1 and 2 as compared to patients from group 3.
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Acquired colonization with Pseudomonadaceae occurred most frequently in
patients from group 3. The differences among the 3 groups were statistically
significant for acquired colonization in the trachea (p<0.01).
Toffl/ co/on izflfioM (ToWe 3)
Patients with persistent and/or acquired colonization were considered to form the
group of colonized patients within an ICU.
Numbers of patients colonized with Enterobacteriaceae differed significantly
between the three groups, both in trachea (p<0.01, Chi-square) and in oropharynx
(p<0.001), being highest in group 3 and lowest in group 1.
In contrast, total colonization with Pseudomonadaceae in the trachea was
demonstrated in comparable proportions of patients in the three groups. However,
this lack of difference was partly influenced by the lower proportion of patients
from group 3 being colonized with Pseudomonadaceae on admission. There was a
tendency of patients from group 3 to be more often colonized with
Pseudomonadaceae in the oropharynx as compared to patients from group 2
(p=0.06).
The proportion of patients in each group colonized with ppmo in oropharynx and
trachea in subsequent five day periods is shown in Figure 3. Patients from group 1
had lower colonization rates when compared to patients from groups 2 and 3.
Moreover, patients from group 2 had lower colonization rates when compared to
patients from group 3.
To exclude a selection bias between patients from group 2 and 3, a case-control
analysis was performed, in which all patients from group 2 were matched with 21
patients from group 3. Matching was based on age, hospitalization before admission
to ICU, APACHE II-score, intubation and medical specialty. In this analysis the
proportions of patients colonized in both control subgroups were comparable to
those obtained from the complete groups (data not shown). In addition, a separate
analysis of both subgroups 3a and 3b demonstrated comparable percentages of
patients colonized with Enterobacteriaceae and Pseudomonadaceae (Table 4).
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TflWe 4' Co/onizafion rates in subgroups 3^ 4 and 3B
Trachea! colonization Oropharyngeal colonization
Patients included
Colonization on admission:
Cultures available
ppmo (% ')
Enterobacteriaceae
Pseudomonadaceae
Staphylococcus aureus
Acquired colonization (% *):
Enterobacteriacea
Pseudomonadaceae
Persistent and acquired colonization
Enterobacteriaceae
Pseudomonadaceae
Group 3A
23
20
10 (50)
7(35)
0 (0)
6(30)
5(22)
10 (43)
12 (52)
10 (43)
Group 3B
31
26
10 (38)
7(27)
1 (4)
4(15)
10 (32)
11 (35)
16 (52)
12 (39)
Group 3A
23
20
8(40)
6(30)
0(0)
3(15)
6(26)
5(22)
11(48)
5(22)
Group 3B
31
27
11 (41)
10 (37)
1(4)
0(0)
9(29)
6(19)
18(58)
7(23)
' = % o/ samp/es auai/aWe; * = % o/ patients inc/uifed in fhe groups (group 3/1 n=23, group 3B n=31J
Oropharynx Trachea
100
CH group 1 | group 2
Days in ICU
group3
Figure 3: Percentages o/ par/enrs in fhe 3 study groups u>ifn eit/ier persistent or acquired colonization
u>M ppmo i7i tracnen or oropnarynx
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Co/on izaf ion wif/i f/me
The time patients, not colonized with ppmo in oropharynx and trachea on
admission, remained free of colonization was estimated by Kaplan-Meyer analysis.
Thirty-two out of 43 patients (74%) admitted to the ICU where TAP was
administered (group 1 and 2) and 37 out of 54 (69%) patients admitted to the ICU
where no prophylaxis was administered were free of colonization with ppmo.
Patients in the ICU where TAP was administered remained free of colonization for
a longer period as compared to patients from group 3 (n=37, 69%) (p<0.05) (Figure
4).
group 1/2
10 15 20
Days in ICU
25 30
Figure 4.- ACap/nn-Meier esfimfl/e o/ f/ie co/oni'zafi'oii /ree periods o/ pa/ien(s nof co/onized in
orop/inn/nx and frachen on admission toifft ppmo. Numbers o/ pafienfs no/ co/omzfd on admission;
group 1/2 n=32, group 3 n=37
Cross-acquisifion
The total number of patient days was 681 for group 1/2 and 1409 for group 3. Since
patients in group 1/2 had lower incidences of acquired colonization, the numbers
of non-colonized patientdays were proportionally higher in this group for
K/ebsi'e//a pneumonia (p<0.00001, Chi-square), Pseudomonas aerug/Mosa (p=0.005),
Esdienc/jia co// (p<0.00001) and ppmo (p<0.00001), as compared to group 3 (Table 5).
Such a difference was not observed for Enterobacter species (92% and 91%). In order
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to determine the transmission rates, the number of days for non-colonized patients
at risk for transmission were calculated from the total numbers of non-colonized
patient days in each group. In addition, the numbers of events for each group of
microorganisms were calculated. In both groups none of the patients was colonized
with all four bacteria simultaneously. Therefore, all patients from group 3 were
constantly at risk for transmission and the number of days at risk was equal to the
total number of patientdays. However, in group 1/2 72 patientdays were calculated
without any patient being colonized with ppmo. Thus, for group 1/2 the number of
days at risk for transmission was lower than the total number of patientdays. For
ppmo the transmission rate was higher among patients from group 3 as compared
to group 1/2 (p<0.001). For the individual microorganisms the differences in
transmission rates did not reach statistical significance.
Tafc/e 5: Number o/ non-co/onized pa/ie/ifdays, days at risJt /or transmission, events o/ transmission and
transmission ru/es /or patients treated in /he /CU u;ere fopica/ anfi'mi'crobia/ prophy/axis u»as
ndmim's/ered as compared fo patients treated in an /CU u>ere no prop/iy/axis tuas administered.
Klebsiella pneumoniae
group 1/2
group 3
Pseudomonas aeruginosa
group 1/2
group 3
Escherichia coli
group 1/2
group 3
Enterobacter cloacae
group 1/2
group 3
ppmo
group 1/2
group 3
number of non-
colonized
patient days
613 (90%)
1029 (73%)*
513 (75%)
977 (69%)**
610 (90%)
1094 (78%)*
626 (92%)
1283 (91%)
508 (75%)
601 (43%)*
number of days for non-
colonized patients at
risk for transmission
179
889
372
762
211
874
152
502
609
1409
number of
events of
transmission
3
23
6
28
1
5
0
5
10
61
transmission
rate *
1.7
2.6
1.6
3.7
0.5
0.6
0
1.0
1.6
4.3#
= f/ie percentage o/ fhe fofa/ number o/ pafi'enfdays in earn group (681 /or group 1/2; 1409 /or group 3);
= number o/ euenfs o/ transmission'/ number o/ days o/ non-co/onized pe/ienfs a/ risJt /or transmission
p<0.0000I, group 1/2 fo group 3, Oii-souare; ** p=0.005, group 1/2 fo group 3, Chi-square
* " ' " " " ' 2/2 (o group 3, Chi-souare according fo a Poisson distribution
* t ;
# p<0.001, group t .
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Co/oN/zarion pressure
The number of patients colonized with ppmo in oropharynx or trachea at the same
day ranged from 0 to 3 in group 1/2 and from 1 to 7 in group 3, and as clearly shown i
in Figure 5 more patients were colonized simultaneously in group 3 as compared to i
group 1/2, which probably contributed to the higher transmission rate in this
group.
1 2 3 4 5 6
Number of patients colonized
group 1/2 group 3
Figure 5: 77ie percentage o/ days in <?ac/i group (group 3/2 and group 3,) a»id t/ie number o/ patients
co/on/zed simu/fuiit'Oi/s/y. Tota/ number o/days in group 1/2 = 115, in group 3 = 232.
/«/ecf/ons
Seven patients, all from group 3, developed pneumonia after more than 3 days in
ICU. Three patients developed more than one episode of pneumonia and in total
16 different species were isolated: Enterobacteriaceae (n=6), Psewdomonfls
flerugiriostf (n=4), Sfaphy/ococcus aurews (n=2) and others (n=4). So, the overall
incidence of nosocomial pneumonia in this study was 7%, with an incidence of
13% for group 3 and of 0% for groups 1 and 2 (p<0.05 for groups 1 and 2 versus
group 3, Fisher's exact test, two-tailed). Although differences in the incidence of
nosocomial pneumonia were observed, the small number of patients studied does
not allow one to draw definite conclusions.
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/Inf imicrobio/ suscepfibi/ify
Overall, no differences in proportions of patients harboring resistant Gram-
negative microorganisms were observed. Four strains were found to be resistant to
tobramycin. All these strains were cultured from samples obtained from patients
not-receiving TAP. However, the duration of the study and the number of patients
studied were too small to detect differences in antimicrobial susceptibility.
/ COM fro/
During both study periods surveillance cultures were taken from all sanitary
equipment and respiratory machines in both ICU's. Ppmo were not identified from
any of these cultures.
DISCUSSION
The main feature of this study is that the practice of Topical Antimicrobial
Prophylaxis (TAP) of oropharynx and stomach significantly reduced colonization
with ppmo both in patients receiving prophylaxis and in those not receiving
prophylaxis within the same ICU as compared to patients without prophylaxis in
another ICU. In the ICU where TAP was administered, patients not colonized with
ppmo on admission remained free of colonization for a longer period of time than
those in the other ICU. In addition, in the ICU-ward in which half of the patients
received TAP, colonization rates were lower and cross-acquisition with ppmo
occurred less frequently than in the ICU-ward where no TAP was administered.
All patients studied were at risk to develop colonization of the upper respiratory
tract and eventually nosocomial pneumonia during their stay in the ICU, since
over 90% was intubated and on mechanical ventilation and all had a nasogastric
tube (12,13).
At this stage it is important to note that TAP is not identical to conventional
Selective Decontamination of the Digestive tract (SDD), as described by Stoutenbeek
et al (3). As TAP does not include systemic antimicrobial prophylaxis, and since
smaller dosages of non-absorbable antimicrobial agents were used eradication of
ppmo from only the stomach, and not the intestine, was achieved (14).
Nevertheless, colonization rates of the upper respiratory tract observed in patients
receiving TAP (group 1) in the present study were comparable to those reported by
others, who have used conventional SDD (3,4,6,15). This is in line with
observations of Rodriguez, who reported decreased colonization rates in
oropharynx and lower incidences of pneumonia after using only an antimicrobial
oropharyngeal paste (16).
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The high colonization rates (>50%) with Enterobacteriaceae in oropharynx and
trachea in patients from group 3 are similar to those reported by others. One of us
reported an incidence of colonization with Gram-negative microorganisms,
including Psewrfowjo/ias aerMg/Hosa in 45% of 213 mechanically ventilated ICU-
patients (17). Yet, half of them (22%) were shown to be colonized on their first
hospital day, and so, in fact, were probably already colonized on admission.
Several factors enhancing the risk of acquisition and spread of microorganisms are
present in Intensive Care Units, such as crowding of patients and personnel,
necessity of performing patient related procedures and use of antimicrobial agents
on large scale (7,18,19). The first objective of this study was to investigate whether
TAP, in such an environment, would influence colonization of unprotected
patients within the same ICU. The results of the present study clearly demonstrate
the beneficial effect of TAP on microbiological ecology between patients in an ICU
where a prophylactic regimen is instituted and patients in another ICU: the rates of
acquired colonization were lower and non-colonized patients remained free of
colonization for a longer period of time in the ICU where antimicrobial
prophylaxis was administered. Moreover, the number of patients colonized
simultaneously and the number of events of transmission were higher in the ICU
where patients did not receive prophylaxis.
Besides the prophylactic regimen, other factors may have been responsible for these
differences as well. The survival analysis of the colonization free periods excludes
the possible influence of differences in ICU-stay on colonization rates. Acquisition
of ppmo from the inanimate environment of the ICU could also have led to
differences between study groups. During both study periods, surveying
bacteriological examinations of all sanitary equipment neither revealed bacterial
contamination with ppmo, nor were microorganisms cultured from artificial
ventilators. In addition, colonization rates were comparable in groups 3a and 3b
(Table 4), thereby excluding differences in hygienic procedures between medical and
nursing staffs of both ICU's.
Although hands and clothes of medical and nursing staff were not cultured in this
study, transfer via these vectors often has been documented (7,18,20) and cross-
acquisition is likely to occur within ICU's, even despite barrier precautions (21).
Although, the analysis of cross-acquisition (Table 5) did not demonstrate
differences in transmission rates between Gram-negative bacteria and
Psewdomowfls nerMginosa, colonization (Table 3) tended to occur more frequently
with Enterobacteriaceae than with Pseudomonadaceae, thereby suggesting a wider
spread of Enterobacteriaceae. The latter would be in agreement with data reported
by Weinstein et al (21). These investigators studied the epidemiology of endemic
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aminoglycoside-resistant Enterobacteriaceae and concluded that these
microorganisms spread largely by cross-acquisition. In contrast, colonization with
Pseuiomo/ias aerugiwosa seemed to originate from undetected endogenous
sources, rather than cross-acquisition. The authors suggested that patients who
appeared to acquire Psewdomonas aerug/wosa in the ICU actually entered the unit
colonized with this microorganism in numbers below the threshold for detection
(21). Although our analysis of acquired colonization indeed demonstrated a larger
influence on Enterobacteriaceae, our data also suggest spreading of Pseudowonos
flerug/nosfl within an ICU by cross-acquisition. This would be in agreement with
other studies that emphasize the importance of exogenous sources, since
colonization with Pseudornowas aerugiwosa occurred more frequently and earlier
in trachea than in oropharynx or intestine (18,22). The importance of both routes of
colonization needs further study.
The positive influence of TAP on cross-acquisition within an ICU has, to our
knowledge, never been studied before, although the existence of such an effect has
been suggested (23). Brun-Buisson et al demonstrated in a randomized trial that
enterai decontamination resulted in decreased intestinal colonization rates with
Gram-negative bacteria, both in the test group as well as in the control group that
was studied concomitantly (24). Unfortunately, no data on oropharyngeal and
trachéal colonization were provided. As almost all studies on SDD were designed
and executed with treated and untreated patients in the same ICU, the differences
measured in these studies might have been diluted, because control patients ran a
lower risk of acquisition of microorganisms than under normal situations. The real
benefit of prophylactic regimens with topical, non-absorbable antimicrobial agents
can only be established when treated and untreated patients are studied in separate
but otherwise comparable ICU's. However, we would like to stress that the results
of the present study do not provide evidence to support the use of SDD in
mechanically ventilated patients, because colonization and cross-acquisition, rather
than infection, mortality and side-effects, were studied and our regimen differed
from the conventional SDD regimen. Recently, two randomized double-blind
placebo-controlled studies failed to show any benefit of SDD on the incidence of
pneumonia and mortality among mechanically ventilated patients (5,6). Moreover,
SDD has been associated with increasing bacterial resistance of Pseudomonas
aeru i^nosa to the antibiotics used (25,26) and increased incidences of colonization
and infections with Gram-positive bacteria (5,6,26,27).
In conclusion, the results of the present study demonstrate that modulation of the
upper respiratory tract flora, by TAP, reduced colonization rates of patients
receiving and of patients not-receiving the prophylactic regimen in the same ICU.
In addition, in the ICU where part of the patients received TAP, non-colonized
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patients remained free of colonization for a longer period of time. Moreover, tb
number of patients colonized simultaneously was lower and cross-acquisition^
occurred less frequently in this group, as compared to patients in an identical ICU
where no prophylaxis was administered. This strongly suggests that cross-
acquisition plays an important role in colonization of patients within an ICU, and
this should be taken into account when developing strategies to prevent
nosocomial pneumonia.
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ASSESSMENT OF GASTRIC ACIDITY IN INTENSIVE CARE PATIENTS:
INCIDENTAL pH REGISTRATION CAN NOT REPLACE CONTINUOUS pH
MONITORING
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SUMMARY
The accuracy of color-scaled indicator papers to measure pH values was tested, and
the correlation between measuring gastric juice pH once daily with this method
and the 24-hour continuous intragastric pH-monitoring was studied in intensive
care patients. The accuracy of indicator papers was tested in the laboratory in
colorless solutions and aspirated gastric juice and verified with a laboratory pH-
meter. Continuous intragastric pH monitoring was performed in mechanically
ventilated ICU-patients, 150 registrations in 91 patients. Percentages of time with a
pH value <3.0 and median pH values of 24-hour continuous intragastric pH-
monitoring were compared to pH values measured once daily with indicator paper.
Correlation between pH measured with indicator paper and verified with a
laboratory pH-meter in colorless solutions was 0.96 (regression coefficient (RC) 0.98,
95% confidence interval (CI) 0.91 to 1.05) and in gastric juice 0.95 (RC 0.95, 95% CI
0.88 to 1.01). Correlation between median pH values, determined with 24-hour
continuous intragastric pH-monitoring, and values measured with indicator
papers was 0.39 (RC 0.43, 95% CI 0.26 to 0.59). The mean difference in pH, as
determined with the analysis of Bland and Altman, was 0.9 with a standard
deviation of 4.7. The correlation between the percentage of time with pH<3.0, as
obtained with continuous registration, and median gastric pH values (also obtained
with continuous registration) was -0.94 (RC -0.06, 95% CI -0.06 to -0.05) and gastric
pH values (measured with indicator papers) was -0.40 (RC -0.0234, 95% CI -0.03 to
-0.02).
The color-scaled indicator paper is a reliable method to measure pH values, but
there is a poor correlation between once daily measured gastric pH values and 24-
hour continuous intragastric pH monitoring. Changes in intragastric pH values
cannot be accurately studied when measuring acidity once daily. The influence of
various treatment regimens on intragastric acidity in relation to the development
of gastric colonization and nosocomial pneumonia should be investigated with
continuous intragastric monitoring.
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INTRODUCTION
Gastric colonization has been assumed to be important in the pathogenesis of
nosocomial pneumonia in mechanically ventilated ICU-patients (1,2). Bacterial
overgrowth in the stomach is facilitated by alkalinization of the intragastric
environment (3-5). Therefore, maintainance of intragastric acidity has been used to
prevent gastric colonization and pneumonia in mechanically ventilated ICU-
patients (6-13). In all studies the effect of stress ulcer prophylactic agents and enterai
feeding on intragastric pH was determined with color-scaled indicator papers in
aspirated gastric juice samples (6-13). Measurements were performed
discontinuously, in some studies once daily (10,12,13) or with an unknown
frequency (6).
However, it is questionable whether results obtained by randomly measured
intragastric pH values with indicator papers are valid for definite conclusions
regarding modulation of intragastric acidity. In the first place, two studies
demonstrated a poor accuracy of indicator papers, when compared to values
obtained with pH electrodes (14,15). Secondly, most probably physiologic diurnal
changes of the intragastric acidity are not registered when samples are obtained
infrequently. Both pitfalls can be overcome by using computerized continuous
intragastric pH-measurement with intraluminal electrodes. In other research
settings this method has become an established technique because of its high
accuracy and reproducibility (16-19).
We determined the accuracy of color-scaled indicator papers for the determination
of pH in gastric samples of intensive care patients, and compared the results of this
method with those obtained by continuous intragastric pH-monitoring.
PATIENTS AND METHODS
Accuracy o/ indicator paper
First, the accuracy of color-scaled indicator papers was studied in two in vitro
experiments. In the first experiment 60 measurements with indicator paper
(Schleicher & Schiill, range of 1.0 to 12.0, with steps of 0.5) were performed in a
blinded fashion in colorless solutions with pH values ranging from pH 1.0 to 7.5.
As a standard, the pH values of these solutions were verified with a laboratory pH
meter (PHM82 Standard pH Meter, Radiometer a/s Copenhagen, Denmark). To
account for factors that possibly affect the accuracy of measurements with pH paper
in gastric samples, in a second experiment pH values of 93 random and
unprocessed gastric samples were determined in parallel with a laboratory pH-
meter and with indicator paper. In all cases measurements with pH papers were
performed first.
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For the in-vivo comparison of random and continuous pH monitoring, 91 patients
admitted to the ICU who needed mechanical ventilation were prospectively
enrolled in the study. All patients were endotracheally intubated and had a
nasogastric tube.
The protocol was approved by the institutional review board of the hospital and
informed consent was obtained from all participants, or if this was not possible
because of the clinical condition, from a representative of the family.
c pH recording
A pH stomach probe with a glass electrode at the tip (LoT 440, Ingold AG, Urdorf,
Switzerland) was transnasally positioned in the stomach with the tip situated
approximately 10 cm below the cardia. The position of the tip was verified by
radiography. The distance from tip to nostrils was kept constant for the entire
recording period. Recording of intragastric acidity was performed for 24 hours and
pH values were registered every 4 seconds. The pH-data were stored in a
Digitrapper Mk III (Synectics Medical, Alphen aan den Rijn, The Netherlands) and
after the procedure transferred to a personal computer. Analysis was performed
using Esophogram software (Gastrosoft Inc., Synectics Medical). Electrodes and
recorders were calibrated at 20 °C using commercial buffer solutions at pH 7.0 and
1.3 (Ingold AG), before starting every experiment and repeated afterwards.
pH record/n^ o/ gastric samp/es
Gastric juice samples of the patients were obtained routinely once daily at 9:00 am
by aspirating gastric fluid into a syringe. Thereafter, pH values were determined
with indicator paper. All measurements of pH-values with indicator papers were
performed by the same technician, who was unaware of the results of the
continuous intragastric pH-measurements.
Data analyst's
Because of the non-parametric data, the median pH and the percentage of recording
time with a pH-value below 3.0 were calculated from continuous intragastric pH-
measurements. The pH value of 3.0 was arbitrarily chosen. The median pH values
from continuous pH monitoring and the pH values obtained by color-scaled pH
papers were analyzed by the method of Bland and Altman (20) and by calculating
the correlation coefficient (r value) and the 95% confidence interval of the
regression line.
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RESULTS
.Accuracy 0/ i/ia7cafor papers
In the two laboratory experiments good correlations were observed between pH-
values measured with indicator papers and those determined with a laboratory pH-
meter. The correlation coefficient between the indicator paper method and the pH
values of colorless solutions was 0.96 (regression coefficient (RC) 0.98, 95%
confidence interval (CI) 0.91-1.05). The correlation coefficient of pH values of gastric
samples, measured in the laboratory with indicator papers and verified with a
laboratory pH-meter, was 0.95 (RC=0.95, 95% CI 0.88-1.01).
Paf/enfs
In total 150 episodes of intragastric pH monitoring were performed in 91 patients.
Mean age (±SD) of the patients was 61 ±18 years with a range from 19 to 88 years and
the mean APACHE II score on admission was 21 (SD=8) with a range from 6 to 40.
Thirty-seven patients were surgical, 22 medical, 15 pulmonary, 9 trauma and 8
neurologic. All patients were mechanically ventilated.
In 46 patients more than one episode of 24-hours intragastric pH monitoring was
performed (2 episodes n=36, 3 episodes n=7 and 4 episodes n=3).
Tiifcfe 1; Resu//s 0/ con/inuous infragasfric pH-mfasurfmenfs and Me indicator paper technique
Intragastric pH-monitoring Indicator paper
150
5.3 * 2.0
1.0-8.5
no of recordings with pH<3.0 46 (31%) * 24 (16%)
' = mean 0/ median t>a/ues; * = median pH wj/uf <3.0
Conjparjsow 0/ once-dai/y measurements ana" continuous infragasfric pH
no of recordings
(91 patients)
mean of pH-values ± SD
range
mean % of time with pH<3.0 ± SD
range
150
4.4 ± 2.2 '
0.5-8.0
34.2 ± 34.9
0-100
The average of the median pH values and the average percentage of time with pH
values below 3.0 obtained from 24 hours intragastric monitoring are listed in Table
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I. The mean pH value of aspirated gastric samples obtained with indicator papers~is]
also listed in Table I. The average pH value, determined from median values of !
continuous intragastric measurements, was lower than the mean pH value as j
determined once daily with indicator paper (4.4 ± 2.2 (SD) versus 5.3 ± 2.0).
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Figure J: Corre/afion befuven median j>H va/ues (median ci j>H, X-axis) and //ie percentage o/ time
tw'fn pH wj/ues <3.0 C% pH <3, Y-axis), both obtained by continuous intragasfric pH monitoring, r=-
0.94.
Median gastric pH-values and percentages of time with gastric pH-values <3.0, both
obtained with continuous intragastric pH-measurement, are plotted in Figure 1 (r=
-0.94, RC=-0.06, 95% CI -0.06 to -0.05). In contrast, the correlation between the gastric
pH-values, obtained once daily with indicator papers, and the percentages of time
with pH-values below 3.0 was only -0.40, (RC=-0.02, 95% CI -0.03 to -0.02, Figure 2).
The median pH-values from continuous intragastric recordings and the
corresponding pH value of the indicator paper method are plotted in Figure 3.
Considerable differences between both methods were observed.
The analysis according to Bland and Altman (20) is shown in Figure 4: Averages of
pH-data obtained with the two methods are plotted against their differences. The
average difference between the two methods was -0.9, with a standard deviation of
4.7.
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(% pH <3, Y-axis, r=-0.40), and (Fig3.) median pH ua/ues as obtained iwi't/i 24-nours infragastrtc
monitoring (median ci pH, Y-axis, r=0.39).
DISCUSSION
The main feature of the present study is that there is a poor correlation between
results of gastric pH values obtained once daily with color-scaled indicator papers
and pH-data obtained with continuous 24-hour intragastric pH monitoring.
It seems unlikely that the difference between the two methods was caused by
inaccuracies of either one. Continuous intragastric pH-measurements have been
validated repeatedly (16), and in this study calibration of the electrodes was
performed before each measurement and verified afterwards. Moreover, the
reliability of the indicator paper method was studied and showed a good correlation
when pH measurements were verified with measurements performed with a
laboratory pH meter, both in colorless solutions and in gastric juice. This is in line
with observations made by others (21), although two other studies have
demonstrated a poor accuracy of the indicator paper method (14,15). In one study
the indicator paper method had a sensitivity of 67% and a specificity of 95% for
determining pH values a4, taking electrode measurements as gold standard. The
authors suggested that the inhomogeneous mixture of gastric acid, mucus, bile
pigments and antacids interfered with the accurate measurement of pH values
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with indicator paper (15). Caballero et al also demonstrated poor accuracy of the
indicator paper method as compared to a standard laboratory meter in a clinical
setting (14). However, in that study results were obtained from different hospitals
(14). The fact that all pH measurements with indicator papers in the present study
were performed by the same technician might explain the reliability of this method
in our hands.
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Figure 4: Disagreement between pH paper (sticJ: pH) and continuous pH monitoring (ci pH.)
assessed /M/ t/ie difference fcefuieen methods (continuous monitoring minus pH paper).
It appears that measurements of pH values in aspirated gastric samples performed
once daily do not accurately reflect 24-hour pH values in the intragastric milieu.
However, when pH measurements are performed half-hourly or even hourly
there is a good correlation (17-19,22). The need for frequent assessment of
intragastric acidity was also stressed by investigators who studied the efficacy of
antacids to prevent gastrointestinal bleeding in critically ill patients (23,24). In these
studies it was emphasized that intragastric acidity should be checked at least every 2
hours.
Several studies in which incidental pH measurements of gastric juice were used,
have addressed the effect of modifying gastric juice pH on gastric bacterial
colonization and the development of nosocomial pneumonia (Table 2). As
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demonstrated in Table 2 significant differences in pH values for the different stress
ulcer prophylactic agents were observed in all studies (6-9,11). However, the
frequency of measurements ranged from 3 to 12 times per day. In the study of Driks
et al 805 gastric samples were obtained from 130 patients with a mean ICU-stay of 10
days, which implies that gastric acidity was measured every second day (6). In
addition to the studies listed in Table 2, the effects of modulation of intragastric
acidity by gastric feeding were addressed in three other studies (10,12,13). Heyland et
al compared the influence of acidified gastric feeding (pH=3.5) as compared to
nonacidified feeding (pH=6.5) administered either in the stomach or the
duodenum, whilst Lee et al and Spilker et al compared the effects of continuously
or intermittently administered gastric feeding on intragastric acidity (10,12). In these
three studies gastric pH was measured once daily with color-scaled papers in
aspirated gastric juice.
Based on the data of the present study we feel that the results regarding intragastric
acidity from the studies where pH values were not measured continuously, should
be interpreted with caution. However, computerized continuous intragastric
monitoring is expensive and may not be available to all investigators. To establish
the minimal number of measurements that is required to accurately determine
long-term intragastric acidity with indicator papers in aspirated gastric juice, a study
comparing this method, using different frequencies of measurement, to
computerized intragastric monitoring is needed.
2: Frequencies and resu/fs o/ pH measwrements in aspirated gastric ;uice using co/or-sca/ed
indicafor papers.
Author
Driks (6)
Tryba (7)
Kappstein (8)
Eddleston (9)
Simms (11)
Frequency of
measurement
(per day)
unknown
3
<6
4
12
Proportion of samples with
pH <4.0 (%)
Test Controls p-value
47.9'
46.5'
20.0'
25.3 2
10.4'
11.1 3
9.4 «
(p<.001)
(p<-01)
(p>.05)
Test
4.34 >
4.26'
4.73'
Mean pH
Controls
4.84 «
5.50 «
5.55 '
5.06 «
p-value
(p<05)
(p<.01)
(p<.01)
(p>.05)
= Test patients received sucra//afe; * = Confro/ patients received antacids and/or Hj-anfagonsists
= Contro/ patients received antacids; * = Control patients received ^-antagonist
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We conclude that changes in intragastric pH values cannot be accurately studied
when measuring acidity only once daily or even less frequently. The correlation
between modulation of intragastric acidity by different treatment regimens and the
subsequent development of gastric bacterial colonization and nosocomial
pneumonia should be re-evaluated using continuous intragastric pH monitoring.
130
J
pH measurements
REFERENCES
1. Heyland D, Mandell LA. Gastric colonization by Gram-negative bacilli and nosocomial
pneumonia in the intensive care unit patients: evidence for causation. Chest 1992; 101: 187-193
2. Tryba M. The gastropulmonary route of infection - fact or fiction? Am J Med 1991; 91 (Suppl 2A):
135-146
3. Du Moulin, Paterson DG, Hedley-White J, Lisbon A. Aspiration of gastric bacteria in antacid-
treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; i:
242-245
4. Hillman KM, Riordan T, O'Farrel SM, Tabaqchal S. Colonization of gastric contents in critically
ill patients. Crit Care Med 1982; 10: 444-447
5. Garvey BM, McCambley JA, Tuxen DV. Effects of gastric colonization on bacterial colonization in
critically ill patients. Crit Care Med 1989; 17: 211-216
6. Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, Kunches LM, Farber HW,
Wedel SA, McCabe WR. Nosocomial pneumonia in intubated patients give sucralfate as
compared with antacids of histamine type 2 blockers. New Engl J Med 1987; 317:1376-82
7. Tryba M. Risk of acute stress and nosocomial pneumonia in ventilated intensive care patients:
Sucralfate versus antacids. Am J Med 1987; 83 (Suppl 3B): 117-124
8. Kappstein I, Schulgen G, Friedrich T, Hellinger P, Geiger K, Daschner FD. Incidence of
pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as
prophylaxis for stress bleeding: bacterial colonization of the stomach. Am J Med 1991; 91 (Suppl
2A): 125S-131S
9. Eddleston JM, Vohra A, Scott P, Tooth JA, Pearson RC, McCloy RF, Morton AK, Doran BH. A
comparison of the frequency of stress ulcération and secondary pneumonia in sucralfate- or
ranitidine-treated intensive care patients. Crit Care Med 1991; 19: 1491-6
10. Lee B, Chang RWS, Jacobs S. Intermittent nasogastric feeding: A simple and effective method to
reduce pneumonia among ventilated ICU-patients. Clin Intensive Care 1990; 1: 100-102
11. Simms HH, DeMaria E, McDonald L, Peterson D, Robinson A, Burchard KW. Role of gastric
colonization in the development of pneumonia in critically ill trauma patients: results of a
prospective randomized trial. J Trauma 1991; 31: 531-537
12. Spilker CA, Hinthron DR, Pingleton SK. Intermittent enterai feeding and gastric colonization in
critically ill patients, [abstract] Am Rev Respir Dis 1993; 147: A200
13. Heyland D, Bradley C, Mandell LA. Effect of acidified enterai feedings on gastric colonization
in the critically ill patient. Crit Care Med 1992; 20: 1388-1394
14- Caballero GA, Ausman RK, Quebbeman EJ, Schulte WJ, Lin L. Gastric secretion pH measurement:
what you see is not what you get! Crit Care Med 1990; 18: 396-99
15. Dobkin ED, Valcour A, McCloskey CR, Allen L, Kambe JC, Gleason E, Orlando III R, Berger R,
Yeston NS. Does pH paper accurately reflect gastric pH? Crit Care Med 1990; 18: 985-8
16. Fimmel CJ, Etienne A, Ciluffo T et al. Long-term ambulatory gastric pH monitoring: validation of
a new method and effect of r^-antagonists. Gastroenterology 1985: 88; 1842-51
131
Chapter 8
17. Savarino V, Mela GS, Scalabrini P, Magnolia MR, Percario G, Di Timoteo E, Celle G. 24-h
Comparison between pH values of continuous intraluminal recording and simultaneous gastric
aspiration. Scand J Gastroenterol 1987; 22: 135-40
18. Andersen J, Naesdal ] , Strom. Identical 24-hour gastric pH profiles when using intragastric
antimony or glass electrodes or aspirated gastric juice. Scand J Gastroenterol 1988: 23; 375-9
19. Savarino V, Mela GS, Zentilin P, Magnolia MR, Scalabrini P, Valle F, Moretti M, Bonifacino G,
Celle G. Gastric aspiration versus antimony and glass pH electrodes. A simultaneous
comparative in vivo study. Scand J Gastroenterol 1989: 24; 434-9
20. Bland JM, Altman DG. Statistical methods for assesing agreement between two methods of
clinical measurement. Lancet 1986; i: 307
21. Meiners D, Clift S, Kaminski D. Evaluation of various techniques to monitor intragastric pH.
Arch Surg 1982; 117: 288-291
22. Albin M, Friedlos J, Hillman K. Continuous intragastric pH measurement in the critically ill and
treatment with parenteral ranitidine. Intensive Care Med 1985; 11: 295-299
23. Hastings PR, Skillman JJ, Bushnell LS, Silen W. Antacid titration in the prevention of acute
gastrointestinal bleeding. A controlled, randomized trial in 100 critically ill patients. N Engl J
Med 1978; 298:1041-1045
24. Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W. Antacid versus cimetidine in preventing
acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients. N Engl J Med
1980; 302: 426-430
132
Chapter 9
THE RELEVANCE OF THE STOMACH AS A SOURCE FOR COLONIZATION OF
THE UPPER RESPIRATORY TRACT AND PNEUMONIA IN ICU-PATIENTS
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SUMMARY
Sequences of colonization of different species of microorganisms and the
importance of gastric colonization for the development of nosocomial pneumonia
were determined prospectively in 64 patients admitted to two identical ICU's of a«
university hospital. All patients were studied for at least 5 days, and, 59 werej
intubated. Microbiological cultures of serially taken samples of gastric aspirates,
oropharyngeal swabs and trachéal aspirates were performed on admission and
subsequently twice a week. Diagnosis of pneumonia was based on quantitative
cultures from bronchoalveolar lavage and protected specimen brush. Sequences of
colonization were examined by comparing isolates of the same species, with
concordance of MIC-values to six antibiotics.
Eleven patients developed 14 episodes of nosocomial pneumonia, yielding 20
species of microorganisms. Seventeen out of 20 species (85%), associated with
pneumonia, were cultured, previous to or on the day of diagnosis, from trachéal
aspirates and six out of 20 (30%) species were cultured from gastric samples. For
none of these six species a sequence of colonization from the stomach to the upper
respiratory tract eventually leading to pneumonia was observed. Initial
colonization with Pse«domo?ifls aerug/nosa and Enterobacter species was more
often demonstrated in the trachea (16/24 and 13/25 cases) as compared to the
stomach (1/24 and 6/25 cases; p<0.0001 and p=0.02 respectively). In contrast, initial
colonization with Klebsiella species and Enterococcus /aeca/i's was more frequently
demonstrated in the stomach (13/28 and 8/15 cases) as compared to the trachea
(6/28 and 0/15 cases; p=0.02 and p<0.0001 respectively).
Based on studying sequences of colonization in ICU-patients we concluded that the
stomach is unlikely to be an important source of pathogens leading to nosocomial
pneumonia. Furthermore, the initial site and route of colonization might not be
the same for all microorganisms.
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INTRODUCTION
Seriously ill ICU-patients are prone to life-threatening nosocomial infections, such
as pneumonia (1). There is no doubt about the causal relationship between
preceding colonization of oropharynx and trachea with potentially pathogenic
microorganisms (ppmo) and the development of nosocomial pneumonia (2).
However, the exact sources and routes involved in acquiring colonization of
oropharynx and trachea are still under debate. Microorganisms can colonize the
oropharynx and trachea from exogenous sources, such as medical equipment and
hands of medical and nursing staff, or from endogenous sources, i.e. the intestinal
tract. In the latter scenario intestinal microorganisms possibly colonize the upper
respiratory tract via the stomach (the endogenous route of colonization). The
endogenous route of colonization has been assumed to be of main importance in
the development of nosocomial pneumonia and many preventive regimens have
been developed with the idea of interfering with this route of colonization (3).
However, the central role of gastric colonization in the pathogenesis of nosocomial
pneumonia has been questioned recently (4,5).
Analysis of initial sites of colonization might indicate where colonization with
microorganisms originates. For instance, Niederman et al demonstrated that
Pseudomonas spp. preferentially colonized the trachea rather than the oropharynx
and the stomach, indicating that the exogenous route of colonization probably is
more important for colonization with this group of microorganisms than the
endogenous route (6). However, what is apparent for Pseudomonas spp. may not
apply to other species of microorganisms.
In order to determine the importance of gastric colonization for the development
of nosocomial pneumonia we prospectively examined colonization of trachea,
oropharynx, stomach and rectum by several microorganisms, the occurrence of
bacterial pneumonia as well as their time course in 64 adult patients, admitted to
the ICU for at least five days.
MATERIAL AND METHODS
The study was conducted prospectively in two identical eight-bed ICU's in the
University Hospital of Maastricht. Both ICU's contained a mixed population of
trauma, medical, surgical and neurological patients. Patients were enrolled in the
study if they were older than 15 years and intubated, with an expected period of
intubation of at least five days. Thirty-four patients received antacids, 10 patients
received ^-antagonists, and 6 patients received omeprazole during the whole
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study period. Fourteen patients initially received ^-antagonists on the first day of
admission to ICU, but in these patients stress ulcer prophylaxis was discontinued
for unknown reasons. Sucralfate was not used for stress ulcer prophylaxis as this
agent might decrease gastric colonization (7,8). To assess the severity of acute illness
the APACHE II score was calculated on admission to the ICU as described elsewhere
(9). Informed consent was obtained from the patient or, if this was not possible
because of the clinical condition, from a representative of the family. The study
protocol was approved by the hospital ethical committee.
Colonization was defined as the isolation of microorganisms, in the absence
infection, from gastric aspirate, oropharyngeal swab or trachéal aspirate.
Colonization on admission was established by a positive culture obtained within 24
hours after admission to the ICU. Colonization was designated as 'acquired' if there
were positive cultures of the same species of microorganism from at least two
consecutive samples, the first of which was taken no sooner than 24 hours after
admission to the ICU. Sterile cultures or colonization with normal oropharyngeal
flora were labelled 'no colonization'.
The initial site of colonization was defined as that site at which colonization was
identified first. A sequence of colonization was examined by comparing isolates of
the same species, cultured from two or more sites. These strains were considered
identical when the MIC's to six antimicrobial agents were concordant. Concordance
implied that the MIC-values for one strain differed from those of the other strain
by no more than one step of a twofold dilution sequence in the MIC determination
and for no more than three antimicrobial agents. In case of concordance, a time
sequence of strain isolation from different sites was assumed to indicate the
direction of colonization.
Exogenous colonization was defined as colonization originating from exogenous
sources and as a consequence, the trachea or oropharynx acted as the initial site of
colonization. In case the stomach was the initial site of colonization the route of
colonization was labelled as endogenous.
In the analysis of colonization being present on admission or acquired during ICU-
stay species of microorganisms were grouped as follows: Enterobacteriaceae,
Pseudomonadaceae, Stap/iy/ococcus aureus and finally Enterococcus
Pneumonia was considered as ICU-acquired if a clinical condition fulfilling the
criteria for pneumonia developed after the patient had been in the ICU for at least
three days. In case of a clinical suspicion of pneumonia Bronchoalveolar Lavage
(BAL) was performed. In general, a Protected Specimen Brush (PSB) was performed
as well. The diagnosis of pneumonia was established when a positive quantitative
culture of samples was obtained by BAL (cutoff point 10^  cfu/ml) or PSB (cutoff
136
Gastric colonization and VAP
point 103 cfu/ml), and a new or persistent infiltrate was seen on chest radiograph
and when at least three of the following criteria were met: (1) rectal temperature
above 38.0 °C or below 35.5 °C, (2) blood leukocytosis (>10.103 /mm') and/or left
shift or blood leukopenia (<3.103 /mm'), (3) more than ten leukocytes per high-
power field in gram stain of trachéal aspirate and (4) a positive culture from
trachéal aspirate. BAL was performed as described elsewhere (10), using 5 aliquots
of 20 ml of sterile saline for lavage. PSB was performed as originally described by
Wimberley (11). PSB always preceded the BAL.
Bflcferio/ogic monitoring
Colonization was assessed by culturing gastric aspirates, oropharyngeal swabs,
trachéal aspirates and rectal swabs on admission and subsequently at least twice a
week (every Monday and Thursday). Gastric juice was aspirated into a sterile vial
after the first 10 ml was discarded. In non-intubated patients sputum was obtained
after spontaneous production by the patient. Colonization was analyzed semi-
quantitatively as follows: oropharyngeal swabs, gastric aspirate (10 jil), and trachéal
aspirate (10 1^) were streaked using the four-quadrant streak method on sheep
blood, CLED, chocolate, and Sabauroud plates. All media were incubated at 35.0 °C
for 18 to 24 hours. Growth density was graded as follows: growth in the first
quadrant= + l, in the second quadrant=+2, in the third quadrant=+3, and on the
whole plate=+4. All samples were processed and cultured by the same analyst.
Samples obtained by BAL and PSB were cultured quantitatively. Rectal swabs were
stored immediately at -20 °C and, in case of pneumonia, retrospectively analysed
semi-quantitatively. Aerobic or facultatively anaerobic Gram-negative rods were
identified using the API20E/20NE-system. The susceptibility pattern to
antimicrobial agents was determined by measurement of minimal inhibitory
concentrations by means of broth microdilution method.
Frequency comparisons were analyzed by Chi-square test. A probability value of less
than 0.05 was considered to be significant.
RESULTS
Pafienfs
The characteristics of all 64 patients are listed in table 1. Age ranged from 17 to 96
years with a mean of 61 years. The mean duration of ICU-stay was 25 days, with a
range of 5-145 days. The mean APACHE II-score was 18. Most patients were medical
or surgical (63%) and 59 out of 64 remained intubated for at least 5 days.
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1: Characteristics o/ Me pofienfs sfudïed
Characteristics No. of patients (n=64)
age
M/F
days on ICU
APACHE II
Medical conditions: '
cardiovascular disease
gastrointestinal disease
respiratory disease
alcoholism/drug abuse
neoplastic disease
diabetes mellitus
neurologic disease
No intubated
Admitting service:
surgery
trauma
medical
pulmonology
neurology
mean (range)
mean (SD):
mean (SD):
61.0 (17-96)
42/22
25.1 (28,7)
18.0 (8.0)
29
10
24
4
14
8
10
59
24
9
16
10
5
more f/ian on? condi/ion possiWe per pafienf
Co/onizafioM OM admission
Gastric samp/es
On admission gastric samples of 36 patients (57%) were not colonized (Figure 1).
Enterobacteriaceae were cultured from gastric aspirates of 23 patients (36%). Gastric
colonization with Pseudomonadaceae, SfapJiy/ococcus awrews or Enferococcws
/aeca/is on admission was demonstrated in 1 (2%), 4 (7%) and 8 (12%) patients,
respectively.
Enterobacteriaceae were cultured from oropharyngeal swabs of 27 patients (427»)/
Pseudomonadaceae in 5 patients (8%) and no colonization was demonstrated in 29
patients (46%) on admission. Enferococcus /aeca/is and Sfap/iy/ococcus awrens were
cultured from the oropharynx of 6 (10%) and 3 (4%) patients, respectively.
Tradiea/ aspirates
Nearly half of the patients (29 out of 64, 46%) were not colonized with bacterial
species in the trachea on admission and none of the patients harbored Enferococcus
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/aeca/ts in the trachea. Among those colonized on admission Enterobacteriaceae
were most frequently cultured (17 out of 64, 27%), while Stap/iy/ococcus awreus was
cultured from trachéal aspirates of 12 (18%) patients. Three patients (5%) harbored
Pseudomonadaceae in the trachea on admission (Figure 1).
Enterobact. Ps.
aeruginosa
E. faecalis
Sites
St. Aureus No
colonization
stomach I oropharynx H trachea
Figure 1: Percentages o/ pa/ienfs ivif/i 'no co/onizafion ' or co/onized ui/fh En/erobocteriflceae
(EnferobacfJ, Pseudomonas aeruginosa fPs. aeruginosa.), Enferococcus /aecu/is (E. /aeca/is), or
Sfopfty/ococcus aureus fS/. aureus) in stomach, oropharynx and trachea on admission to (ne /CU.
Acquired co/om'zafion
Acquired colonization with Enterobacteriaceae and Pseudomonadaceae in the
stomach, oropharynx and trachea were observed with equal frequency, the number
of patients ranging from 17 to 24 (27% to 38%) for Enterobacteriaceae and from 10 to
14 (16% to 22%) for Pseudomonadaceae (p>0.05, chi-square) (Figure 2). Colonization
with Enferococcus /aeco/is was less often acquired in trachea (1 patient, 2%) as
compared to both oropharynx (12 patients, 19%) (p<0.05, chi-square) and stomach
(20 patients, 32%) (p<0.0001, chi-square).
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Enterobact. Ps. aeruginosa E. faecalis
Sites
St. Aureus
stomach I oropharynx ID trachea
Figure 2: Percentages of pa/i'en/s u>i'//i acquired co/o/iization U)i'Jh E»iferobacfenaceae, Pseudomonns
aeruginosa (Ps. aerug/nosa,), Enferococcus /aeca/i's (E. /aeca/is.) a«d Sfap/iy/ococcus aureus (St.
in /CU.
Sequence o/ co/oMizaf/'on
Simultaneous colonization at more than one site with one out of five species of
microorganisms, listed in table 2, was demonstrated in 62 out of 64 patients,
yielding 154 different cases of colonization (column A). In 35 cases newly acquired
colonization was demonstrated at more than one site at the same time (column B),
which precluded the identification of an initial site of colonization. Thus, for five
different bacterial species 119 cases of initial colonization could be determined.
The trachea was more often an initial site of colonization than the stomach for
both Pseudomonas aerug/nosa and Enterobacter species (p<0.0001 and p<0.05,
respectively, chi-square). In contrast, colonization with Klebsiella species and
Ewterococcus /aeca/is originated more often in the stomach as compared to the
trachea (p=0.02 and p<0.0001, respectively, chi-square). Although colonization with
Esdienc/n'a co/i originated more often in the stomach than in the trachea (11 and 6
out of 27 cases respectively) the difference did not reach statistical significance
(p=0.08, chi-square). According to the definition of concordance used in this study,
strains isolated from several places in the same patient generally were
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phenotypically similar. No statistical significant differences in sequences of
colonization were observed when patients receiving H2-antagonists or omeprazole
were compared to patients receiving antacids.
TaWe 2: Primary si/e 0/ co/onization
Microorganism
Escherichia coli
Klebsiella species
Pseudomonas aeruginosa
Enterobacter species
Enterococcus faecaiis
A
32
38
32
29
23
B
5
10
8
4
8
No of patients (%) with
initial site of colonization
Trachea
6(22)
6(21)
16 (67)
13 (52)
0(0)
Oropharynx
10 (37)
9(32)
7(29)
6(24)
7(47)
an identified
Stomach
11 (41)
13 (46)
1(4)
6(24)
8(53)
p-value
(Trachea vs
Stomach)
>.O5
0.02
<.0001
0.02
<.0001
/\ = No. 0/ pade/ifs co/o/iized af aJ site si/nu/fa/ieous/y u>iM We /isfed bacteria/ species; B = No. 0/
pdtieufs in u>/iic/i co/omza/ion tw/fAi Me /isted bacteria/ species u>as /irs( prese/if simulfaneous/y a/ >I
sile, a/id in lu/n'c/i a/i i/11'tùt/ sire 0/ co/onizafio/i couW /iof be determined.
Colonization in rc/afion fo nosocomj'a/
During the study period 11 patients developed ICU-acquired pneumonia as
established by microbiologically confirmed positive quantitative culture results
from BAL or PSB, and in which 20 different species were involved (Table 3). In two
patients pneumonia occurred more than once and in total 14 episodes of
nosocomial pneumonia were diagnosed. For 17 of the 20 species (85%) isolates of
the same species were previously or simultaneously cultured from trachéal
aspirate, and for 10 out of 20 species (50%) isolates of the same species were cultured
from oropharynx before or on the day pneumonia was diagnosed. Preceding or
simultaneous colonization of the stomach was observed for 6 of 20 species (30%).
However, in four cases, microorganisms initially colonized the oropharynx or
trachea before colonization of the stomach occurred and in the other two cases
colonization of the stomach was demonstrated at the same time as colonization of
oropharynx and trachea. Thus, a sequence of colonization from stomach to the
upper respiratory tract eventually leading to pneumonia was never observed.
Simultaneous isolation of the same species from samples of BAL/PSB and rectal
swabs were observed for five out of 17 species; no rectal swabs were taken from two
patients. Escneri'cnia co/i was isolated from rectal swabs, reflecting rectal
colonization, prior to or simultaneously with the diagnosis of four episodes of
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pneumonia in three patients. In one of these episodes species of Proteus
were isolated from both the rectal swab and PSB and BAL. Of the 11 patients
developing nosocomial pneumonia, seven received antacids and four received H2-
antagonists for stress ulcer prophylaxis (not significant).
Tab/e 3: Corre/ation betoeen positive ^uant/tatiyf cu/fures /rom Bi4L and preceding or simu/faneous
co/onizafion 0/ trachea, oropharynx and stomach and sequence 0/ co/onizafion.
pa
tie
nt
nu
m
be
r
1
2
3
4
5
6
7
8
9
10
11
Sp
ec
ies
Pseudomonas aeruginosa
Klebsiella pneumoniae
Staphylococcus aureus
Escherichia coli
Escherichia coli
Streptococcus group B
Escherichia coli
Pseudomonas aeruginosa
Pseudomonas aeruginosa
Pseudomonas aeruginosa
Staphylococcus aureus
Streptococcus pneumoniae
Haemophilus influenzae
Proteus vulgaris
Escherichia coli
Pseudomonas aeruginosa
Staphylococcus aureus
Escherichia coli
Streptococcus mitis
Pseudomonas aeruginosa
n
o
 
of
 
da
ys
in
 
IC
U 
'
18
5
5
10
9
9
65
65
14
11
4
4
5
17
17
21
11
11
6
6
preceding or simultaneous colonization of
tr
ac
he
a
yes
yes
no
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
no
yes
yes
yes
no
yes
o
ro
ph
ar
yn
x
no
yes
no
no
yes
no
yes
yes
yes
yes
no
no
no
yes
no
yes
no
yes
no
yes
st
om
ac
h
no
yes
no
no
yes
no
yes
yes
no
no
no
no
no
yes
no
no
no
yes
no
no
re
ct
um
no
?
?
?
yes
no
yes
no
no
no
no
no
no
yes
yes
no
no
yes
no
yes
se
qu
en
ce
 
*
Trach ->Lung
Oroph->Trach->Stom->Lung
Lung
Trach->Lung
Oroph->Stom/Trach->Lung
Trach/Lung
Oroph->Stom/Trach->Lung
Trach->Stom/Oroph->Lung
Oroph/Trach->Lung
Oroph ->Trach->Lung
Trach /Lung
Trach/ Lung
Trach->Lung
Stom/Oroph/Trach->Lung
Lung
Oroph->Trach->Lung
Trach->Lung
Stom / Oroph->Trach->Lung
Lung
Trach->Oroph / Lung
': = on the day 0/ diagnosing pneumonia; *: -> = indicates direction 0/ co/onizafion based on the fime
differences 0/ commencing 0/ co/oniznf ion u>i'th the same species at different sites; -/- = co/om'zation
demonstrated simuffaneous/y at fux> or three sites and no direction 0/ co/onizati'on cou/d be ana/yzed.
Oroph = co/om'zdfion 0/ the oropharynx, Trach = co/onization 0/ the trachea, Stom = co/onizfltion 0/
the stomach. Lung = bacteria cu/tured /rom PSB or B/4L and associated zwifh nosocomia/ pneumonia
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DISCUSSION
The results of this study suggest that gastric colonization may not be the main
source for nosocomial pneumonia in ICU-patients. Eleven out of 64 patients (17%)
developed 14 episodes of ICU-acquired pneumonia, established by positive
quantitative cultures from BAL or PSB. A sequence of colonization from the
stomach to the upper respiratory tract with the causative agent was never observed.
Moreover, the initial site of colonization was markedly different for several species
of microorganisms and colonization with Pseudomorins aeruginosa and
Enterobactericeae in most cases was found to start in the trachea.
The study population was at risk for developing nosocomial pneumonia, since one
or more risk factors were present in all 64 patients, i.e. intubation, presence of a
nasogastric tube and ICU-stay exceeding five days (1,12,13). Moreover, none
received sucralfate as stress ulcer prophylaxis, an agent that has been reported to
prevent nosocomial pneumonia (7,8).
On admission, trachéal colonization with Enterobacteriaceae was observed in 17
out of 64 patients (27%) and another 20 patients (31%) acquired colonization with
these microorganisms during their ICU-stay. Pse«rfomo«fls aerugniosa was
cultured in trachéal aspirates from only 3 out of 64 patients (5%) on admission, and
acquired colonization occurred in another 14 patients (22%). These percentages are
comparable to those observed by others. Johanson et al reported acquired
colonization with Pseudomonas aerug/nosa in 26% (2) and Olson et al in 16% of
ICU-patients on mechanical ventilation (14).
Colonization of the upper respiratory tract has been assumed to originate from the
inanimate environment or the gastrointestinal tract (15,16). Determination of the
initial site of colonization could help in establishing the origin of colonization (6).
This analysis, however, is hampered by some unavoidable pitfalls, such as taking
samples twice a week (every Monday and Thursday). In addition, numbers of
microorganisms below the culture threshold might lead to false negative culture
results. Despite these limitations, an initial site of colonization could be established
in 119 cases. Psendo/wonas aeruginosa was isolated more frequently from trachea
and oropharynx than from the stomach and often earlier from the trachea than
from the oropharynx or stomach. This is in line with observations made by others
(6,15). Niederman et al described primary colonization of the trachea with
Pseudomcmas aeru^/«osa in four of 14 intubated patients, whereas other Gram-
negative microorganisms never followed this pattern (6). In addition, the same
authors observed that Pseudomonas aeruginosa, in contrast to other Gram-
negative microorganisms, preferentially colonized the lower respiratory tract in
patients with chronic tracheostomy (17). These data may indicate that colonization
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of the upper respiratory tract with this species takes place via an exogenous route.
The in vitro capacity of trachéal cells to adhere Pseudomowas aerug/Mosa strains
more easily than buccal cells do (17,18), might explain the observation that
colonization more frequently occurred first in trachea than in oropharynx.
Similar to Pseudomo/ias aerug/Hosa, we found that Enterobacter species initially
and preferentially colonized the trachea (52% of all patients colonized with
Enterobacter species), indicating that colonization with these microorganisms
occurred via exogenous routes. This is in line with conclusions drawn by Flynn et
al (19). These authors demonstrated spreading of these microorganisms,
accompanied by heavy throat carriage, among cardiac surgery patients who were
intubated for at least five days. Unfortunately, in that study gastric samples were
not cultured and sequences of colonization could not be determined.
A total of six patients had Pseudomonas «erugzuosa pneumonia. Although initial
colonization of the trachea with this species was a common finding in our study,
two out of six patients suffering from Pseudowio/ias aerMgz'nosa pneumonia had
oropharyngeal to trachéal transfer of colonization. Therefore, the oropharyngeal to
trachéal route might be of some importance in the pathogenesis of pneumonia.
In contrast to Pseudomonas aerug/nosa and Enterobacter species, Klebsiella species
and Ewterococcus /aeca/is were isolated earlier from gastric samples than from the
trachéal aspirates, indicating that the intestine is a possible source of colonization.
In fact, both species belong to the commensal colon flora. Although Esc/ienc/im co/i
shares the same reservoir, no preferential initial site of colonization could be
determined for this species, indicating that colonization may take place via either
the exogenous or endogenous route.
In some studies an association between nosocomial pneumonia and treatment
with H2-antagonists or antacids has been observed in ICU-patients on mechanical
ventilation. However, the role of gastric colonization as a source of pathogens
causing pneumonia was not evaluated in these studies (7,8,20). Although gastric
colonization with ppmo occurred frequently, only six of the 20 isolates of species,
associated with nosocomial pneumonia, were cultured from gastric samples, prior
to or on the same day as the diagnosis was established. However, for these six
isolates no sequence of colonization from the stomach to the upper respiratory tract
could be demonstrated.
The fact that sucralfate was not used as stress ulcer prophylaxis reinforces two
points. In the first place, our finding that gastric colonization is not important in
the pathogenesis of pneumonia is not the result of artificial suppression of gastric
bacterial growth, and secondly, it can be questioned whether elevation of gastric pH
is a pathogenetically important mechanism for the development of nosocomial
pneumonia. The observations of the present study are in agreement with those
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reported by Reusser et al (4). Among 40 patients, 15 developed nosocomial
pneumonia and the stomach was the evident source of pneumonia in only one
case. However, in that study exclusively neurosurgical patients with a median age
of 34 years were studied for only seven days, and the diagnosis of pneumonia was
not established with quantitative cultures of samples obtained from the lower
respiratory tract. In another study of 100 ICLJ-patients, gastric colonization preceded
infection of the respiratory tract with the same microorganism in 6 out of 35
episodes of infection (5).
At this point it is important to recognize that the possibility still exists that the
intestinal flora is the origin of strains colonizing the oropharynx, albeit not
through retrograde colonization via the stomach. We, therefore, analyzed the
temporal relationship between colonization of the rectum by ppmo and the
occurrence of pneumonia caused by a pathogenic microorganism of the same
species. Preceding or concurrent colonization of the rectum by the same species as
that of the strain(s) of the pathogenic microorganism, was only observed if
pneumonia was caused by Esc/ier/c/i/a co/i or Proteus uu/garis. Since these species
belong to the commensal flora of the large intestine, the above finding cannot be
interpreted until further microbiological identity is established for fecal and
pathogenic strains. The question whether the intestinal flora is relevant as a source
of colonization and infection of the respiratory tract, has already been put forward
by Brun-Buisson et al (21). These investigators studied selective decontamination
of the digestive tract without decontamination of the oropharynx and systemic
prophylaxis. Although intestinal decontamination decreased intestinal
colonization with Gram-negative microorganisms, it had no effect on infection
rates.
In conclusion, the results of this study do not support the alleged importance of the
stomach as a source of colonization of the oropharynx or trachea by ppmo, prior to
the development of pneumonia.
Firstly, colonization of the trachea by Psewrfomonas aeri/ginosa and Enterobacter
species was only sporadically found to be associated with colonization of the
stomach. Secondly, gastric colonization by those strains, that were identified as
pathogenic agents for pneumonia, was never found to precede colonization of the
oropharynx or trachea in any of the 14 episodes of nosocomial pneumonia in this
study. Furthermore, the initial site of colonization may not be the same for all
microorganisms.
If these results are confirmed in further studies, preventive regimens should be
directed against colonization of the oropharynx and trachea rather than against
colonization of the stomach.
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COLONIZATION OF THE STOMACH AND INTRAGASTRIC ACIDITY ARE NOT
IMPORTANT FOR THE DEVELOPMENT OF RESPIRATORY TRACT
COLONIZATION AND INFECTION IN MECHANICALLY VENTILATED ICU-
PATIENTS
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SUMMARY
Gastric bacterial colonization, stimulated by decreased gastric acidity, has been
assumed to be important for the development of Ventilator-associated pneumonia
(VAP) in ICU-patients. Sucralfate has been associated with a lower incidence of
VAP as compared to patients receiving antacids and/or H2-antagonists. To evaluate
the effects of sucralfate and antacids, we conducted a randomized double-blind trial
in mechanically ventilated ICU-patients, in which patients were stratified on initial
gastric pH. Intragastric acidity was measured with computerized continuous
intragastric monitoring. The diagnosis of VAP was established with Protected
specimen brush and /or Bronchoalveolar lavage.
Altogether 141 patients were included (74 receiving Antacids, 67 Sucralfate) and
continuous intragastric pH-monitoring was performed in 112 patients (58 Antacids,
54 Sucralfate), with a mean of ±75 hours per patient. No significant differences in
median pH-values (4.7 ±2.2 and 4.5 ±2.0 for Antacids and Sucralfate respectively)
were observed. Median pH-values were higher in patients with gastric bacterial
colonization than in non-colonized patients (5.5 ±2.1 and 3.3 ±2.0, p<0.01), but
colonization of oropharynx and trachea was not related to intragastric acidity. A
sequence of colonization from the stomach to the trachea was demonstrated twice
for Enterobacteriaceae and 4 times for Pseudomomis aeruginosa in 141 patients.
Thirty-one patients (22%) developed VAP, with a similar incidence in both
treatment groups. Of the 58 bacteria associated with VAP, the stomach was the
initial site of colonization in only 1 case.
Antacids and Sucralfate had a similar effect on intragastric acidity, colonization
rates and incidence of VAP. Intragastric acidity influenced gastric colonization, but
not colonization of the upper respiratory tract or the incidence of VAP. The
stomach seldom was an initial site of colonization, and therefore it is unlikely that
the gastropulmonary route is important for the development of VAP.
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INTRODUCTION
Ventilator Associated Pneumonia (VAP) is an infection associated with increased
morbidity and mortality among mechanically ventilated patients (1). Enteric Gram-
negative bacteria, Ps<?Hdomc»ias aerwgniosa and Stap/iy/ococcus aureus are the
most frequent pathogens causing this infection (2), mostly after preceding
colonization of the oropharynx (3). Currently it is widely assumed that the stomach
is an important reservoir for bacteria causing VAP via the so-called
gastropulmonary route of infection, especially when gastric pH is raised above
bactericidal levels (4,5). Evidence for a causative relationship between gastric
colonization and development of VAP is based on studies relating gastric
colonization to species causing pneumonia (6,7,8). Craven et al investigated risk
factors for pulmonary infection in patients undergoing long-term mechanical
ventilation (9). Stress ulcer prophylaxis, aimed to decrease gastric acidity, was
associated with a higher risk on VAP. In keeping with these results, Driks et al
described the effect of modification of intragastric acidity on the incidence of VAP
(10).
Indeed, in critically ill patients gastric pH may be raised artificially by stress ulcer
prophylaxis (11). In theory, patients receiving stress ulcer prophylactic agents which
do not influence gastric acidity, should have lower rates of gastric bacterial
colonization and thus a lower risk on VAP. Sucralfate is a stress ulcer prophylactic
agent which does not influence gastric pH values (12). In several studies, a lower
incidence of VAP among patients receiving sucralfate than among patients
receiving antacids and/or ^-antagonists (10,13-15) was reported, thereby
furnishing supportive evidence for the proposed importance of the
gastropulmonary route of infection. However, interpretation of the studies
underscoring the importance of the gastropulmonary route of infection is seriously
hampered. In the first place, in all studies VAP was diagnosed on the basis of
clinical criteria in combination with radiography, which has a poor specificity to
establish the diagnosis in mechanically ventilated patients (16). Secondly, species
causing VAP were not related to identical strains that previously colonized the
stomach. Furthermore, gastric pH values were determined once daily or even less
frequently with an indicator stick in aspirated gastric juice, a method which has
been demonstrated to be unreliable (17,18). And finally, none of the studies used a
double-blind design.
The aim of the present study was to establish the role of gastric acidity in the
development of gastric and respiratory tract colonization and pneumonia in
mechanically ventilated patients. We compared sucralfate to high dosages of
antacids with regard to intragastric pH, colonization of stomach and respiratory
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tract and the occurrence of VAP. In addition, we studied the importance of the
gastropulmonary route for the development of VAP. The influence of the two
stress ulcer prophylactic agents was studied in a randomized double-blind fashion,
in which patients were stratified according to the initial gastric pH.
METHODS
Study popu/arion
All patients admitted to the ICU between August 1992 and 1993, who were
mechanically ventilated, and had an expected ICU-stay of at least three days were
eligible for this clinical trial. Patients were not eligible if they were less than 15 years
of age, when they were admitted for massive gastric hemorrhage or bleeding
esophageal varices, after esophageal or gastric surgery, when a nasogastric tube
could not be placed or when receiving ^-antagonists or H+K+ATPase inhibitors.
Stwdy
Sucralfate (Ulcogant®, Merck, Mannheim, Germany) and antacids (Antagel PCH®,
Pharmachemie b.v., Haarlem, The Netherlands) were compared in a double-blind
fashion and analyzed according to a prospectively developed plan that used
definitions adopted before the treatment-allocation code was broken. Gastric pH
values were determined within 24 hours after admission using continuous
intragastric monitoring. Patients were stratified into two groups, according to the
gastric pH value measured on the first day of admission, being <3.0 or >.3.0. If
intragastric pH monitoring was not possible, stratification occurred after
determination of pH with color-scaled indicator paper in aspirated gastric juice.
Demographic characteristics, diagnosis on admission, underlying diseases, vital
signs, medications and laboratory values were recorded prospectively. The
APACHE II scoring system was used to assess the severity of illness (19). Clinical
and laboratory values were recorded daily.
Samples of gastric and trachéal aspirates and oropharyngeal swabs were collected
serially on admission and subsequently twice weekly. Additional specimens were
collected and analyzed as required. The attending physician was unaware of the
results of oropharyngeal and gastric samples. Patients were studied until
extubation, death, or the institution of therapy influencing gastric acidity. In
general, all patients were in supine position during controlled mechanical
ventilation and if possible in semirecumbent position during weaning.
The protocol was approved by the institutional review board of the hospital and
informed consent was obtained from all participants, or if this was not possible
because of the clinical condition, from a representative of the family.
Sucralfate vs. antacids
Patients were randomly allocated to receive sucralfate (1 gram every four hours, at
0.00 through 20.00 hour) or antacids (30 ml every four hours, at 2.00 through 22.00
hour). Patients receiving sucralfate also received an antacid-placebo at the hours
that antacids were administered, and vice versa (sucralfate-placebo, Merck,
Mannheim, Germany) (double dummy model). The antacid-placebo was developed
and produced by the department of clinical pharmacy. In vitro, both placebos had
no buffering capacity, a pH of ±6.0, and could visually not be distinguished from
the active treatment. After administration of each of the compounds the
nasogastric tube was flushed with 10 ml of sterile water to prevent clogging.
c pH
A pH stomach probe with a glass electrode at the tip (Lot 440, Ingold AG, Urdorf,
Switzerland) was positioned in the stomach with the tip situated approximately 10
cm below the cardia. The position of the tip was verified radiographically. The
distance from tip to nostrils was kept constant for the complete recording period.
The pH was recorded at 3.45-15 Hz, depending on the total length of recording. The
pH-tracings were stored in a Digitrapper Mk III (Synectics Medical, Alphen aan den
Rijn, The Netherlands) and subsequently transferred to a personal computer.
Analysis was performed using Esophagram software (Gastrosoft Inc., Synectics
Medical). Electrodes and recorders were calibrated at 20 °C, before and after every
experiment, using commercial buffer solutions at pH 7.0 and 1.3 (Ingold AG). The
validation and accuracy of computerized continuous intragastric pH-monitoring
was described previously (20,21). The duration of monitoring, median pH value
and percentage of time with an intragastric pH <3.0 and <4.0 were calculated from
each measurement. All analyses were performed for both the percentage of time
with pH<3.0 and pH<4.0. The outcome was comparable for both analyses, and
therefore only the values for pH<3.0 are shown. Results were expressed as median
values with the Interquartile Range (IQR).
Bronc/joscopy
In case of clinical suspicion of pneumonia bronchoscopy with protected specimen
brush (PSB) and bronchoalveolar lavage (BAL) was performed as described
elsewhere (22). In brief, the fiberoptic bronchoscope was introduced and advanced
to the bronchial orifice of a lung segment containing a new or persistent infiltrate.
A PSB was advanced into a wedged, peripheral position to obtain lower airway
secretions. After brushing, the bronchoscope was positioned in the adjacent
subsegment and BAL was performed using one aliquot of 20-ml of sterile saline
(0.9% NaCl) followed by three aliquots of 50-ml. The liquid recovered after the first
aliquot was discarded and the remaining lavage fluid was pooled. In all cases PSB
was performed first.
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Colonization was analyzed semi-quantitatively as follows: Oropharyngeal swabs, 10
|xl of gastric aspirate, or 10 ul of trachéal aspirate were streaked using the four-
quadrant streak method on sheep blood, CLED, chocolate, and Sabauroud plates.
All media were incubated at 35 °C for 18 to 48 hours. Growth density was graded as
follows: Growth in the first quadrant= + l, in the second quadrant=+2, in the third
quadrant=+3, and on the whole plate=+4. Normal oropharyngeal flora included
alpha-hemolytic streptococci, non-pathogenic neisseria, micrococci and diptheroids.
Potential pathogenic microorganisms (ppmo) included Enterobacteriaceae
co/i, Klebsiella species, Enterobacter species, Proteus species,
morgfliiii, C/'frobacfer /re«nrf/i, Acinetobacter species),
Pseudomonadaceae (Pseudomonas aerugircosa, Xonf/iomonas ma/fop/n/ia), and
SfapJiy/ococcus aurews.
Enterai feeding (Nutrison, Nutricia, The Netherlands, pH=7.0) was administered
continuously and intragastrically, and delivered in sterile containers, containing
volumes for 24 hours, by the nutritional support department.
The influence of enterai feeding on intragastric acidity was analyzed as follows: a
group of patients in which continuous intragastric pH monitoring was performed
without administration of enterai feeding (group 1) was compared to a group of
patients in which enterai feeding was given throughout the whole registration
period (group 2). In addition, a group of patients in which enterai feeding was
started during the continuous pH-monitoring was analyzed (group 3). In this
group, measurements before and after institution of enterai feeding were analyzed
separately, without changing the position of the electrode or interrupting the
procedure.
Furthermore, the effect of enterai feeding on acquired colonization was analyzed.
This analysis was restricted to the first ten days in study. Three different nutritional
regimens could be distinguished: patients not receiving enterai feeding in this
period (group A), patients receiving enterai feeding for the whole study period
(group B), and patients in whom enterai feeding was started after the first day in
study (group C). In group C, only the days after institution of enterai feeding were
analyzed.
ana/ys/s
The sample size of both patient groups was calculated to detect a reduction in the
incidence of VAP from an assumed 30% in the antacid group to an expected
incidence of 10% in the sucralfate group (« = 0.05 and P = 0.2). The percentages of
infection were based on data available at the time the study was designed. Groups
were compared by Student's t-test and chi-square test for categorical variables.
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Median intragastric pH values were compared by Mann-Whitney U-test (MWU). A
p-value <0.05 was deemed statistically significant.
DEFINITIONS
pneumonia
The diagnosis of VAP was established when: (A) at least three of the following
criteria were met (1) rectal temperature >38.0 °C or <35.5 °C, (2) blood leucocytosis
(>10.1()3/mm3) and/or left shift or blood leucopenia (<3.103/mm^), (3) >10
leucocytes per high-power field in gram stain of trachéal aspirate and (4) a positive
culture from trachea! aspirate, in combination with (B) a new or progressive
infiltrate on chest radiograph, and (C) the presence of (1) a positive quantitative
culture of a sample of secretions obtained by bronchoalveolar lavage (cutoff point
>.1O* cfu/ml) or protected specimen brush (cutoff point ^10^ cfu/ml), or (2) a
positive blood culture unrelated to another source and obtained within 48 hours
before and after respiratory sampling, or (3) a positive pleural fluid culture.
Episodes of pneumonia diagnosed within the first 24 hours of admission were
considered present on admission.
Suspicion of gastrointestinal tract bleeding was endoscopically confirmed and
treated according to standard clinical practice. The patient was excluded from the
study from that day on.
Colonization was defined as the isolation of microorganisms in the absence of
infection, from gastric aspirate, oropharyngeal swab or trachéal aspirate.
Colonization on admission was established by a positive culture obtained within 24
hours. Colonization was designated as 'persistent' when present on admission and
persisting for at least three days. Colonization was designated as 'acquired' if there
were positive cultures of the same species of microorganism from at least two
consecutive samples, the first of which was taken no sooner than 24 hours after
admission. Sterile cultures or colonization with normal oropharyngeal flora were
labelled 'no colonization'.
site o/ co/om'zaf/on
The initial site of colonization was defined as that site at which colonization was
identified first. A sequence of colonization was examined by comparing isolates of
the same species, cultured from two or more sites. Enterobacteriaceae and
Sfap/iy/ococcMs aureus were deemed identical when the Minimal Inhibitory
Concentrations (MIC) to six antimicrobial agents were concordant, i.e. when no
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more than three out of six MIC-values differed no more than one step of a twofold
dilution sequence in the MIC determination. For Enterobacteriaceae identity was
further grounded on identical biochemical reactions (i.e. API20E-profile).
Isolates of Pseudomonas aerug/nosa were considered identical on the basis of MIC-
values, biochemical profile (API20NE-system) and evaluation of plasmid analysis,
serotyping, phagetyping and analysis of outer membrane proteins.
In case of concordance, a time sequence of strain isolation from different sites was
assumed to indicate the direction of colonization.
RESULTS
Sfwdy popu/afion
A total of 155 patients were eligible for the trial, of which four refused participation,
and 10 succumbed within 24 hours. Of the remaining 141 patients, 74 received
antacids and 67 sucralfate (Figure 1). The two treatment groups were similar in
terms of demographic characteristics and severity of illness on admission (Table 1).
Stratification was based on measurements obtained with continuous intragastric
monitoring in 84 and indicator papers in 57 patients (Figure 1): in 28 of the latter
group continuous pH monitoring was performed later on.
pH < 3.0
n = w
romp, n =
stick n =
antacids
n = 36
>
= 45
24
sucralfate
n = 33
patients eligible
n = 155
1
stratification
n = 141
pH z 3.0
n = 72
comp. n =
stick n =
antacids
n = 38
. refused participation
n = 4
death within 24 h.
n = 10
 39
33
sucralfate
n = 34
Figure 1: Sc/ieme o/ imr/usi'on, sfrafi/icafion and randomization o/ a// pafienfs e/igib/e /or the frifl/.
COMP = sfrati/ica/ion based on computerized infrogasfric pH-meosuremenf, ST7CK = strafi/ica/ion
based on pH-measwremen/ tuir/i co/or-sca/ed indicator paper.
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Characteristics Antacids Sucralfate
n
Age (yr)
Male/Female
Admitting service:
surgery
trauma
medical
pulmonology
neurology
APACHE II score
Tracheotomized
Underlying diseases: **
Cardiovascular disease
Gastrointestinal disease
Respiratory disease
Alcoholism or drug abuse
Neoplastic disease
Diabetic mellitus
Neurologic disease
Renal insufficiency
Immunodeficiency
Reason for intubation:
Respiratory failure
Trauma
Shock or hypoxic acidosis
Cardiopulmonary failure
Pneumonia on admission
Neurologic disease
Elective
Pneumonia on admission:
bacterial
atypical
no causative agent identified
74
58.6±18.6
46/28
30 (40.5)
13 (17.6)
13 (17.6)
12 (16.2)
6 (8.1)
20.3*9.4
1
30 (40.5)
7 (9.5)
19 (25.7)
4 (5.4)
12 (16.2)
7 (9.5)
8 (10.8)
1 (1.4)
3 (4.1)
23 (31.1)
11 (14.9)
2 (2.7)
7 (9.5)
9 (12.2)
6 (8.1)
16 (21.6)
9 (12.2)
8
1
0
67
57.3±19.4
42/25
24 (35.8)
7 (10.4)
20 (29.9)
8 (11.9)
8 (11.9)
20.9*8.0
2
30 (44.8)
7 (10.4)
16 (23.9)
7 (10.4)
5 (7.5)
9 (13.4)
5 (7.5)
6 (9.0)
7 (10.4)
19 (28.4)
7 (10.4)
7(10.4)
7 (10.4)
10 (14.9)
6 (9.0)
11 (16.4)
10 (14.9)
4
3
3
* P/us-minus ua/ues are means * SD. Numbers m parenfneses are percentages o/ group; ** More
condition possib/e per patient
none o/ f/ie di/ferences between patients receiving antacids and sucra//ate were s/afistica//y
significant
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On admission no significant differences in colonization rates were observed
between both treatment groups (Table 2). As expected, patients stratified in the 'low
pH' group were less frequently colonized with Enterobacteriaceae in the stomach
on admission (5/66 versus 27/67, p<0.0001, Chi-square) than patients in the 'high'
pH group, but no such differences in colonization were observed in oropharynx
and trachea (data not shown).
Tab/e 2: Colonization on admission and acquired co/omzafion*
Trachea
Enterobacleriaceae
Pseudomonadaceae
Staphylococcus aureus
Candida species
colonized with ppmo "
Oropharynx
Enterobacteriaceae
Pseudomonadaceae
Staphylococcus aureus
Candida species
colonized with ppmo "
Stomach
Enterobacteriaceae
Pseudomonadaceae
Staphylococcus aureus
Candida species
colonized with ppmo **
Colonization on admission
Antacids
(n=72)
14 (19)
10 (14)
3(4)
10 (14)
25 (36)
(n=72)
32 (44)
9(13)
2(3)
22 (31)
38 (53)
(n=69)
17(25)
4(6)
0(0)
17 (25)
20 (29)
Sucralfate
(n=67)
8(12)
4(6)
5(8)
10 (15)
15(22)
(n=67)
20 (30)
7(10)
4(6)
15 (22)
26 (39)
(n=64)
15 (23)
2(3)
1(2)
12 (19)
17 (27)
Acquired
Antacids
(n=74)
16(23)
19(27)
12 (16)
7(9)
35 (47)
(n=74)
26 (36)
18(25)
9(12)
6(8)
49(54)
(n=74)
22(31)
14 (20)
2(3)
8(11)
35 (47)
colonization
Sucralfate
(n=67)
19 (29)
23 (35)
5(7)
9(13)
32(48)
(n=67)
32 (48)
19 (29)
3(4)
11 (16)
38(57)
(n=67)
30 (46)
10 (15)
0(0)
3(4)
32 (48)
None o/ Me differences foefwee» patients receiving antacids and sucra//afe were sfafis(ico//y
sigm/iawt; * Number o/ patients (percent); ** 'co/onization u»it/i ppmo' inc/udes Enterobacteriaceae,
Pseudomonadaceae, Sfap/iy/ococcus aureus, and /4cinefobacter species
c pH wion/for/ng
Continuous intragastric pH monitoring was performed in 112 patients; 58 patients
receiving antacids (78.4%) and 54 patients receiving sucralfate (80.6%). For safety
reasons intragastric pH monitoring was not performed in patients with trauma of
head or neck region (n=7), intracerebral bleeding (n=4), coagulation disorders (n=3)
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or esophageal obstruction (n=4). In addition, 6 patients (or relatives) refused
intragastric pH monitoring and in five patients data were lost due to technical
failures.
The mean duration of measurements was comparable in both treatment groups:
4310 ±1786 minutes for the antacid group and 4500 ±1833 minutes for patients
receiving sucralfate. Intragastric pH monitoring was in all cases performed within
the first ten days of admission. The median pH value (IQR) of patients stratified in
the 'low pH' group was 2.8 (1.8-5.4) compared to 5.9 (3.6-6.7) in the 'high pH' group
(p<0.00001, MWU) (Figure 2), and the median percentages of time with pH<3.0
(IQR) were 50.0 (15.1-75.2) and 9.2 (0.5-42.4) respectively (p<0.00001, MWU).
In contrast, no significant differences in median pH values were observed between
the two treatment groups, the median pH (IQR) being 4.7 (2.2-6.2) for patients
receiving antacids and 4.5 (2.7-6.0) for those receiving sucralfate (ns, MWU) (Figure
2). The median percentages of time with pH<3.0 (IQR) were 32.6 (7.8-64.1) and 26.0
(3.3-66.0) for patients receiving antacids and sucralfate respectively (ns, MWU).
I
a.
8 i
7 -
6 -
5 .
3 -
2 .
1 .
0
according to
treatment
IT
T
p = NS
according to
initial pH
T
I
-L T
p< .00001
antacids sucralfate
n=58 n=54
pH*3
n=53
p H < 3
n=59
Figure 2: Median iiifragasfnc pH-zw/ues (5, 25, 50, 75 and 95-percewfi7es), as obtained UJM co«(inuous
mfragasfric monitoring, according (o frea/menf and ini/ia/ infragasfric pH be/ore sfrafi/ica/ion.
Sfafisfica/ ana/ysis: Mann-W/iilney U-fesf.
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uni l'nfragasfric pH
No significant differences in acquired colonization in stomach, oropharynx or
trachea were observed between patients according to treatment groups (Table 2).
The relationship between intragastric pH levels and colonization in the first 10 days
of admission were analyzed for patients in whom pH monitoring was performed
(n=112).
Gastric colonization with Enterobacteriaceae was related to median pH values:
colonized patients had a median pH value (IQR) of 5.5 (2.8-6.5), and non-colonized
patients of 3.3 (1.9-5.7) (p<0.01 MWU). The percentages of time with pH<3.0 were
12.6 (3.0-52.4) in colonized, and 44.9 (8.6-74.4) in non-colonized patients (p<0.05
MWU).
Comparable observations were made regarding gastric colonization with
Pseudomonadaceae; colonized patients had higher median intragastric pH values
(IQR) (5.9 (2.8-6.8) versus 4.1 (2.2-6.0) respectively, p<0.05, MWU) and lower
percentages of time with pH<3.0 as compared to non-colonized patients (7.8 (0.5-
38.0) versus 35.0 (7.5-72.4) respectively, p<0.05 MWU).
and frac/iea
No significant differences in intragastric acidity were observed between patients
colonized and not colonized in oropharynx and trachea with Enterobacteriaceae or
Pseudomonadaceae. The median pH values (IQR) were 4.2 (2.0-6.3) versus 5.0 (2.3-
6.0), and 5.0 (2.8-6.5) versus 4.2 (2.1-6.0) for patients colonized versus not-colonized
with Enterobacteriaceae in oropharynx and trachea respectively. The median pH
values were 5.2 (2.4-6.6) versus 4.2 (2.1-5.9), and 4.9 (2.6-6.4) versus 4.4 (2.1-6.0) for
patients colonized and not-colonized with Pseudomonadaceae in oropharynx and
trachea respectively.
Sequences o/
The analysis of initial sites of colonization and transmissions to other sites was
performed for Psendo/noias aerug/MOsa, Sfap/iy/ococcus awreus and Esc/ienchia
co/i, K/ebsie//a pneumomae, Enterobacter species and Proteus species (Table 3).
Since colonization with one of these microorganisms was demonstrated at all three
sites simultaneously 40 times, these episodes were not included. The oropharynx
(or oropharynx and stomach simultaneous) was the preferential initial site of
colonization for the Enterobacteriaceae, whereas Pseudomonas aerug/wosa and
Sfap/jy/ococcMS awrews most frequently colonized the upper respiratory tract first. A
gastropulmonary route of colonization (from stomach to trachea) was
demonstrated only twice for Enterobacteriaceae, four times for Pse«domonas
aerug/nosa, and not for Sfap/iy/ococcus aurews (Table 3).
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3: Sequences 0/ co/omzafion u>ifn Enferobac/en'aceae, Pseudomomts aeruginoso and
Sfap/iy/ococcus aureus according fo fne inifia/ sife 0/ co/omznfion.
Microorganism
Enterobacteriaceae *
Pseudomonas aeruginosa
Staphylococcus aureus
Initial site
stomach
stomach/oropharynx
oropharynx
oropharynx / trachea
trachea
stomach
stomach / oropharynx
oropharynx
oropharynx / trachea
trachea
stomach
stomach / oropharynx
oropharynx
oropharynx / trachea
trachea
n
20
31
48
10
11
4
3
14
18
7
0
3
5
10
16
Stomach
-
-
16
4
2
-
-
10
8
4
-
-
0
1
3
Number of sequences to
Oropharynx
8
-
-
-
1
4
-
-
-
3
0
-
-
-
7
Trachea
2
13
17
-
.
4
3
11
-
-
0
0
0
-
-
1
No sequence
12
18
22
6
9
0
0
3
10
4
0
3
5
9
12
* Enferofaflc/eriacene inc/ude Eschen'c/iia co/i, K/ebsie//a pneumonia, Enferobacfer species, Profeus
species.
Jn/ecfiows and morfa/i'fy
There was a clinical suspicion of pneumonia in 29 patients receiving antacids (34%)
and in 24 patients receiving sucralfate (35%). However, the diagnosis of pneumonia
was established in 16 patients receiving antacids and 15 patients receiving sucralfate
(Table 4). In two patients, 1 in each treatment group, no bronchoscopy was
performed because of the terminal stage of illness, and the diagnosis VAP was
based on clinical criteria and results obtained by autopsy. The incidence of VAP was
comparable in the two stratification groups (15/69 in Tow' pH group and 16/72 in
the 'high' pH group). The mean number of days prior to the first episode of VAP
was similar in both groups; 9.2 days in the antacid and 9.3 days in the sucralfate
group. Intragastric pH monitoring was performed in 24 patients developing VAP.
The median pH values and percentages of time with a pH <3.0 (IQR) were similar
between patients with and without VAP: median pH 4.1 (2.7-6.2) and 4.8 (2.2-6.0),
and percentages of time 36.7 (3.8-53.3) and 26.6 (5.4-70.4) respectively.
Since antacids and sucralfate had a similar effect on intragastric acidity, patients
were divided into 2 groups according to median intragastric pH values lower or
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higher than 4.0. The first group (pH<4.0, n=50, 27 antacids, and 23 sucralfate) had a
median pH (IQR) of 2.1 (1.5-2.8). The second group (pH>4.0, n=62, 31 antacids, and
31 sucralfate) had a median pH of 6.0 (5.2-6.6). Gastric colonization with
Enterobacteriaceae during the first 10 days in study was significantly less frequently
observed in patients of group 1 (pH<4.0, 30%) as compared to patients of group 2
(pH>4.0, 56%, p=0.004). However, no differences were observed for colonization of
the oropharynx (54% and 48%), the trachea (22% and 29%), or the incidence of VAP
(22% and 21%).
Since VAP was polymicrobial in 19 episodes, a total of 58 isolates were associated
with VAP. For these isolates initial sites of colonization could be determined in 51
cases. The upper respiratory tract (oropharynx and/or trachea) was the
predominant initial site of colonization of microorganisms eventually causing
VAP (41 out of 58 cases). In one case a microorganism causing VAP initially
colonized the stomach, whereas initial colonization of the stomach and
oropharynx simultaneously occurred five times.
The incidence of infections other than VAP, the mean durations of time spent in
study and in ICU, the use of antibiotics, and the mortality rates were comparable in
both treatment groups (Table 4). Ten patients receiving sucralfate and 4 receiving
antacids were tracheotomized (p=ns), but only 2 patients, 1 in each treatment group,
developed VAP after being tracheotomized.
1
Upper gasfrointesfi'na/ tracf
In seven patients (four receiving antacids and three receiving sucralfate) the study
protocol was discontinued because an H+K+ATPase inhibitor (n=6), or an H2-
antagonist (n=l) was instituted. In two of these patients (one in each treatment
group) a bleeding ulcer was diagnosed and surgical intervention was performed.
One patient, receiving antacids, eventually succumbed in hypovolaemic shock.
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4: Numbers 0/ patients zfi't/i JCL/-ac<;uired in/ecti'oiis according to treatment groups. *
Pneumonia
Pseudomonas aeruginosa
Staphylococcus aureus
Haemophilus influenzae
Klebsiella pneumoniae
Escherichia coli
Enterobacter species
Streptococcus pneumoniae
other
Recurrent episode of pneumonia
Pseudomonas aeruginosa
Enterobacter species
Pleura empyema
Other infections
Urosepsis
Sepsis (± haemodynamic instability)
Abdominal sepsis
(+ haemodynamic instability)
Bacteraemia due to other infection **
Total number with ICU-acquired infection
Tracheostomy
Days in study (±SD)
range
Days in ICU
range
Use of antibiotics
number of antibiotics (± SD)
number of days (± SD)
number of episodes (± SD)
Mortality:
in ICU
in hospital ***
Antacids
n=74
16(22)
7
7
4
2
2
1
2
2
2
2
1
1
1
3
1
3
24(32)
4
11.0 (±16.8)
2-133
19.0 (±43.4)
3-350
2.0 (±1.8)
6.7 (±9.6)
1.1 (±1.1)
24 (32)
27 (36)
Sucralfate
n=67
15(22)
11
4
1
3
2
1
1
3
1
1
1
3
1
1
2
23(34)
10
13.3 (±12.7)
2-61
16.8 (±15.1)
2-78
2.2 (±1.6)
8.2 (±8.8)
1.3 (±1.0)
26(39)
32 (48)
ot/ier inc/«de: Moraxe//a cijturrnad's, Acinetobacfer species, Morgane//a morgunii, Serratia
'igue/«ciens, Proteus mirabi/is; * P/us-minus ua/ues are means ± SD. Numbers in parent/ieses are
percentages 0/ group; ** Bacteremia due to (inesepsis (n=3), uioundin/ection (n=l) and sinusitis (n=3);
*** Patients discharged to ot/ier nospita/s or sf/// in our nospita/ iwere considered a/iwe.
None 0/ the dif/erences between patients receiving antacids and sucra//ate zuere sfatistica//y
signi/icanf.
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Eighty-two patients (40 receiving sucralfate (60%) and 42 receiving antacids (57%))
received enterai feeding in most cases initiated within the first five days after
admission (median=2.0, range 1-23 days), in 54 initiated before or during
continuous pH measurement. The median pH values and percentages of time with
pH<3.0 did not differ significantly between patients in group 1 (n=58, monitored
without enterai feeding) and group 2 (n=23, monitored with enterai feeding). The
median pH was 3.8 and 4.8 in groups 1 and 2 respectively (ns, MWU), and the
percentages of time with pH<3.0 were 39.0% and 25.0% in group 1 and 2
respectively (ns, MWU) (Figure 3a). In the remaining 31 patients (group 3, enterai
feeding started during monitoring) median pH values and percentages of time with
pH<3.0, of periods without and with enterai feeding, did not differ significantly.
The median pH was 4.7 and 5.2 respectively (ns, Wilcoxon rank test for matched
pairs), and the percentages of time with pH<3.0 were 26.5% and 9.9% respectively
(ns, Wilcoxon rank test for matched pairs) (Figure 3b).
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sijuare
Co/o«/2flh'on
During the first ten days in study 65 patients did not receive enterai feeding (group
A), 22 patients received enterai feeding for the whole study period (group B), and in
54 patients enterai feeding was started during the first ten days (Group C). In this
analysis of colonization, the median number of days studied in each groep were 6.0,
10.0 and 5.0 for groups A,B and C respectively. The difference in number of days
studied between group B, as compared to groups A and C, was statistically
significant (p<0.001, MWU). Patients receiving enterai feeding (groups B and C)
acquired colonization with Enterobacteriaceae in the stomach more frequently
(Figure 4). The difference being statistically significant when all three groups were
analyzed (p<0.001, Chi-sq.) as well as when groups 1 and 3, with similar numbers of
days studied, were compared (p<0.001, Chi-sq.). No significant differences were
observed for acquired colonization with Enterobacteriaceae in oropharynx and
trachea or for acquired colonization with Pseudomonadaceae. These results suggest
that gastric colonization with Enterobacteriaceae is related to enterai feeding rather
than to intragastric acidity, as measured with long-term continuous intragastric pH
monitoring. Eighteen patients developed an episode of VAP after enterai feeding
had been instituted (11 receiving antacids and 7 receiving sucralfate, p>.05). The
'ïn; ïsnj «tesrnaqvn am no r
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median days at which VAP was diagnosed was 5 (range 3-23 days) in patients
without and 8 (range 3-39 days) in patients with enterai feeding (p>.05).
DISCUSSION
The results of this study demonstrate that the stomach is not an important
reservoir for bacteria colonizing the upper respiratory tract and that intragastric
acidity does not influence colonization and/or incidence of Ventilator-Associated
Pneumonia. In addition, the effects of antacids and sucralfate on intragastric acidity
were comparable. In line with these observations, colonization rates of the stomach
and upper respiratory tract, and the incidences of VAP were similar between
patients receiving sucralfate or antacids.
Modulation of intragastric acidity and colonization was studied using two different
stress ulcer prophylactic agents. However, a high dosage of antacids (30 ml, 6 times
daily), comparable to the dosages used by others (13,23), resulted in median
intragastric pH-values and percentages of time with a pH below 3.0 that were
comparable to the values from patients receiving sucralfate (Figure 2). Our results
confirm observations made by others, also demonstrating limited efficacy of
antacids to raise gastric pH when tested with continuous intragastric pH-
monitoring (24,25).
Many of the data regarding intragastric acidity in intensive care patients originate
from studies determining intragastric acidity with color-scaled indicator papers in
aspirated gastric juice, with frequencies ranging from one to 12 measurements per
day (6,7,10,13-15,23). However, the reliability of color-scaled indicator papers has
been criticized (17,18), and the accuracy of determination of intragastric acidity is
related to the frequency of measurements (26), since incidentically measured pH
values neither detect temporary changes in acidity (27), nor necessarily reflect the
mean acidity.
As expected, patients with a gastric pH above 3.0 on admission were more
frequently colonized with Enterobacteriaceae and Pseudomonadaceae in the
stomach, and patients with gastric colonization had significantly higher median
intragastric pH values as compared to non-colonized patients. These observations
are in line with other reports (6,28-30). Overall, no differences in gastric
colonization rates observed between patients receiving sucralfate or antacids,
reflecting the similar median intragastric pH values in both treatment groups.
Although lower colonization rates have been reported in sucralfate treated patients
• as compared to patients receiving antacids and/or ^-antagonists (10,16), the results
of these studies cast doubt on the hypothesis that the differences in colonization
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could be explained by sucralfate's lack of effect on gastric pH. The mean pH values
were above 4.3 for patients receiving sucralfate (15) and more than 50% of the
samples had a pH >4.0 (10). Taking into account that the bactericidal pH value for
bacterial growth is ±3.0 (31), it is questionable whether these high pH values
influence bacterial colonization. Because patients in the current study were
stratified according to pH on admission, we could analyze our data with regard to
intragastric acidity as measured with continuous pH monitoring. In this analysis,
patients with a median pH >4.0 were more frequently colonized in the stomach, but
no differences were observed for colonization of the respiratory tract and the
incidence of VAP, as compared to patients with a low intragastric pH (<4.0).
Although gastric acidity was not actively raised in these patients, these data
underscore the observation that colonization and infection of the respiratory tract
may not be related to intragastric acidity.
In contrast to gastric colonization, oropharyngeal and trachéal colonization were
not related to intragastric acidity, which questions the assumed importance of the
stomach as a source for bacteria causing colonization of the upper respiratory tract
and VAP. Moreover, the stomach was only sporadically the initial site of
colonization, and a sequence of colonization from the stomach to the trachea was
demonstrated only four times with Pse«domo«as aerugircosa and two times with
Enterobacteriaceae in 141 patients. Our data underscore observations recently made
by others (32,33). Inglis et al and Cade et al demonstrated chronological patterns of
colonization from the stomach to the tracheobronchial tree in only six and eight
out of 100 mechanically ventilated ICU-patients respectively (32,33). The results of
the present study also confirm our previous observations that Pseudomonas
aerugiMosa and Enterobacter species initially colonized the trachea rather than the
stomach, and that routes of colonization differ between species of microorganisms
(34).
The incidence and etiology of VAP in the present study are in line with data from
other reports (1,10,35). Importantly, colonization of the upper respiratory tract and
the development of VAP were not related to stress ulcer prophylaxis or intragastric
pH. The analysis of sequences of colonization of bacteria eventually causing VAP
indicates that the gastropulmonary route is not important in the pathogenesis of
VAP, which confirms observations made previously by us and Reusser et al (34,36).
The observation that colonization with bacteria, eventually causing VAP, most
frequently originated in the oropharynx and/or trachea, underscores the
importance of colonization at these sites prior to development of VAP, which was
first reported by Johanson et al (3).
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Thus, the results of this study put questions to the hypothesis that tfie
gastropulmonary route of colonization is important in the pathogenesis of VAP,
although this has been accepted by many investigators (4,5). However, data from
the literature do not provide solid support for this notion. Indeed, several studies
clearly demonstrated a relation between gastric colonization and bacteria causing
VAP, but incidences of chronological patterns of colonization from the stomach to
the lungs, including colonization of the oropharyngeal cavity, were not studied
(6,7,8,10,13,14,29). Secondly, reported beneficial effects of sucralfate on the incidence
of VAP were also considered to provide evidence for the importance of the
gastropulmonary route of colonization (4,5), although the small differences
between gastric pH values in these studies (4.26-4.73 versus 4.85-5.55) could hardly
explain the differences in incidences of VAP (10,13-15,37). Moreover, no
sophisticated methods were used for the measurement of intragastric acidity and
for diagnosing VAP, and no double-blind study-design was employed.
Enterai feeding has been associated with an increased risk of gastric bacterial
colonization and pneumonia (38). In the present study the numbers of patients
receiving, and the day on which enterai feeding was instituted were comparable in
both treatment groups. Although, the results of the present study do not
underscore the relationship between enterai feeding and VAP, this study was not
designed specifically to determine the influence of enterai feeding on intragastric
acidity, colonization, and VAP, and this presumed relationship therefore remains
to be elucidated.
In conclusion, antacids and sucralfate had a similar effect on intragastric acidity,
and as a result sucralfate had no preventive effect on the incidences of colonization
and infection in these patients. Moreover, intragastric acidity and colonization was
not associated with colonization of the upper respiratory tract and development of
pneumonia in mechanically ventilated ICU-patients. The results of this study
provide evidence that the gastropulmonary route may not be important for the
development of VAP in mechanically ventilated ICU-patients.
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Chapter 11
SUMMARY, ANSWERS TO THE QUESTIONS, AND CONCLUDING REMARKS
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This thesis describes studies on the role of colonization of the upper
gastrointestinal tract in the pathogenesis of nosocomial pneumonia in
mechanically ventilated ICU-patients. Nosocomial pneumonia, sometimes called
late or secondary pneumonia, is an infection developing after at least three days of
admission to hospital. Among mechanically ventilated ICU-patients this infection
has also been called ventilator-associated pneumonia (VAP). In chapter 1 the
pathogenesis of ventilator-associated pneumonia was reviewed. It is widely
accepted that most bacteria causing pneumonia originate from an endogenous
reservoir, i.e. the digestive tract, and that the gastropulmonary route of
colonization is of main importance for the development of nosocomial
pneumonia. However, data from the literature do not, in our opinion, provide
convincing evidence for this hypothesis. Although many preventive strategies,
such as selective decontamination of the digestive tract and the use of sucralfate for
stress ulcer prophylaxis, have been developed, based on the gastropulmonary route
of colonization, the clinical benefits of each attempt have been disputed. A critical
appraisal of the literature led to the conclusion that most studies, addressing the
prevention of VAP, suffer from methodological inadequacies: i.e. the endpoint of
most studies, nosocomial pneumonia, was not diagnosed adequately, colonization
of several body sites was not monitored in time, and modulation of intragastric
acidity was not studied reliably.
Selective Decontamination of the Digestive tract (SDD) is the preventive regimen
most frequently used and most extensively studied. In this regimen of infection
prevention non-absorbable antimicrobial agents are applied to the oropharynx,
stomach and intestine. The antibacterial spectrum of the antibiotics include
Enterobacteriaceae, Psewdomonas aerug/Mosa and Sfap/iy/ococcus aurews, the
potential pathogenic microorganisms (ppmo) most frequently associated with VAP.
The term "selective" refers to the fact that the anaerobic bacteria are not to be
eliminated since these are believed to increase colonization resistance. Despite
many studies, the benefits of SDD have not been unequivocally established.
Moreover, interpretation of the studies, especially those performed before 1990, is
seriously hampered because of methodological flaws. Seven studies on SDD,
published after 1991, have been reviewed in chapter 2. All studies were prospective
and randomized with at least 100 patients in each study: 6 studies were placebo-
controlled, and 3 were double-blind. Only 2 studies showed a significant decrease in
the incidence of ICU-acquired pneumonia. Moreover, data from these studies and
other recent publications demonstrated an increased incidence of colonization and
infection due to Gram-positive bacteria, an increasing number of bacteria resistant
to the antibiotics used in SDD, and high costs associated with this method of
infection prevention. It was concluded that the recently published well-designed
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studies failed to show any beneficial effects of SDD on mortality, the incidence of
VAP, or other parameters such as duration of mechanical ventilation or ICU-stay.
As an accurate diagnosis of nosocomial pneumonia is essential when studying its
pathogenesis, problems in diagnosing pneumonia were reviewed in chapter 3.
Since most ICU-patients are heavily colonized with bacteria in the upper
respiratory tract, it is rather difficult to distinguish colonization from infection. In
addition, bedside chest radiographs often are difficult to interprète, and therefore
not reliable enough to establish or reject the diagnosis of VAP, even in
combination with clinical parameters. Bronchoscopic techniques, such as Protected
Specimen Brush (PSB) and Bronchoalveolar Lavage (BAL) have been developed to
obtain uncontaminated samples from distal airways. Quantitative microbiological
analysis of these samples, in combination with clinical parameters of infection and
interpretation of chest radiographs, probably is thé optimal method to diagnose
VAP. Several studies demonstrated a good sensitivity and an acceptable specificity
for diagnosing VAP with these methods. Therefore, in all studies described in this
thesis quantitative microbiological analysis of samples obtained by Protected
Specimen Brush and Bronchoalveolar Lavage, in combination with clinical
parameters, were used for diagnosing VAP.
In chapter 5 the influence of topical antimicrobial prophylaxis (TAP) of oropharynx
and stomach on colonization of the upper respiratory tract was studied. In contrast
to conventional SDD, intestinal decontamination was not aimed for and systemic
prophylaxis was not administered. In order to maintain the aerobic and anaerobic
intestinal flora, the amounts of non-absorbable antibiotics administered via the
nasogastric tube into the stomach were lower as compared to those used in SDD.
The results of this study demonstrated that colonization of the upper respiratory
tract with ppmo could be prevented without intestinal decontamination. However,
a tendency towards increased colonization of the upper respiratory tract with Gram-
positive bacteria, especially Enferococcus /aeca/is, intrinsically resistant to the
antibiotics used, was observed. Moreover, of 61 patients receiving TAP, 6 developed
polymicrobial pneumonia and 2 bacteremia with E/i/erococcus /aeca/is, which
species was generally considered not to cause respiratory tract infection.
In chapter 6 we studied gastric colonization in patients receiving and not-receiving
the TAP-regimen, described in chapter 5. TAP, including sucralfate, prevented
gastric colonization effectively. Patients receiving 'gastric pH raising' stress ulcer
prophylaxis acquired gastric colonization more frequently. Interestingly, in both
patient groups gastric colonization occurred more frequently and more rapidly
when enterai feeding was administered simultaneously.
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In chapter 7 the influence of TAP on colonization with ppmo of the upper
respiratory tract was investigated both in patients receiving TAP (n=22) as well as in
2 groups of patients not receiving TAP. These two control groups included patients
treated within the same ICU-ward (n=21) as the patients receiving TAP, and
patients treated in another identical ICU (n=54), where none of the patients
received TAP. Patients receiving TAP were less frequently colonized in oropharynx •
or trachea as compared to patients not receiving TAP. However, among both
control groups, those patients treated in the ICU where other patients received TAP
were less frequently colonized as compared to the patients treated in the ICU where
no TAP was instituted. Moreover, of the patients not colonized on admission,
those admitted to the ICU where TAP was administered remained free of
colonization for a longer period of time. Furthermore, in the ICU where no
prophylaxis was administered more patients were colonized simultaneously and
cross-acquisition occurred more frequently. From this study it was concluded that
TAP influenced colonization of oropharynx and trachea both in patients receiving
as well as in patients not-receiving the prophylaxis within the same ICU. This
strongly suggests that cross-acquisition plays an important role in colonization of
patients within an ICU.
Chapter 8 addressed the topic of measuring intragastric acidity with optimal
accuracy. Generally speaking, intragastric acidity is determined by pH
measurements with color-scaled indicator papers in aspirated gastric juice, with
sampling frequencies ranging from 6 times daily to twice weekly. However, this
method had been criticized for several reasons. In the first place the reliability of
the color-scaled papers had been questioned. Secondly, a large interobserver
variability has been reported. And finally, incidental measurements can never
accurately reflect changes in intragastric acidity. Computerized continuous
intragastric pH-monitoring, the reliability and reproducibility of which has been
clearly demonstrated, overcomes these problems. In chapter 8 we tested the
accuracy of color-scaled indicator papers and compared the pH values obtained with
this method to the median pH values obtained with continuous intragastric pH
monitoring during 24 hours. The accuracy of the color-scaled papers as verified
with a laboratory pH meter was high, both in colorless buffered solutions with
variable pH values as well as in gastric juice. However, when used once daily, the
pH values had a poor correlation with median pH values obtained with
continuous intragastric monitoring, probably because changes in intragastric acidity
could not be measured well. Therefore, continuous intragastric pH monitoring
should be used to investigate the influence of certain manoeuvres on intragastric
acidity.
I
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In the study described in chapter 9 colonization of the stomach, the oropharynx and
the trachea was monitored serially and chronologically in order to determine
sequences of colonization. Eleven patients developed VAP and cultures from PSB
and BAL yielded 20 species of microorganisms. Previously to or on the day that
pneumonia was diagnosed, 17 of these species associated with VAP were cultured
from trachéal aspirates, and 6 from gastric aspirates. For none of these 6 species a
sequence of colonization from the stomach to the upper respiratory tract could be
demonstrated. The initial site of colonization with Pseudomonos aerugi/iosa and
Enterobacter spp. was more frequently the trachea than the stomach. In contrast,
species such as Klebsiella spp. and Enterococcus /aeca/zs, preferentially colonized
the stomach first. Based on these data, it seemed unlikely that the stomach was an
important source of bacteria causing VAP. In addition, different species of bacteria
probably had different initial sites and routes of colonization.
The influence of intragastric acidity on gastric colonization, colonization of the
upper respiratory tract and the incidence of VAP was described in chapter 10. In
addition, the influence of 2 different regimens for stress ulcer prophylaxis, namely
sucralfate and antacids, on these parameters were compared. The latter was done in
a prospective randomized double-blind fashion, in which patients were stratified
on initial gastric pH. No significant differences in median pH values were
observed. Furthermore, colonization rates in the stomach, the oropharynx and the
trachea were comparable in both treatment groups. However, patients colonized
with ppmo in the stomach had higher median pH values as compared to non-
colonized patients, underscoring the relation between intragastric acidity and
gastric colonization. In contrast, no significant differences in intragastric acidity
were observed between colonized and non-colonized patients in oropharynx or
trachea. In addition, sequences of colonization from the stomach to the trachea
were demonstrated twice for Enterobacteriaceae and 4 times for Psendornowas
aerug/nosa in 141 patients. In agreement with the data on colonization, no
differences were observed in the incidence of VAP between both treatment groups
(22% in both), and only 1 of the 48 bacteria associated with VAP initially colonized
the patient in the stomach. The results of this study provide convincing evidence,
further to the observations already made in chapter 9, that the stomach is not an
important source of bacteria causing VAP. Moreover, sucralfate and antacids had
comparable effects on intragastric acidity, and as a result sucralfate did not prevent
colonization and infection.
Another feature of this study was that the oropharynx and trachea were the most
important initial sites of colonization, which strongly points to the importance of
exogenous routes of colonization, thus confirming our previous observations
made in chapter 7.
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In this study also the influence of enterai feeding on intragastric acidity and gastric
colonization was investigated in a post-hoc analysis. In contrast to the results in
other studies, administration of gastric nutrition did not seem to change
intragastric acidity. However, this might be explained by the difference in
methodology, as described in chapter 8. Although gastric nutrition did not
significantly raise the intragastric pH, it stimulated gastric colonization with ppmo,
which is in keeping with the main observations described in chapter 6.
Answers fo ffte
1. Can colonization of the upper respiratory tract be modulated without
influencing colonization of the colon? Colonization of the upper respiratory
tract can be modulated by a regimen of topical antimicrobial prophylaxis (TAP),
containing antimicrobial agents applied to the oropharynx and administered
into the stomach, but without decontaminating the intestine or administering
systemic prophylaxis.
2. Can colonization of the stomach be modulated by topical antimicrobial
prophylaxis of stomach and oropharynx? The TAP-regimen effectively
prevented gastric colonization.
3. Does continuous enterai feeding influence the protective effect of topical
antimicrobial prophylaxis of the stomach? The protective effects of the TAP-
regimen on gastric colonization decreased when continuous gastric nutrition
was administered simultaneously.
4. Does modulation of the bacterial flora of the upper respiratory tract by topical
antimicrobial prophylaxis influence colonization in other patients not-
receiving prophylaxis and treated within the same ICU-ward? Modulation of
colonization of the upper respiratory tract by TAP decreased colonization of
other patients, not-receiving TAP, treated within the same ICU, thereby
confirming the importance of cross-acquisition.
5. What is the role of the gastropulmonary route of colonization in the
pathogenesis of nosocomial pneumonia in mechanically ventilated patients?
Based on the results of 2 studies, described in this thesis, it seems unlikely that
the gastropulmonary route is important in the pathogenesis of pneumonia in
mechanically ventilated ICU-patients.
6. Do incidentally obtained measurements of acidity in aspirated gastric juice
accurately reflect 24 hour values of intragastric acidity, as obtained with
computerized continuous monitoring? Although color-scaled indicator papers
accurately measure pH values, incidental measurements of gastric acidity with
this method do not accurately reflect the median pH values obtained by
continuous 24 hour monitoring. Therefore, computerized continuous
intragastric pH monitoring is recommended when studying the influence of
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certain manoeuvres on intragastric acidity. The data regarding gastric pH from
studies where indicator papers were used should be interpreted with caution.
7. What is the influence of sucralfate on intragastric acidity as compared to high
dosages of antacids? Sucralfate (1 g/q4h) and Antagel (30 ml/q4h) had
comparable effects on intragastric acidity in mechanically ventilated patients,
irrespective of their initial gastric pH (above or below 3.0).
8. Does sucralfate influence colonization rates and the incidence of pneumonia as
compared to the effect of high dosages of antacids? The incidence of VAP and
colonization of the stomach, the oropharynx and the trachea were comparable
in patients receiving sucralfate or antacids.
9. What is the role of intragastric acidity and gastric colonization in the
pathogenesis of pneumonia in mechanically ventilated ICU-patients?
Intragastric acidity and gastric colonization are unlikely to be important in the
pathogenesis of VAP.
10. What is the influence of enterai feeding on intragastric acidity and gastric
colonization? Continuous gastric nutrition did not seem to raise intragastric
pH values, as determined with continuous monitoring, but continuous gastric
nutrition was associated with an increase in gastric colonization.
Remarks
The main feature of this thesis is that the gastropulmonary route of colonization is
unlikely to be important in the pathogenesis of pneumonia in mechanically
ventilated patients. This has, in our opinion, major implications for the
development of preventive regimens for this infection. According to our findings,
the use of sucralfate has no beneficial effects on the incidence of VAP.
Another feature of this thesis is the relationship between continuous gastric
nutrition and development of gastric colonization, and, interestingly, this relation
seemed to be independent of intragastric acidity. However, it was also
demonstrated that increased gastric colonization was not a risk factor for
colonization of the upper respiratory tract and pneumonia. The modulatory effect
of enterai feeding on gastric colonization, therefore, is an important issue for
further studies, although, based on this thesis, beneficial effects on colonization and
infection of the respiratory tract are not expected. The latter has been suggested by
several investigators, but these studies suffered from important methodological
drawbacks.
Instead of the stomach, the oropharynx seems to be the pivotal tissue in the
pathogenesis of VAP, since this was the initial site of colonization for most bacteria.
Therefore, modulation of the oropharyngeal flora should be the next step in
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studying the pathogenesis of VAP. Although two studies reported a reduced
incidence of VAP whit decontamination of the oropharynx, several other studies
did not demonstrate a beneficial effect of SDD, with oropharyngeal
decontamination incorporated. If the oropharynx really is crucial in the
pathogenesis, why then did oropharyngeal decontamination fail? In the first place,
application of non-absorbable antimicrobial agents into the oropharyngeal cavity
might have led to false negative culture results of oropharyngeal swabs. If so,
effective decontamination may have never occurred and the rapidly observed
colonization with Gram-negative bacteria after the application of the antibiotics
had been stopped, as reported by several investigators, would be explained as well.
Another explanation might be overgrowth and an increased number of infections
with Gram-positive bacteria, that are intrinsically resistant to the antimicrobial
agents used. Finally, it is possible that decontamination of the oropharynx
stimulates other routes of colonization leading to pneumonia, but this can only be
demonstrated when patterns of colonization are determined accurately. In
summary, a study looking at the effects of decontamination of the oropharyngeal
cavity with a combination of antimicrobial agents covering Gram-negative as well
as Gram-positive bacteria, and accurate monitoring of colonization patterns would
shed more light on these questions.
The studies described in this thesis also strongly suggest that so-called potential
pathogenic microorganisms have different colonization characteristics. For
instance, Pseudomonas aerug/nosa and Sfap/iy/ococcMs awreus colonized the
patient in most cases initially in the upper respiratory tract, whereas some species
of Enterobacteriaceae most frequently colonized the stomach first. Moreover,
within the group of Enterobacteriaceae differences in colonization patterns were
demonstrated between different species. These variable colonization patterns
indicate that different bacteria cause pneumonia via different routes. This species-
specific preference probably reflects the different capacity of bacteria to adhere to
different types of epithelial cells. For instance, a preference of Pseudomonns
aerugi'nosa to adhere to trachéal cells has been reported. In addition, the preference
for the initial site of colonization might reflect the importance of the different
routes of colonization present in the ICU. In line with this hypothesis, the
colonization rates and etiology of ventilator-associated pneumonia within an ICU
might reflect the importance of the responsible routes of colonization. High
colonization rates with one particular species and an important etiologic role of
that species, known to preferentially colonize patients via the exogenous route,
might indicate that infection prevention could be achieved by improving hygienic
procedures. On the other hand, the predominance of species preferentially
colonizing the upper respiratory tract via the stomach would suggest that
interruption of the gastropulmonary route might decrease colonization and
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infection rates. Therefore, adequate microbiological monitoring of colonization and
infection might guide the strategy of infection prevention.
If the gastropulmonary route of colonization is of minor importance in the
pathogenesis of VAP, where do the bacteria come from? The results of the different
studies demonstrated that the oropharynx was the pivotal tissue, suggesting
colonization via exogenous routes. However, this does not imply that the sources
of these bacteria are exogenous as well. For instance, bacteria colonizing the rectum
might reach the oropharynx, either after colonization of the skin or via vectors,
such as hands of the nursing and medical staff. When studying this recto-
oropharyngeal route of colonization, it will be essential to determine the identity of
bacteria colonizing the patient at different sites. It is also possible that
phenotypically similar but genotypically different species colonize a patient, both at
different sites as well as in one culture site simultaneously. Molecular biochemical
techniques are indispensable for answering these questions.
Besides the intestine, other patients treated in the ICU-ward proved to be important
sources of bacteria as well. Therefore, cross-acquisition is important in the ICU,
although its existence in most cases cannot be demonstrated easily. The hands of
the nursing and medical staff have been demonstrated to be the most important
vector for transmission of microorganisms from patient to patient. Strict hygienic
procedures are therefore of major importance within the ICU. However, they
probably never will abandon cross-acquisition, especially not when the patient-
nurse ratio further increases, indicating increasing number of contacts with
different patients for each nurse. On the other hand, cross-acquisition might be
imperceptibly present. For instance, spreading of typical ICU-bacteria with a normal
antibiotic susceptibility pattern is hard to detect, and cases of cross-acquisition
probably go unnoticed. The only alternative is to study cross-acquisition within the
ICU with molecular biological typing methods.
Active prevention of colonization of the upper respiratory tract with topical
antibiotics might be an option to decrease cross-acquisition. Patients with an
expected long ICU-stay and not treated in isolation might be candidates to receive
prophylaxis. The hypothesis is that topical antimicrobial prophylaxis can be used to
protect other patients in the ICU, which is the opposite of the principle of SDD. In
SDD decontamination of the whole intestinal tract was achieved to protect the
individual patient against infection, and as a matter of fact it was advocated to use
SDD in all patients admitted to the ICU, since bacteria colonizing non-
decontaminated patients might, exogenously, colonize patients receiving SDD as
well.
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The importance of each of theses routes of colonization should be elucidated, in
order to develop effective preventive regimens. A predominant pathogen within
an ICU might be the first indication of the predominant route of colonization. It is
also imaginable, that the impact of each route of transmission differs between
ICU's, and in that case individual ICU's would need different preventive regimens.
In addition, the continuous care to prevent contamination of medical equipment
or enterai nutrition remains mandatory.
In conclusion, the studies on the pathogenesis of ventilator associated pneumonia
demonstrate that the gastropulmonary route of colonization probably is not
important, that the oropharynx seems to the pivotal source in the pathogenesis,
that cross-acquisition is important within the ICU, and that enterai feeding may
influence gastric colonization. However, ventilator-associated pneumonia still is
the most important ICU-infection, with an enormous impact on morbidity,
antibiotic use, antibiotic resistance, medical costs, and possibly mortality.
Prevention of this infection, therefore, remains warranted, but this can only be
instituted successfully if and when the pathogenesis of this infection has been
elucidated.
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Dit proefschrift beschrijft studies over de roi van bacteriële kolonisatie van het
bovenste deel van de tractus digestivus in de pathogenese van nosocomiale
pneumonie bij mechanisch beademde IC-patiënten. Nosocomiale pneumonie,
soms ook secundaire pneumonie genoemd, is een infectie die optreedt nadat de
patient minimaal drie dagen in het ziekenhuis is opgenomen. Bij mechanisch
beademde IC-patiënten wordt nosocomiale pneumonie ook wel "ventilator-
associated pneumonia" (VAP) genoemd. In hoofdstuk 1 wordt een overzicht
gegeven van verschillende hypothesen omtrent de pathogenese van VAP. Het is
algemeen geaccepteerd dat de meeste bactérien die VAP veroorzaken afkomstig
zijn van een endogeen reservoir, de tractus digestivus. De gastropulmonale route
van kolonisatie geldt als het belangrijkste pathogenetisch model voor het ontstaan
van VAP. Volgens deze hypothèse koloniseren bactérien de maag, waarna
kolonisatie van de orofarynx en aspiratie van bactérien in de luchtwegen optreedt.
De zuurgraad van de maag speelt een belangrijke rol in dit model. Bij gezonde
mensen is de intragastrische zuurgraad hoog, waardoor bactérien niet kunnen
overleven. Bij ernstig zieke en beademde IC-patiënten kan de zuurgraad om een
aatal redenen verlaagd zijn. Een belangrijke oorzaak hiervoor is stress ulcus
profylaxe, welke de patiënten krijgen ter bescherming van de maag. De meeste
middelen beschermen de maag door de zuurgraad te verlagen. Een bijkomend
effect is dat bactérien nu wel in staat zijn in de maag te overleven. Ook
sondevoeding zou een dergelijk effect kunnen veroorzaken.
Hoewel op basis van de gastropulmonale route verschillende preventieve
strategieën zijn ontwikkeld, leveren de literatuurdata geen sluitende bewijzen
voor deze hypothèse. De klinische voordelen van deze strategieën (b.v. selectieve
darmdecontaminatie en het gebruik van sucralfaat voor stress ulcus profylaxe)
staan echter nog steeds ter discussie. De meeste studies die preventie van VAP
hebben bestudeerd vertonen ernstige methodologische tekortkomingen (hoofdstuk
1). Zoals bijvoorbeeld het niet adekwaat diagnostiseren van VAP, het niet in de tijd
bestuderen van kolonisatie op verschillende plaatsen in het lichaam, en het niet
betrouwbaar meten van veranderingen van de zuurgraad in de maag.
Selectieve decontaminatie van de tractus digestivus (SDD) is in dit kader de meest
gebruikte en bestudeerde méthode van infectie preventie. Bij deze méthode
worden niet-resorbeerbare antibiotica aangebracht in de orofarynx, maag en darm.
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De gebruikte antimicrobiële middelen zijn gericht tegen de belangrijkste
verwekkers van VAP: Enterobacteriaceae, Pseudomonas aeruginosa en
Sfap/iy/ococcMS aurews, de zogenaamde potentieel pathogène micro-organismen
(ppmo's). De anaerobe bactérien worden niet geëlimineerd, vandaar "selectieve"
decontaminatie. Men verondersteldt dat deze anaerobe bactérien de kolonisatie
resistentie verhogen. Ondanks een groot aantal studies is het effect van SDD niet
onomstotelijk vastgesteld, mede doordat interpretatie van de meeste voor 1990
verrichte studies ernstig bemoeilijkt wordt door methodologische tekortkomingen.
Zeven SDD-studies, gepubliceerd na 1991, worden besproken in hoofdstuk 2. In
tegenstelling tot eerder uitgevoerde studies waren deze studies alien prospectief
gerandomiseerd met minimaal 100 patiënten. Zes studies waren placebo-
gecontroleerd en drie studies waren dubbel-blind. Slechts twee studies toonden een
significante vermindering van het aantal IC-verworven pneumonieën bij
patiënten die SDD kregen. Daarnaast tonen de gegevens van deze studies en van
andere récente publikaties aan, dat het gebruik van SDD leidt tot kolonisatie en
infecties met Gram-positieve bactérien en tot een toename van het aantal bactérien
résistent voor de in SDD gebruikte antibiotica. Daarnaast gaat het gebruik van SDD
gepaard met extra kosten. Geconcludeerd wordt dat deze recent gepubliceerde
studies geen positief effect van SDD op mortaliteit, incidentie van VAP of andere
parameters, zoals beademingsduur en opnameduur, aantonen.
Een accurate diagnose van pneumonie is essentieel wanneer pathogenese en
preventie van deze infectie bestudeerd worden. De problemen die met de
diagnostiek van VAP gepaard kunnen gaan worden beschreven in hoofdstuk 3.
Omdat de meeste IC-patiënten gekoloniseerd zijn met bactérien in de bovenste
luchtwegen, kan het onderscheid tussen kolonisatie en infectie vaak niet gemaakt
worden. Daarnaast zijn thoraxfoto's van bedlegerige IC-patiënten moeilijk te
interpreteren en daardoor niet betrouwbaar genoeg om de diagnose VAP te stellen
of te verwerpen, zelfs niet in combinatie met klinische parameters.
Bronchoscopische technieken, zoals de "protected specimen brush" (PSB) en
"bronchoalveolaire lavage" (BAL) zijn ontwikkeld om materiaal uit de onderste
luchtwegen te verkrijgen zonder verontreiniging met bactérien van de bovenste
luchtwegen. Kwantitatieve microbiologische analyse van deze monsters, in
combinatie met klinische parameters van infectie en interpretatie van thoraxfoto's,
is waarschijnlijk de beste méthode om VAP te diagnostiseren. Verschillende
studies beschrijven een goede sensitiviteit en acceptabele specificiteit voor de
diagnose VAP met deze methoden. In allé studies, beschreven in dit proefschrift,
wordt de diagnose VAP gesteld op basis van kwantitatieve microbiologische
kweken van monsters verkregen via PSB en/of BAL in combinatie met klinische
parameters en thoraxfoto's.
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In hoofdstuk 5 wordt de invloed van lokale antimicrobiële profylaxe ("topical
antimicrobial prophylaxis" =TAP) van orofarynx en maag op kolonisatie van de
bovenste luchtwegen bestudeerd. In tegenstelling tot de conventionele SDD-
methode is geen darm decontaminatie nagestreefd en is geen systemische profylaxe
gegeven. Teneinde de aerobe en anaerobe darmflora in stand te houden, zijn, ten
opzichte van SDD-schema's, geringere hoeveelheden niet-resorbeerbare antibiotica
in de maag gegeven. De resultaten van deze studie tonen aan dat kolonisatie van
luchtwegen met ppmo kan worden voorkomen zonder de darmflora te
beinvloeden. Echter, bij patiënten die TAP krijgen, wordt vaak kolonisatie van de
bovenste luchtwegen met Gram-positieve bactérien, vooral Enterococcus /aeca/is,
waargenomen. Deze bactérien zijn intrinsiek résistent voor de gebruikte
antibiotica. Van de in totaal 61 patiënten die TAP kregen, ontwikkelden zes een
polymicrobiële pneumonie en twee een bacteriëmie met Enferococcus /aeca//s; deze
bactérie veroorzaakt normaal gesproken geen infecties van de luchtwegen.
In hoofdstuk 6 is de maagkolonisatie bestudeerd bij patiënten die wel en geen TAP
hebben gekregen. TAP in combinatie met sucralfaat als stress ulcus profylaxe
voorkomt maagkolonisatie. Patiënten die stress ulcus profylaxe krijgen met
middelen die de zuurgraad van de maag verminderen zijn vaker gekoloniseerd in
de maag. In beide patiëntengroepen treedt maagkolonisatie frequenter en sneller op
indien sondevoeding gegeven wordt.
In hoofdstuk 7 is het effect van TAP op kolonisatie van de bovenste luchtwegen
bestudeerd bij een groep patiënten die TAP kregen (n=22) en bij twee groepen
patiënten die geen TAP kregen. Deze twee contrôle groepen bestonden uit
patiënten die in dezelfde IC-afdeling (n=21) verpleegd en bestudeerd werden als de
patiënten met TAP-medicatie en uit patiënten die in een IC-afdeling werden
bestudeerd (n=54) waar geen enkele patient TAP kreeg. Kolonisatie van orofarynx
en trachea trad minder vaak op bij patiënten die TAP kregen vergeleken met
patiënten die geen TAP kregen. Binnnen de twee contrôle groepen werden echter
eveneens verschillen in kolonisatie gevonden: Patiënten die bestudeerd werden in
de IC waar de andere helft van de patiënten TAP kreeg, waren minder vaak
gekoloniseerd dan de andere contrôle groep. Daarnaast bleven patiënten die nog «
niet gekoloniseerd waren bij opname en die opgenomen werden op de IC-afdeling
waar TAP-medicatie gegeven werd, langer kolonisatie vrij. In de IC-afdeling waar
geen TAP gegeven werd waren meer patiënten gelijktijdig gekoloniseerd en trad
ook vaker kruis-acquisitie op. Deze studie toont aan dat TAP de kolonisatie van
orofarynx en trachea beinvloedt, zowel bij patiënten die TAP krijgen als bij .?
patiënten die geen TAP krijgen maar die in dezelfde afdeling verpleegd worden.
Dit is een duidelijke aanwijzing dat kruis-acquisitie een belangrijke rol speelt bij de
kolonisatie van patiënten in de Intensive Care.
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In hoofdstuk 8 wordt de methodiek van het meten van de intragastrische
zuurgraad bestudeerd. In andere studies, onder andere hoofdstuk 6, is de
intragastrische zuurgraad van geaspireerd maagsap bepaald met behulp van kleur-
indicator papiertjes, waarbij de frequentie van metingen varieerde tussen zesmaal
daags tot twee maal per week. Deze méthode werd om verschillende redenen
echter ter discussie gesteld. In de eerste plaats worden vraagtekens geplaatst bij de
betrouwbaarheid van de kleur-indicator papiertjes. Daarnaast wordt bij het gebruik
van deze méthode een grote inter-observer variatie gevonden. Ook is het
onwaarschijnlijk dat incidentele metingen een representatieve weergave zijn van
veranderingen van de intragastrische zuurgraad. Deze problemen kunnen
voorkomen worden door gebruik te maken van gecomputeriseerde continue
intragastrische pH-registratie, een méthode die betrouwbaar en reproduceerbaar is.
In hoofdstuk 8 wordt de betrouwbaarheid van kleur-indicator papiertjes bestudeerd
en vergeleken met de resultaten van een continue intragastrische 24-uurs meting.
De betrouwbaarheid van de kleur-indicator papiertjes - geverifieerd met een
laboratorium pH-meter - is hoog, zowel in kleurloze vloeistof als in geaspireerd
maagsap. Anderzijds blijkt de correlatie tussen de pH-waarde van de eenmaal
daagse meting in geaspireerd maagsap en de médiane pH-waarde van de 24-uurs
meting slecht te zijn, waarschijnlijk omdat veranderingen in pH met een
eenmalige meting gemist worden. De continue intragastrische pH-registratie dient
daarom gebruikt te worden indien modulatie van de intragastrische zuurgraad
bestudeerd wordt.
In hoofdstuk 9 worden kolonisatie van maag, orofarynx en trachea bij 64 patiënten
gedurende de gehele IC-opname bestudeerd, teneinde chronologische kolonisatie
patronen te analyseren. Elf patiënten ontwikkelden een VAP, waarbij met behulp
van PSB en/of BAL in totaal 20 micro-organismen als verwekkers werden
geidentificeerd. Voorafgaande aan, of op de dag van de diagnose VAP werden 17
van deze micro-organismen geïsoleerd uit de trachea en zes uit de maag. Voor geen
van deze zes bactérien kon een kolonisatie patroon van de maag naar de bovenste
luchtwegen worden aangetoond. De initiële plaats van kolonisatie van
Psewdomonas aeru^inoso en Enterobacter spp. was vaker de trachea dan de maag.
Anderzijds werden species zoals Klebsiella spp. en Enferococcus /«eca/i's vaker als
eerste in de maag aangetroffen. De resultaten van deze studie suggereren dat de
maag in de pathogenese van VAP geen belangrijke bron van bactérien is. Tevens
werd aangetoond dat de initiële plek en route van kolonisatie waarschijnlijk
verschillend zijn voor verschillende soorten bactérien.
De invloed van de intragastrische zuurgraad op maagkolonisatie, kolonisatie van
de bovenste luchtwegen en de incidentie van VAP is bestudeerd in hoofdstuk 10.
In deze studie is eveneens de invloed van twee verschillende middelen van stress
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ulcus profylaxe - sucralfaat en antacida - op deze parameters vergeleken. Deze
vergelijking is prospectief, gerandomiseerd en dubbel-blind gedaan, waarbij de
patiënten gestratificeerd zijn op de initiële intragastrische pH. Tussen beide
middelen werden geen significante verschillen in intragastrische zuurgraad
aangetoond. Ook kolonisatie in de maag, orofarynx en trachea met ppmo waren
vergelijkbaar in beide behandelingsgroepen. Patiënten gekoloniseerd met ppmo in
de maag hadden een significant hogere médiane intragastrische pH vergeleken met
niet-gekoloniseerde patiënten, waarmee de relatie tussen zuurgraad en maag
kolonisatie bevestigd werd. Er werden echter geen significante verschillen
aangetoond in intragastrische zuurgraad tussen patiënten die wel en niet
gekoloniseerd waren met ppmo in de bovenste luchtwegen. Daarnaast werden
kolonisatie patronen van de maag naar de trachea slechts twee maal aangetoond
voor Enterobacteriaceae en vier maal voor Psewdomowas aerugiMosa bij 141
patiënten. Analoog aan de kolonisatie data werden geen verschillen gevonden in
de incidentie van VAP tussen beide behandelingsgroepen (22% in beide); slechts
één van de 48 geïsoleerde verwekkers die een VAP veroorzaakten werd initieel in
de maag gevonden. De resultaten van deze studie bevestigen de resultaten van de
studie beschreven in hoofdstuk 9 en suggereren nogmaals dat de maag in de
pathogenese van VAP geen belangrijke bron van bactérien is. Daarnaast is
aangetoond dat sucralfaat en antacida een vergelijkbaar effect hebben op de
intragastrische zuurgraad en dat sucralfaat geen bescherming biedt tegen het
ontstaan van een VAP. Een andere observatie van deze studie is, dat de orofarynx
en trachea de belangrijkste initiële plekken van kolonisatie zijn. Dit suggereert een
belangrijk aandeel van exogène routes voor kolonisatie, analoog aan de resultaten
beschreven in hoofdstuk 7.
In hoofdstuk 10 is tevens de invloed van sondevoeding op intragastrische
zuurgTaad en maagkolonisatie bestudeerd. In tegenstelling tot de resultaten van
andere studies lijkt het geven van sondevoeding de intragastrische zuurgraad niet
te beïnvloeden. Deze schijnbare tegenstelling met de resultaten van andere studies
kan echter het gevolg geweest zijn van verschillen in methodiek zoals beschreven
in hoofdstuk 8. Hoewel sondevoeding geen wezenlijk effect heeft op de
intragastrische zuurgraad, lijkt er wel een duidelijk stimulerend effect te zijn op
het ontstaan van maagkolonisatie met ppmo, waarmee de resultaten beschreven in
hoofdstuk 6 ten dele bevestigd worden.
Samenvattend kan gesteld worden, dat de studies beschreven in dit proefschrift
aantonen dat maagkolonisatie geen belangrijke rol speelt in de pathogenese van
"ventilator-associated pneumonia". In het pathogenetisch model van deze infectie
lijken kolonisatie van orofarynx en kruis-acquisitie binnen de IC-afdeling
belangrijk. Tevens suggereren de verschillende studies dat sondevoeding een
stimulerend effect heeft op maagkolonisatie.
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Naschrift
In de 30 maanden die uiteindelijk tot dit proefschrift leidden is er waarschijnlijk
even vaak over voetbal als over wetenschap gesproken. Elke maandagochtend en
de meeste donderdagochtenden begonnen met een grondige analyse van de
gebeurtenissen van de dag of avond voorafgaande. Uiteindelijk waren we het er
altijd over eens dat zowel Ajax als het Nederlands elftal, om maar te zwijgen van
Feyenoord, zwaar te lijden hadden van het feit dat wij voor een medische beroep
gekozen hadden in plaats van een carrière als voetbalcoach.
In feite had ons onderzoeksgroepje veel weg van een voetbalteam. Een nieuw team
dat nog niet ingespeeld was en dat zijn plaats in de competitie nog moest
verwerven.
Het 'Dreh-und-Angelpunkt' van het team was zonder enige twijfel Carlo Gaillard.
Carlo, jij bedacht de taktiek, leidde de verdediging en zette de aanval op. Als het
even tegenzat schroomde je de tackle niet. Door je snelheid van handelen, je
inzicht en je creativiteit was je van onmisbare waarde. Je was het type speler
waarvan gezegd wordt dat je hem kost wat kost moet behouden. Helaas is dat
laatste inmiddels mislukt, maar ik hoop ook in de toekomst nog onderzoek met je
te doen.
De funderingen van het middenveld werden links en rechts gevormd door Ellen
Stobberingh en Siebe van der Geest. Ellen, jij was het loopwonder. Je was
voortdurend in beweging, kwam regelmatig ergens te laat en eenmaal aangekomen
stond je altijd weer op het punt om te vertrekken. Gelukkig bleef je er altijd (nou
ja, bijna altijd) bij lachen. Daarnaast ben ik spéciale dank aan je verschuldigd omdat
je mij in dit team introduceerde. Siebe, jij vormde het aanspreekpunt binnen de IC.
Daarnaast kon je de dagelijkse zaken uitstekend relativeren door het onderwerp
van gesprek te verleggen naar echt belangrijke dingen van het leven, zoals eten en
drinken, vakanties en de herinneringen aan het studentenleven. Het viermans
middenveld werd gecomplementeerd door Frank van Tiel, die aile fouten
corrigeerde en de punrjes op de i zette.
De aanval begint bij de verdediging. De centrale positie hierin werd voortdurend
door vrouwen bezet. In chronologische volgorde verzetten jullie, Wanda,
Monique en Ingrid, letterlijk bergen werk. Ook al werd de druk soms groot en
leken de petri-schalen tot aan het plafond te groeien, er ontstond hooguit lichte
paniek en uiteindelijk werd allés met grote (en Belgische) accuratesse verwerkt.
De flanken van de verdediging werden afgedekt door de beide paranymfen. Hans
Smeets bekeek meer dan duizend thoraxfoto's en wordt dus van harte bedankt
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voor zijn inzicht. Albert Froon hield het al die tijd met mij uit in een kamertje van
drie bij drie zonder daglicht of ventilatie. Menigeen zou inmiddels met
lichamelijke en/of geestelijke verwondingen het speelveld verlaten hebben. Naast
de gezelligheid en collegialiteit bedank ik je speciaal voor het verzorgen van de lay-
out van dit proefschrift. De beste herinneringen aan jullie beiden bewaar ik aan de
momenten dat we de zaken en de glazen nog eens op een rijtje zetten aan de bar.
De doelman heeft de ondankbare taak de gemaakte fouten te corrigeren en kan
zichzelf geen enkele misstap veroorloven. Gelukkig werd het doel verdedigd door
Jolanda, mijn vriendin. Altijd op de post, onberispelijk en streng wanneer er
fouten gemaakt of taken niet uitgevoerd werden. Het nadeel voor de doelman is
dat hij/zij weleens te weinig in het spel betrokken wordt. Daarom draaien we de
rollen nu maar om. Jij gaat lekker promoveren en ik kijk toe.
Tenslotte de aanval. Volgens goed (?) Nederlands gebruik werd er met twee
vleugelspitsen gespeeld. De linkerzijde werd bezet door de verpleging van E3 de
rechter door de verpleging van D3. Net als in Oranje vormden jullie het
kwetsbaarste deel van de ploeg. Want als het op de vleugels niet 'marcheert' komt
er geen gevaarlijke bal voor het doel. Maar het 'marcheerde' prima: Geen vraag
was teveel en op elke dieptepass werd gerend. Bedankt voor jullie inzet en
betrokkenheid.
De spits tenslotte was ikzelf. Niet echt beweeglijk, een paar kilo te zwaar, liever lui
dan moe, zelfzuchtig en eigenwijs. Een probleem was dat niet. Mijn taak bestond
eruit de niet te missen kansen voor open doel af te ronden. Allemaal bedankt.
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